index,study_id,id,author,year,group,group_id,group_desc,url,country,region,city,time_MAX,time_50,MissingTime50,time_MIN,detailed_time,exp_dur,fu_dur,age_base,age_category,age_SD,days_ps,days_cat,yrs_ps,stroke_type,nihss_base,mmse_base,mMmse_base,fim_base,brunstrom_base,frenchay_base,fac_base,barthel_base,mBarthel_base,motricity_base,BBS_base,BBT_base,gcs_base,MAS_base,sis_base,rivermead_base,ashworth_base,mAshworth_base,rankin_base,bdi_base,cesd_base,ops_base,terminal_dropout,outcome_name,outcome_extremity,ue_subscale,le_subscale,outcomenamecat,SCOAR_outcome,p_outcome_stated,itt_analysis,base_n,base_m,base_sd,difference_score,term_n,term_m,term_sd,diff_base,diff_term,fu_n,fu_m,fu_sd,est_corr,term_diff,term_s_diff,fu_diff,fu_s_diff,term_d,fu_d,j_corr_factor,term_g,MissingTermG,MissingData,fu_g,term_Vd,fu_Vd,term_Vg,termvginv,fu_Vg,chck2,notes
464,132,partridge2000,partridge,2000,ctrl,297,conventional PT,http://www.ncbi.nlm.nih.gov/pubmed/11129665,UK,canterbury,canterbury,15,15,Time 50 OK,15,1,42,180,,Not Available,,0,NA,,0,,,,,,,,,,,,,,,,,,,,,,,4,profiles of recovery,,,,other,lohse,1,0,60,5.1,4.1,,56,9.8,4.6,,,49,10.1,3.3,0.5,4.7,4.348411688,5,3.762219965,1.080854422,1.329002569,0.987234043,1.06705628,Term G OK,All OK,1.312036579,0.026402052,0.031385399,0.02573226,38.86172454,0.030589184,,
465,132,partridge2000,partridge,2000,exp,298,CPT + CPT,http://www.ncbi.nlm.nih.gov/pubmed/11129665,UK,canterbury,canterbury,30,30,Time 50 OK,30,1,42,180,,Not Available,,0,NA,,0,,,,,,,,,,,,,,,,,,,,,,,2,profiles of recovery,,,,other,lohse,1,0,54,4.6,4.1,,52,9.5,4.2,,,44,9,4.2,0.5,4.9,4.149339614,4.4,4.145089967,1.180910809,1.061496864,0.985781991,1.164120608,Term G OK,All OK,1.046404491,0.031431022,0.028951626,0.030543602,32.74008089,0.028134209,,
717,197,winstein2004,winstein,2004,ctrl,447,standard care,http://www.ncbi.nlm.nih.gov/pubmed/15083439,USA,CA,los angeles,20,20,Time 50 OK,20,2,28,270,,Not Available,,15.4,<90days,0.042191781,1,,,,61.35,,,,,,,,,,,,,,,,,,3.645,0,fma-ue,ue,fma,,fma,lohse,1,0,20,23.55,22.31,1,20,32.6,,0,1,15,40.93,,0.5,9.05,22.31,17.38,22.31,0.405647692,0.77902286,0.96,0.389421784,Term G OK,All OK,0.747861945,0.054113751,0.065171915,0.049871233,20.05163979,0.060062437,Yes,
718,197,winstein2004,winstein,2004,exp,448,strength training,http://www.ncbi.nlm.nih.gov/pubmed/15083439,USA,CA,los angeles,40,40,Time 50 OK,40,2,28,270,,Not Available,,17.3,<90days,0.04739726,1,,,,62.5,,,,,,,,,,,,,,,,,,3.645,0,fma-ue,ue,fma,,fma,lohse,1,0,20,19.85,19.56,1,20,38.05,,0,1,16,43.43,9.11,0.5,18.2,19.56,23.58,15.82455268,0.930470348,1.490089513,0.96,0.893251534,Term G OK,All OK,1.430485932,0.071644377,0.105509169,0.066027458,15.14521428,0.09723725,Yes,
719,197,winstein2004,winstein,2004,exp,449,function task,http://www.ncbi.nlm.nih.gov/pubmed/15083439,USA,CA,los angeles,40,40,Time 50 OK,40,2,28,270,,Not Available,,15.5,<90days,0.042465753,1,,,,59.55,,,,,,,,,,,,,,,,,,3.91,0,fma-ue,ue,fma,,fma,lohse,1,0,20,18.7,16.4,1,20,35.2,,0,1,13,40.97,4.49,0.5,16.5,16.4,22.27,13.13964845,1.006097561,1.694870307,0.96,0.965853659,Term G OK,All OK,1.627075495,0.075305808,0.121814634,0.069401832,14.40884154,0.112264367,Yes,
275,82,kim2012,kim,2012,exp,181,therapy games using nintendo wii,https://www.jstage.jst.go.jp/article/jpts/24/9/24_901/_pdf,South korea,seoul,seoul,4.5,4.5,Time 50 OK,4.5,1,21,,41.3,25th Percentile,,378,>1year,1.035616438,0,,25.14,,,,,,,,,,,,,,,,,,,,,0,fim,,,,other,lohse,0,0,10,101.5,13.64,,10,103.3,4.32,,,10,,,0.5,1.8,10.11711421,,13.64,0.177916347,,0.914285714,0.162666374,Term G OK,All OK,,0.101582711,,0.084914854,11.77650261,,,
25,10,bolognini2011,bolognini,2011,exp,21,tDCS + CIMT,http://www.ncbi.nlm.nih.gov/pubmed/21803933,Italy,milan,milan,184,112,Time 50 OK,40,1,14,42,42.57,25th Percentile,,1332,>1year,3.649315068,1,,29.42,,,,,,17.86,,,,,,,,,,,,6.8,,,0,jebsen taylor hand function,ue,,,other,lohse,1,0,7,100.65,103.005,,7,67.97,93.37,,,7,72.16,91.15,0.5,-32.68,98.30561257,-28.49,97.25829663,0.332432698,0.292931308,0.869565217,0.289071911,Term G OK,All OK,0.254722876,0.150750821,0.148986339,0.113989279,8.772754848,0.112655077,,reverse the sign for a time based DV; means and SDs estimated from figure 2
181,54,han2013,han,2013,exp,117,CPT at additional increased intensity,http://www.ncbi.nlm.nih.gov/pubmed/22801472,China,shandong,shandong,90,90,Time 50 OK,90,1,42,84,44.6,25th Percentile,,38.3,<90days,0.104931507,1,,,,,,,,50.5,,,,,,,,,,<3,,,,,1,fma-ue,ue,fma,,fma,lohse,0,0,10,6.5,3.06,,10,12.4,5.5,,,10,24.5,7.96,0.5,5.9,4.45048312,18,6.03014096,1.32569877,2.985004848,0.914285714,1.212067447,Term G OK,All OK,2.72914729,0.187873862,0.545512697,0.157047212,6.367511956,0.456004083,,
44,18,chan2009,chan,2009,ctrl,38,bilateral OT without FES,http://www.ncbi.nlm.nih.gov/pubmed/19074684,China,hong kong,hong kong,20,20,Time 50 OK,20,,,,45,25th Percentile,,363,<1year,0.994520548,0,,27.4,,,,,,,,,,,15,,,,,,,,,,0,functiol test of the hemiparetic UE,ue,,,other,lohse,1,1,10,2.8,0.6,,10,3.1,0.6,,,,,,0.5,0.3,0.6,,0.6,0.5,,0.914285714,0.457142857,Term G OK,All OK,,0.1125,,0.094040816,10.63368059,,,
45,18,chan2009,chan,2009,exp,39,bilateral OT with FES,http://www.ncbi.nlm.nih.gov/pubmed/19074684,China,hong kong,hong kong,20,20,Time 50 OK,20,,,,46,25th Percentile,,543,>1year,1.487671233,0,,27.3,,,,,,,,,,,15,,,,,,,,,,0,functiol test of the hemiparetic UE,ue,,,other,lohse,1,1,10,2.4,0.8,,10,3.7,0.5,,,,,,0.5,1.3,0.667083203,,0.8,1.948782391,,0.914285714,1.781743901,Term G OK,All OK,,0.28988764,,0.242322403,4.12673359,,,
439,125,pandian2012,pandian,2012,exp,279,brunnstrom based therapy,http://www.ncbi.nlm.nih.gov/pubmed/22703742,India,new delhi,new delhi,12,12,Time 50 OK,12,1,28,,47.4,25th Percentile,,1016.1,>1year,2.783835616,1,,,,,,,,,,,,,,,,,,,,,,,0,fma-wh,ue,fma,,fma,lohse,0,0,15,14.67,6.1,,15,18.47,4.38,,,,,,0.5,3.8,5.310103577,,6.1,0.715616926,,0.945454545,0.676583276,Term G OK,All OK,,0.08373692,,0.074851117,13.35985407,,,
747,207,yang2010,yang,2010,exp,473,late intervention BWSTT,http://www.ncbi.nlm.nih.gov/pubmed/20382280,Taiwan,taipei,taipei,10,10,Time 50 OK,10,1,28,,48.1,25th Percentile,13.64,1058.5,>1year,2.9,0,,,,,,,,,,,,,,,,,,,,,,,0,fma-le,le,,,other,lohse,0,0,5,23.6,2.5,,5,28.4,3.6,,,5,,,0.5,4.8,3.099193443,,2.5,1.54879006,,0.8,1.239032048,Term G OK,All OK,,0.439875065,,0.281520042,3.552144966,,,
12,5,arya2012,arya,2012,ctrl,10,standard care,http://www.ncbi.nlm.nih.gov/pubmed/22668675,India,uttar pradesh,lucknow,20,20,Time 50 OK,20,1,28,56,50.21,25th Percentile,,86.59,<90days,0.237232877,1,5.29,,,,,,,,,,,,,,,,,,,,,,0,fma-ue,ue,fma,,fma,lohse,0,1,52,9.88,8.82,,52,16.42,11.16,0,0,52,19,12.09,0.5,6.54,10.05828017,9.12,10.5820721,0.650210562,0.861834989,0.985221675,0.640601539,Term G OK,All OK,0.849098512,0.023295902,0.026372688,0.022612441,44.22344319,0.025598959,Yes,
628,172,taub2006,taub,2006,ctrl,392,general fitness,http://stroke.ahajournals.org/content/37/4/1045.abstract,USA,AL,birmingham,60,60,Time 50 OK,60,1,14,730,50.7,25th Percentile,,1934.5,>1year,5.3,0,,,,,,,,,,,,,,,,,,,,,,,0,actual amount of use test,,,,other,lohse,0,0,20,1,0.7,,20,0.9,0.6,,,,,,0.5,-0.1,0.651920241,,0.7,-0.153392998,,0.96,-0.147257278,Term G OK,All OK,,0.050588235,,0.046622118,21.449047,,Yes,
24,10,bolognini2011,bolognini,2011,ctrl,20,sham tDCS + CIMT,http://www.ncbi.nlm.nih.gov/pubmed/21803933,Italy,milan,milan,184,112,Time 50 OK,40,1,14,42,50.8,25th Percentile,,780,>1year,2.136986301,1,,29.57,,,,,,15.14,,,,,,,,,,,,12,,,0,jebsen taylor hand function,ue,,,other,lohse,1,0,7,95.68,105.8,,7,81.83,105.8,,,7,86.79,99.59,0.5,-13.85,105.8,-8.89,102.7419294,0.130907372,0.086527478,0.869565217,0.113832498,Term G OK,All OK,0.075241285,0.144081196,0.143391929,0.108946084,9.178852174,0.108424899,,reverse the sign for a time based DV; means and SDs estimated from figure 2
473,134,peurala2005,peurala,2005,exp,302,BWS gait training + CPT,http://www.ncbi.nlm.nih.gov/pubmed/16084808,Finland,kuopio,kuopio,20.4,20.4,Time 50 OK,20.4,3,21,,51.2,25th Percentile,7.9,876,>1year,2.4,1,,,,,,,4,,,,,,,,,,,,,,,,0,10mwt MAX,le,,speed,speed,lohse,0,0,15,39.6,35.4,,15,30.3,23.6,,,14,,,0.5,-9.3,30.08421513,,35.4,0.309132213,,0.945454545,0.292270456,Term G OK,All OK,,0.069852091,,0.062439687,16.01545504,,,sign reversed for time measure
681,188,waldman2013,waldman,2013,exp,427,training using a portable robot,http://www.ncbi.nlm.nih.gov/pubmed/23648617,USA,IL,evanston,9,9,Time 50 OK,9,3,42,84,51.3,25th Percentile,8,1239,>1year,3.394520548,0,,,,,,,,,,,,,,,,,,,,,,,1,STREAM,,,,other,lohse,0,0,12,28.9,5,,11,33,7.1,,,11,33.2,8.8,0.5,4.1,6.090976933,4.3,7.069047218,0.673126831,0.608285653,0.930232558,0.626164494,Term G OK,All OK,0.565847119,0.102212489,0.098750476,0.0884478,11.30610371,0.085452008,,
450,129,park2013,park,2013,exp,287,overground gait training,https://www.jstage.jst.go.jp/article/jpts/25/4/25_2012-353/_pdf,South korea,daejeon,daejeon,20,20,Time 50 OK,20,1,28,,51.3,25th Percentile,11,495,>1year,1.356164384,1,,>23,,,,,4,,,,,,,,,,,,,,,,0,6minwt,le,,capacity,capacity,lohse,0,0,10,92.5,19.9,,10,121,26.1,,,,,,0.5,28.5,23.20797277,,19.9,1.22802626,,0.914285714,1.122766866,Term G OK,All OK,,0.175402425,,0.146622109,6.820253827,,,
13,5,arya2012,arya,2012,exp,11,"""meaningful"" task specific therapy",http://www.ncbi.nlm.nih.gov/pubmed/22668675,India,uttar pradesh,lucknow,20,20,Time 50 OK,20,1,28,56,51.67,25th Percentile,,83.44,<90days,0.22860274,1,5.63,,,,,,,,,,,,,,,,,,,,,,0,fma-ue,ue,fma,,fma,lohse,0,1,51,11.98,9.74,,51,29,14.7,0,0,51,32.02,15.47,0.5,17.02,12.46911384,20.04,12.92649411,1.364972701,1.550304346,0.984924623,1.344395223,Term G OK,All OK,1.526932924,0.037874024,0.043171015,0.036740701,27.21777138,0.041879188,Yes,
440,125,pandian2012,pandian,2012,exp,280,motor relearning programme,http://www.ncbi.nlm.nih.gov/pubmed/22703742,India,new delhi,new delhi,12,12,Time 50 OK,12,1,28,,51.67,25th Percentile,,1088,>1year,2.980821918,1,,,,,,,,,,,,,,,,,,,,,,,0,fma-wh,ue,fma,,fma,lohse,0,0,15,12.33,3.26,,15,14.13,3.18,,,,,,0.5,1.8,3.220248438,,3.26,0.558963085,,0.945454545,0.528474189,Term G OK,All OK,,0.077081324,,0.068901785,14.5134121,,,
270,81,kim2009,kim,2009,ctrl,178,CPT,http://www.ncbi.nlm.nih.gov/pubmed/19692788,South korea,seoul,seoul,10.72,10.72,Time 50 OK,10.72,1,28,,51.75,25th Percentile,7.09,727.5,>1year,1.993150685,0,,,,,,,,,,,,,,,,,,,,,,,0,bbs,le,,balance,balance,lohse,0,0,12,46.67,3.75,,12,48.25,4.22,,,,,,0.5,1.58,3.991923095,,3.75,0.395799208,,0.930232558,0.36818531,Term G OK,All OK,,0.089860709,,0.077759402,12.8601812,,,
451,129,park2013,park,2013,exp,288,treadmill gait training,https://www.jstage.jst.go.jp/article/jpts/25/4/25_2012-353/_pdf,South korea,daejeon,daejeon,20,20,Time 50 OK,20,1,28,,51.9,25th Percentile,8.9,702,>1year,1.923287671,1,,>23,,,,,4.2,,,,,,,,,,,,,,,,0,6minwt,le,,capacity,capacity,lohse,0,0,10,106.5,14.2,,10,121,26.1,,,,,,0.5,14.5,21.01011661,,14.2,0.690143718,,0.914285714,0.630988542,Term G OK,All OK,,0.123814918,,0.103499164,9.661913791,,,
730,202,wu2010,wu,2010,exp,460,distributed CIMT,http://www.ncbi.nlm.nih.gov/pubmed/20947493,Taiwan,taipei,taipei,156,93,Time 50 OK,30,1,21,,51.91,25th Percentile,,447.3,>1year,1.225479452,0,,27.82,,,"[4,6]",,,,,,,,,,,,,>2,,,,,0,wmft-time,ue,wmft,,wmft,lohse,1,0,22,8.77,7.67,,21,4.02,2.49,,,,,,0.5,-4.75,5.758152016,,7.67,0.824917437,,0.963855422,0.795101144,Term G OK,All OK,,0.060920199,,0.056595918,17.66911882,,,"Outcome measure is WMFT-time, so lower numbers mean better performance"
327,96,lin2010,lin,2010,exp,212,bilateral symmetric movements,http://www.ncbi.nlm.nih.gov/pubmed/19729583,Taiwan,taoyuan,taoyuan,30,30,Time 50 OK,30,1,21,,52.08,25th Percentile,,418.2,>1year,1.145753425,0,,>24,,,4.5,,,,,,,,,<2,,,,,,,,,0,fma,ue,fma,,fma,lohse,0,0,16,48,12.35,,16,57.63,1.03,,,,,,0.5,9.63,8.763087355,,12.35,1.098927765,,0.949152542,1.043050082,Term G OK,All OK,,0.10023882,,0.090304205,11.07368145,,,
619,169,sungkarat2011,sungkarat,2011,exp,387,gait training with a sensored insole and augmented feedback,http://www.ncbi.nlm.nih.gov/pubmed/21148267,Thailand,chiang mai,chiang mai,15,15,Time 50 OK,15,1,21,,52.112,25th Percentile,7.17,118.2,<1year,0.323835616,0,,,,,,,,,,,,,,,,,,,,,,3.55,3,gait speed,le,,speed,speed,lohse,1,0,17,23.52,10.8,,17,35.09,13.6,,,,,,0.5,11.57,12.28006515,,10.8,0.942177412,,0.952380952,0.897311821,Term G OK,All OK,,0.084932302,,0.077036102,12.98092679,,,
210,63,hsieh2012,hsieh,2012,exp,136,low dose robot assisted therapy,http://www.ncbi.nlm.nih.gov/pubmed/22895994,Taiwan,taipei,taipei,30,30,Time 50 OK,30,4,28,,52.2,25th Percentile,,840,>1year,2.301369863,1,,28,,,,,,,,,,,,,,,,<3,,,,,0,fma-ue,ue,fma,,fma,lohse,1,1,18,43.1,9.18,,18,46.3,10.3,,,,,,0.5,3.2,9.75608528,,9.18,0.328000413,,0.955223881,0.313313827,Term G OK,All OK,,0.058544008,,0.053418636,18.72005867,,Yes,
729,202,wu2010,wu,2010,exp,459,bilateral arm training,http://www.ncbi.nlm.nih.gov/pubmed/20947493,Taiwan,taipei,taipei,30,30,Time 50 OK,30,1,21,,52.22,25th Percentile,,477.6,>1year,1.308493151,0,,28.05,,,"[4,6]",,,,,,,,,,,,,>2,,,,,0,wmft-time,ue,wmft,,wmft,lohse,1,0,22,7.57,8.79,,22,4.25,5.03,,,,,,0.5,-3.32,7.16118007,,8.79,0.463610741,,0.963855422,0.446853726,Term G OK,All OK,,0.05033943,,0.0467662,21.38296462,,,"Outcome measure is WMFT-time, so lower numbers mean better performance"
472,134,peurala2005,peurala,2005,ctrl,301,overground walking + CPT,http://www.ncbi.nlm.nih.gov/pubmed/16084808,Finland,kuopio,kuopio,20.4,20.4,Time 50 OK,20.4,3,21,,52.3,25th Percentile,6.8,1460,>1year,4,1,,,,,,,4.13,,,,,,,,,,,,,,,,0,10mwt MAX,le,,speed,speed,lohse,0,0,15,39.5,25.5,,15,32.1,15.9,,,14,,,0.5,-7.4,21.24923528,,25.5,0.348247826,,0.945454545,0.32925249,Term G OK,All OK,,0.070709218,,0.06320586,15.82131783,,,sign reversed for time measure
179,54,han2013,han,2013,ctrl,115,regular rehabilitation therapy and medical treatment,http://www.ncbi.nlm.nih.gov/pubmed/22801472,China,shandong,shandong,30,30,Time 50 OK,30,1,42,84,52.4,25th Percentile,,41.4,<90days,0.113424658,1,,,,,,,,51.5,,,,,,,,,,<3,,,,,1,fma-ue,ue,fma,,fma,lohse,0,0,10,6.7,2.26,,10,7.8,2.9,,,10,13,6.38,0.5,1.1,2.599769221,6.3,4.786021312,0.423114479,1.316333461,0.914285714,0.386847524,Term G OK,All OK,1.203504879,0.108951293,0.186636689,0.091074387,10.98003547,0.156013036,,
271,81,kim2009,kim,2009,exp,179,CPT + locomotor VR training,http://www.ncbi.nlm.nih.gov/pubmed/19692788,South korea,seoul,seoul,18.7,18.7,Time 50 OK,18.7,1,28,,52.42,25th Percentile,10.09,777.3,>1year,2.129589041,0,,,,,,,,,,,,,,,,,,,,,,,0,bbs,le,,balance,balance,lohse,0,0,12,44.42,5.99,,12,51.17,4.02,,,,,,0.5,6.75,5.101004803,,5.99,1.323268701,,0.930232558,1.230947629,Term G OK,All OK,,0.156293336,,0.13524572,7.393949324,,,
207,62,hsieh2011,hsieh,2011,exp,133,low dose robot assisted therapy,http://www.ncbi.nlm.nih.gov/pubmed/21436390,Taiwan,taipei,taipei,30,30,Time 50 OK,30,4,28,,52.45,25th Percentile,,390,>1year,1.068493151,0,,27.3,,,,,,,,,,,,0.57,,,,,,,,,0,fma-ue,ue,fma,,fma,lohse,1,1,6,37.67,10,,6,40,10.47,,,,,,0.5,2.33,10.2376975,,10,0.227590237,,0.842105263,0.191654936,Term G OK,All OK,,0.17098311,,0.12125118,8.247342418,,,
591,163,stein2004,stein,2004,exp,369,robot assisted training,http://www.ncbi.nlm.nih.gov/pubmed/15314537,USA,MA,boston,18,18,Time 50 OK,18,1,42,,52.5,25th Percentile,,819,>1year,2.243835616,0,,,,,,,,,,,,,,,,,,10.1,,,,,0,fma-ue,ue,fma,,fma,lohse,1,0,9,35.3,11.6,1,9,40.1,,,,,,,0.5,4.8,11.6,,11.6,0.413793103,,0.903225806,0.37374861,Term G OK,All OK,,0.120623596,,0.098406763,10.1619032,,,
661,182,varoqui2011,varoqui,2011,exp,415,balance practice with feedback (group b),http://www.ncbi.nlm.nih.gov/pubmed/21628724,France,montpellier,montpellier,3,3,Time 50 OK,3,1,28,,52.8,25th Percentile,,69.25,<90days,0.189726027,1,,,,57.75,,,3,,,,,,,,,,,2.13,,,,,0,pass,,,,other,lohse,0,0,8,28.25,4.62,,8,33.38,1.77,,,,,,0.5,5.13,3.498378196,,4.62,1.466393773,,0.888888889,1.303461131,Term G OK,All OK,,0.259394419,,0.204953615,4.879152778,,,
680,188,waldman2013,waldman,2013,ctrl,426,instructed home exercise program,http://www.ncbi.nlm.nih.gov/pubmed/23648617,USA,IL,evanston,9,9,Time 50 OK,9,3,42,84,53,25th Percentile,7.1,894,>1year,2.449315068,0,,,,,,,,,,,,,,,,,,,,,,,0,STREAM,,,,other,lohse,0,0,12,30.3,7.7,,12,31.7,8,,,12,32.5,8.3,0.5,1.4,7.85143299,2.2,8.005623024,0.178311399,0.274806844,0.930232558,0.165871069,Term G OK,All OK,0.255634274,0.084658123,0.08647995,0.073257435,13.65049158,0.074833921,,
665,184,verma2011,verma,2011,exp,419,task oriented circuit training,http://www.ncbi.nlm.nih.gov/pubmed/22120031,India,lucknow,lucknow,8.12,8.12,Time 50 OK,8.12,1,14,42,53.27,25th Percentile,8.53,42.49,<90days,0.116410959,1,5.47,26.87,,,,,,,,,,,,,,,,,,,,,0,rivermead vga,,,,other,lohse,0,1,15,32.8,4.76,,15,20.13,6.42,,,15,18.67,5.56,0.5,-12.67,5.65128304,-14.13,5.175480654,2.241968755,2.730181203,0.945454545,2.11967955,Term G OK,All OK,2.581262229,0.23421413,0.315129647,0.209360333,4.776454,0.281689443,,"higher scores indicate worse performance on RM-VGA, sign of Cohen's d switched"
474,134,peurala2005,peurala,2005,exp,303,BWS gait training with stimulation + CPT,http://www.ncbi.nlm.nih.gov/pubmed/16084808,Finland,kuopio,kuopio,20.4,20.4,Time 50 OK,20.4,3,21,,53.3,25th Percentile,8.9,949,>1year,2.6,1,,,,,,,4.1,,,,,,,,,,,,,,,,0,10mwt MAX,le,,speed,speed,lohse,0,0,15,44,36.2,,15,35.9,29.9,,,15,,,0.5,-8.1,33.1997741,,36.2,0.243977564,,0.945454545,0.230669697,Term G OK,All OK,,0.068650835,,0.061365903,16.29569437,,,sign reversed for time measure
592,163,stein2004,stein,2004,exp,370,robot aided progressive resistence training,http://www.ncbi.nlm.nih.gov/pubmed/15314537,USA,MA,boston,18,18,Time 50 OK,18,1,42,,53.3,25th Percentile,,810,>1year,2.219178082,0,,,,,,,,,,,,,,,,,,10.3,,,,,1,fma-ue,ue,fma,,fma,lohse,1,0,9,38,9.6,1,9,43.2,,,,,,,0.5,5.2,9.6,,9.6,0.541666667,,0.903225806,0.489247312,Term G OK,All OK,,0.127411265,,0.103944258,9.62054104,,,
234,69,janssen2008,janssen,2008,ctrl,152,cycling exercise,http://www.ncbi.nlm.nih.gov/pubmed/18295624,Netherlands,amsterdam,amsterdam,6,6,Time 50 OK,6,3,42,,53.3,25th Percentile,,549,>1year,1.504109589,1,,,,,,,4.7,,,,,,,,,,,,,,,,0,6minwt,le,,capacity,capacity,lohse,0,0,6,0.52,0.26,,6,0.59,0.33,,,,,,0.5,0.07,0.297069016,,0.26,0.23563548,,0.842105263,0.198429878,Term G OK,All OK,,0.171293673,,0.121471414,8.232389556,,,
453,129,park2013,park,2013,exp,290,treadmill gait training (less impaired group),https://www.jstage.jst.go.jp/article/jpts/25/4/25_2012-353/_pdf,South korea,daejeon,daejeon,20,20,Time 50 OK,20,1,28,,53.4,25th Percentile,7.1,582,>1year,1.594520548,1,,>23,,,,,5,,,,,,,,,,,,,,,,0,6minwt,le,,capacity,capacity,lohse,0,0,10,301,74.1,,10,338.2,64.5,,,,,,0.5,37.2,69.46603487,,74.1,0.535513508,,0.914285714,0.48961235,Term G OK,All OK,,0.114338736,,0.095577849,10.4626753,,,
180,54,han2013,han,2013,exp,116,CPT at increased intensity,http://www.ncbi.nlm.nih.gov/pubmed/22801472,China,shandong,shandong,60,60,Time 50 OK,60,1,42,84,53.7,25th Percentile,,42.9,<90days,0.117534247,1,,,,,,,,62.5,,,,,,,,,,<3,,,,,0,fma-ue,ue,fma,,fma,lohse,0,0,10,8.2,3.43,,10,12.3,6.55,,,10,19.7,7.09,0.5,4.1,5.228164114,11.5,5.569245909,0.784214097,2.064911514,0.914285714,0.716995746,Term G OK,All OK,1.887919098,0.130749588,0.313192978,0.109295982,9.149467178,0.261803763,,
618,169,sungkarat2011,sungkarat,2011,ctrl,386,conventional programme of gait retraining,http://www.ncbi.nlm.nih.gov/pubmed/21148267,Thailand,chiang mai,chiang mai,15,15,Time 50 OK,15,1,21,,53.83,25th Percentile,11.18,141,<1year,0.38630137,0,,,,,,,,,,,,,,,,,,,,,,3.44,2,gait speed,le,,speed,speed,lohse,1,0,18,22.24,9.1,,18,26.3,8.5,,,,,,0.5,4.06,8.805112151,,9.1,0.461095774,,0.955223881,0.440449694,Term G OK,All OK,,0.06146137,,0.05608059,17.83148144,,,
749,208,yang2014,yang,2014,exp,475,conventional rehab + cycling training up to cross-over,http://www.ncbi.nlm.nih.gov/pubmed/24388057,Taiwan,kaohsiung,kaohsiung,30,30,Time 50 OK,30,1,28,,53.9,25th Percentile,,333,<1year,0.912328767,1,,,,,4.4,,,17.4,,,,,,,,,,1.1,,,,,1,fma-le,le,,,other,lohse,0,0,16,24.1,7.2,,15,28.3,5.7,,,15,,,0.5,4.2,6.519096616,,7.2,0.644261045,,0.949152542,0.611502009,Term G OK,All OK,,0.075471009,,0.067991119,14.70780324,,,Data taken up to the crossover point
695,191,wang2005,wang,2005,exp,433,bobath therapy severe subset,http://www.ncbi.nlm.nih.gov/pubmed/15759530,Taiwan,taipei,taipei,13.3,13.3,Time 50 OK,13.3,1,28,,53.9,25th Percentile,,21.9,<90days,0.06,0,,,,,2 to 3,,,,,,6.09,,,11.18,11.6,,,,,,,,0,stroke impairment assessment set,,,,other,lohse,1,0,10,0.91,1.91,,10,4.1,2.81,,,,,,0.5,3.19,2.402519511,,1.91,1.327772776,,0.914285714,1.213963681,Term G OK,All OK,,0.188149027,,0.157277228,6.358199548,,,
18,8,blennerhassett2004,blennerhassett,2004,exp,16,targeted lower limb mobility therapy + usual therapy,http://www.ncbi.nlm.nih.gov/pubmed/15574110,Australia,victoria,melbourne,31.2,31.2,Time 50 OK,31.2,1,28,180,53.9,25th Percentile,19.8,36,<90days,0.098630137,1,,,,,,,,,,,,,,,,,,,,,,,0,6minwt,le,,capacity,capacity,lohse,0,1,15,183,85,,15,404,101,0,0,15,416,171,0.5,221,93.34345183,233,135.0296264,2.367600465,1.725547247,0.945454545,2.238458622,Term G OK,All OK,1.631426488,0.253517732,0.16591711,0.22661552,4.412760432,0.148310699,Yes,
725,200,wu2007,wu,2007,exp,455,CIMT,http://www.ncbi.nlm.nih.gov/pubmed/17678656,Taiwan,taipei,taipei,178.5,115.5,Time 50 OK,52.5,1,21,,53.93,25th Percentile,,375.3,>1year,1.028219178,0,,,84.42,,4.5,,,,,,,,,,,,,,,,,,0,fma-ue,ue,fma,,fma,lohse,0,0,24,39.5,13.45,,24,46.75,11.58,,,,,,0.5,7.25,12.54987849,,13.45,0.577694837,,0.967032967,0.558649952,Term G OK,All OK,,0.048619403,,0.045466568,21.99418263,,Yes,
733,203,wu2012,wu,2012,exp,463,distributed CIMT with trunk restraint,http://www.ncbi.nlm.nih.gov/pubmed/22228607,Taiwan,taipei,taipei,156,93,Time 50 OK,30,1,21,,54,25th Percentile,,471,>1year,1.290410959,0,,27.2,,,,,,,,,,,,,,,,,,,,,0,arat,ue,arat,,arat,lohse,0,0,20,35.9,16.7,,20,43.4,13.9,,,,,,0.5,7.5,15.36391877,,16.7,0.488156707,,0.96,0.468630439,Term G OK,All OK,,0.055957424,,0.051570362,19.39098275,,,
403,116,nilsson2001,nilsson,2001,exp,259,body-weight supported treadmill training,http://www.ncbi.nlm.nih.gov/pubmed/11594641,Sweden,gothenburg,gothenburg,48.57,48.57,Time 50 OK,48.57,1,68,180,54,25th Percentile,12.4,22,<90days,0.060273973,1,9.5,,,,,,0,,,,23.9,,,,,,,,,,,,3,fim,,,,other,lohse,0,0,36,53.7,17.7,1,33,78.8,,1,0,28,80.3,,0.5,25.1,17.7,26.6,17.7,1.418079096,1.502824859,0.978417266,1.387473072,Term G OK,All OK,1.47038979,0.055707616,0.059145591,0.05332892,18.75155169,0.056620095,,
206,62,hsieh2011,hsieh,2011,ctrl,132,conventional physical and occupational therapy,http://www.ncbi.nlm.nih.gov/pubmed/21436390,Taiwan,taipei,taipei,30,30,Time 50 OK,30,1,28,,54,25th Percentile,,849,>1year,2.326027397,0,,28.67,,,,,,,,,,,,0.66,,,,,,,,,0,fma-ue,ue,fma,,fma,lohse,1,1,6,37.5,11.67,,6,40.33,11.86,,,,,,0.5,2.83,11.76538355,,11.67,0.240536145,,0.842105263,0.202556753,Term G OK,All OK,,0.171488136,,0.121609316,8.223054227,,,
151,46,fuzaro2011,fuzaro,2011,exp,99,mCIMT,http://www.ncbi.nlm.nih.gov/pubmed/22378476,Brasil,sao paulo,sao paulo,39.67,28.17,Time 50 OK,16.67,1,28,90,54.15,25th Percentile,12.94,587.1,>1year,1.608493151,1,,,,,,,,,,,51.83,,,,42.63,,,,,,,,10,SIS,,,,other,lohse,0,0,19,42.63,8.23,,19,58.78,4.66,,,19,57.9,8.08,0.5,16.15,6.687619158,15.27,8.155344873,2.414910242,1.872391694,0.957746479,2.312871781,Term G OK,All OK,1.793276552,0.206099776,0.144890807,0.189050856,5.289581974,0.132905195,Yes,
204,61,housman2009,housman,2009,exp,130,T-WREX assisted UE therapy,http://www.ncbi.nlm.nih.gov/pubmed/19237734,USA,IL,chicago,24,24,Time 50 OK,24,2,63,243,54.2,25th Percentile,,2535,>1year,6.945205479,0,,,,,,,,,,,,,,,,,,,,,,,2,fma-ue,ue,fma,,fma,lohse,1,0,14,21.7,5.9,1,14,25,,1,0,14,25.3,,0.5,3.3,5.9,3.6,5.9,0.559322034,0.610169492,0.941176471,0.526420738,Term G OK,All OK,0.574277168,0.082601469,0.084725243,0.073169468,13.6669027,0.075050734,,
235,69,janssen2008,janssen,2008,exp,153,electrical stimulation plus cycling,http://www.ncbi.nlm.nih.gov/pubmed/18295624,Netherlands,amsterdam,amsterdam,6,6,Time 50 OK,6,3,42,,54.2,25th Percentile,,369,>1year,1.010958904,1,,,,,,,4.5,,,,,,,,,,,,,,,,0,6minwt,le,,capacity,capacity,lohse,0,0,6,0.44,0.37,,6,0.51,0.41,,,,,,0.5,0.07,0.390512484,,0.37,0.179251632,,0.842105263,0.150948743,Term G OK,All OK,,0.169344262,,0.120089006,8.327156942,,,
748,208,yang2014,yang,2014,ctrl,474,conventional rehabilitation up to the cross-over point,http://www.ncbi.nlm.nih.gov/pubmed/24388057,Taiwan,kaohsiung,kaohsiung,20,20,Time 50 OK,20,1,28,,54.5,25th Percentile,,333,<1year,0.912328767,1,,,,,4.2,,,16.5,,,,,,,,,,1.2,,,,,0,fma-le,le,,,other,lohse,0,0,15,20.5,10.2,,15,20.7,10,,,15,,,0.5,0.2,10.10049504,,10.2,0.01980101,,0.945454545,0.018720955,Term G OK,All OK,,0.066679736,,0.059603969,16.77740622,,,Data taken up to the crossover point
629,172,taub2006,taub,2006,exp,393,CIMT,http://stroke.ahajournals.org/content/37/4/1045.abstract,USA,AL,birmingham,172,116,Time 50 OK,60,1,14,730,54.6,25th Percentile,,1314,>1year,3.6,0,,,,,,,,,,,,,,,,,,,,,,,0,actual amount of use test,,,,other,lohse,0,0,21,0.8,0.4,,21,1.5,0.9,,,,,,0.5,0.7,0.696419414,,0.4,1.005141422,,0.962025316,0.966971495,Term G OK,All OK,,0.07167403,,0.066333793,15.07527242,,Yes,
195,59,hidler2009,hidler,2009,ctrl,127,conventional gait training,http://www.ncbi.nlm.nih.gov/pubmed/19109447,USA,DC,washington DC,24,24,Time 50 OK,24,3,63,153,54.6,25th Percentile,11.3,138.9,<1year,0.380547945,1,,26.8,,,,,,,,,,,,,,,,,,,7.4,,4,gait speed SSV,le,,speed,speed,lohse,1,0,30,0.35,0.164,1,30,0.6,,1,0,30,0.65,,0.5,0.25,0.164,0.3,0.164,1.524390244,1.829268293,0.973913043,1.484623542,Term G OK,All OK,1.78154825,0.07206276,0.089103708,0.068352005,14.63014874,0.084515457,,
209,63,hsieh2012,hsieh,2012,ctrl,135,conventional physical and occupational therapy,http://www.ncbi.nlm.nih.gov/pubmed/22895994,Taiwan,taipei,taipei,30,30,Time 50 OK,30,1,28,,54.83,25th Percentile,,672,>1year,1.84109589,1,,28.3,,,,,,,,,,,,,,,,<3,,,,,1,fma-ue,ue,fma,,fma,lohse,1,1,18,44.61,11.06,,18,47.56,10.5,,,,,,0.5,2.95,10.78363575,,11.06,0.273562653,,0.955223881,0.261313579,Term G OK,All OK,,0.057634348,,0.052588614,19.01552302,,Yes,
274,82,kim2012,kim,2012,ctrl,180,no treatment?,https://www.jstage.jst.go.jp/article/jpts/24/9/24_901/_pdf,South korea,seoul,seoul,0,0,Time 50 OK,0,1,21,,55,25th Percentile,,385,>1year,1.054794521,0,,25.14,,,,,,,,,,,,,,,,,,,,,3,fim,,,,other,lohse,0,0,7,101,7.89,,7,101.28,8.11,,,7,,,0.5,0.28,8.000756214,,7.89,0.034996692,,0.869565217,0.030431906,Term G OK,All OK,,0.142944626,,0.108086674,9.25183432,,,
430,122,page2004,page,2004,exp,273,modified CIMT,http://www.ncbi.nlm.nih.gov/pubmed/14970962,USA,OH,cincinnati,280,155,Time 50 OK,30,1,70,,55,25th Percentile,,762.8,>1year,2.089863014,0,,,>70,,,,,,,,,,,,,,,>3,,,,,0,fma-ue,ue,fma,,fma,lohse,1,0,7,30.85,7.41,,7,49.2,7.41,,,,,,0.5,18.35,7.41,,7.41,2.476383266,,0.869565217,2.153376753,Term G OK,All OK,,0.580891006,,0.439237055,2.276674949,,,standard deviations are estimated from the standard errors  in Table 3
664,184,verma2011,verma,2011,ctrl,418,standard therapy group,http://www.ncbi.nlm.nih.gov/pubmed/22120031,India,lucknow,lucknow,8.12,8.12,Time 50 OK,8.12,1,14,42,55.07,25th Percentile,6.8,46.2,<90days,0.126575342,1,4.6,26.67,,,,,,,,,,,,,,,,,,,,,0,rivermead vga,,,,other,lohse,0,1,15,33.87,9.48,,15,30.53,9.52,,,15,29.4,6.42,0.5,-3.34,9.500021053,-4.47,8.095887845,0.351578168,0.552132155,0.945454545,0.332401177,Term G OK,All OK,0.522015855,0.070786907,0.076828331,0.063275305,15.80395385,0.068675638,,"higher scores indicate worse performance on RM-VGA, sign of Cohen's d switched"
705,194,westlake2009,westlake,2009,ctrl,441,manually assisted BWSTT,http://www.ncbi.nlm.nih.gov/pubmed/19523207,USA,CA,san francisco,6,6,Time 50 OK,6,3,28,,55.1,25th Percentile,13.6,1104,>1year,3.024657534,0,,,,,,,,,,,,,,,,,,,,,,,0,gait speed 4.3m SSV,le,,speed,speed,lohse,1,0,8,0.62,0.28,,8,0.65,0.29,,,,,,0.5,0.03,0.285043856,,0.28,0.105246962,,0.888888889,0.093552855,Term G OK,All OK,,0.125692308,,0.099312441,10.06923191,,,
728,202,wu2010,wu,2010,ctrl,458,routine physical therapy,http://www.ncbi.nlm.nih.gov/pubmed/20947493,Taiwan,taipei,taipei,30,30,Time 50 OK,30,1,21,,55.19,25th Percentile,,533.1,>1year,1.460547945,0,,27.36,,,"[3,5]",,,,,,,,,,,,,>2,,,,,0,wmft-time,ue,wmft,,wmft,lohse,1,0,22,7.18,6.95,,21,5.83,4.65,,,,,,0.5,-1.35,5.940359068,,6.95,0.22725899,,0.963855422,0.219044809,Term G OK,All OK,,0.046628333,,0.043318527,23.0848108,,,"Outcome measure is WMFT-time, so lower numbers mean better performance"
355,106,michielsen2011,michielsen,2011,exp,234,homebased mirror therapy,http://www.ncbi.nlm.nih.gov/pubmed/21051765,Netherlands,rotterdam,rotterdam,36,36,Time 50 OK,36,1,42,180,55.3,25th Percentile,,1715.5,>1year,4.7,1,,,,,4,,,,,,,,,,,,,,,,,,3,fma-ue,ue,fma,,fma,lohse,1,1,20,39.7,14.1,,20,43.5,14,,,20,41.1,14.9,0.5,3.8,14.05008897,1.4,14.50551619,0.270460921,0.096515007,0.96,0.259642484,Term G OK,All OK,0.092654407,0.051828728,0.050232879,0.047765355,20.93567608,0.046294621,,"the authors state an intention to treat principle, but this is not clear from the flowchart and tables. No sample size is reported in the tables for the different timepoints, so it is assumed that all observations were in fact, carried forward."
322,94,lee2012,lee,2012,ctrl,207,standard care,http://www.ncbi.nlm.nih.gov/pubmed/22469877,South korea,seoul,seoul,20,20,Time 50 OK,20,1,28,,55.4,25th Percentile,,108,<1year,0.295890411,0,,25.6,,,,,,,,,,,,,,,,,,,,,1,fma-shoulder/elbow,ue,fma,,fma,lohse,0,0,13,15.1,7,,13,19.7,6.3,,,,,,0.5,4.6,6.659204157,,7,0.690773235,,0.936170213,0.646681327,Term G OK,All OK,,0.095275679,,0.083501003,11.97590405,,,
452,129,park2013,park,2013,exp,289,overground gait training (less impaired group),https://www.jstage.jst.go.jp/article/jpts/25/4/25_2012-353/_pdf,South korea,daejeon,daejeon,20,20,Time 50 OK,20,1,28,,55.4,25th Percentile,7.2,441,>1year,1.208219178,1,,>23,,,,,4.8,,,,,,,,,,,,,,,,0,6minwt,le,,capacity,capacity,lohse,0,0,10,298.7,66.6,,10,329.7,68.1,,,,,,0.5,31,67.35417582,,66.6,0.460253572,,0.914285714,0.420803266,Term G OK,All OK,,0.110591668,,0.092445606,10.81717178,,,
743,206,yang2008,yang,2008,exp,469,virtual reality treadmill training,http://www.ncbi.nlm.nih.gov/pubmed/18358724,Taiwan,taipei,taipei,3,3,Time 50 OK,3,1,21,51,55.45,25th Percentile,12.15,2164.45,>1year,5.93,0,,,,,,,,,,,,,,,,,,,,,,,0,gait speed 12m MAX,le,,speed,speed,lohse,0,0,12,0.69,0.3,,11,0.85,0.31,,,11,0.86,0.33,0.5,0.16,0.304802825,0.17,0.314642654,0.524929519,0.540295467,0.930232558,0.488306529,Term G OK,All OK,0.502600435,0.094814625,0.095496633,0.082046187,12.18825684,0.082636351,,
326,96,lin2010,lin,2010,ctrl,211,standard OT,http://www.ncbi.nlm.nih.gov/pubmed/19729583,Taiwan,taoyuan,taoyuan,30,30,Time 50 OK,30,1,21,,55.5,25th Percentile,,393.6,>1year,1.078356164,0,,>24,,,5,,,,,,,,,<2,,,,,,,,,0,fma,ue,fma,,fma,lohse,0,0,17,53.53,7.58,,17,54.99,1,,,,,,0.5,1.46,5.406311127,,7.58,0.27005475,,0.952380952,0.257195,Term G OK,All OK,,0.060968517,,0.055300242,18.08310351,,,
373,110,morone2011,morone,2011,exp,242,robot assisted therapy for the low motricity group,http://www.ncbi.nlm.nih.gov/pubmed/21444654,Italy,rome,rome,60,60,Time 50 OK,60,1,28,102.6,55.58,25th Percentile,9.11,16.25,<90days,0.044520548,1,,>24,,,,,0.11,,,16.08,,,,,,,,1.5,,,,,5,fac,le,,,other,lohse,1,1,12,0.11,0.39,,12,2.6,0.9,,,12,3.94,0.87,0.5,2.49,0.693577681,3.83,0.674166152,3.59008092,5.681092103,0.930232558,3.339610158,Term G OK,All OK,5.28473684,0.620361709,1.428116978,0.536819218,1.862824516,1.235796195,,
253,76,kahn2006,kahn,2006,exp,167,robot assisted reaching,http://www.jneuroengrehab.com/content/3/1/12,USA,CA,irvine,18,18,Time 50 OK,18,4,56,180,55.6,25th Percentile,,2274,>1year,6.230136986,0,,,,,,,,,,,,,,,,,,,,,,,0,chedoke mcmaster,,,,other,lohse,0,0,10,3.5,0.9,1,10,3.7,,,,9,,,0.5,0.2,0.9,,0.9,0.222222222,,0.914285714,0.203174603,Term G OK,All OK,,0.102469136,,0.085655833,11.67462816,,,
252,76,kahn2006,kahn,2006,ctrl,166,dosage matched unassisted reaching,http://www.jneuroengrehab.com/content/3/1/12,USA,CA,irvine,18,18,Time 50 OK,18,4,56,180,55.9,25th Percentile,,3093,>1year,8.473972603,0,,,,,,,,,,,,,,,,,,,,,,,0,chedoke mcmaster,,,,other,lohse,0,0,9,3.2,1,1,9,3.5,,,,8,,,0.5,0.3,1,,1,0.3,,0.903225806,0.270967742,Term G OK,All OK,,0.116111111,,0.094725402,10.55683036,,,
639,177,van de port2012,van de port,2012,exp,403,progressive circuit training,http://www.bmj.com/content/344/bmj.e2672,Netherlands,utrecht,utrecht,36,36,Time 50 OK,36,1,84,168,56,25th Percentile,10,91,<1year,0.249315068,1,,,,,,,4.64,,,,,,,,80.9,12.67,,,,,,,1,sis mobility subscale,,,,other,lohse,1,1,126,80.9,13.04,,125,87.27,12.38,,,125,86.56,13.19,0.5,6.37,12.71560809,5.66,13.11491324,0.500959133,0.431569763,0.993987976,0.497947354,Term G OK,All OK,0.428975155,0.008932381,0.008675605,0.008825301,113.3105828,0.008571603,,
237,70,jin2012,jin,2012,ctrl,155,low-intensity over ground walking,http://www.ncbi.nlm.nih.gov/pubmed/22376194,China,taixing,taixing,46.8,46.8,Time 50 OK,46.8,1,56,,56,25th Percentile,,537,>1year,1.471232877,1,,,,,,,,,,,47.4,,,,,10.2,,,,,,,0,6minwt,le,,capacity,capacity,lohse,1,0,65,0.589,0.14,,65,0.593,0.141,,,,,,0.5,0.004,0.14050089,,0.14,0.028469571,,0.988235294,0.028134634,Term G OK,All OK,,0.01539085,,0.015030843,66.52986795,,,
402,116,nilsson2001,nilsson,2001,ctrl,258,overground walking training,http://www.ncbi.nlm.nih.gov/pubmed/11594641,Sweden,gothenburg,gothenburg,47.14,47.14,Time 50 OK,47.14,1,66,280,56,25th Percentile,12.1,17,<90days,0.046575342,1,8,,,,,,0,,,,23.3,,,,,,,,,,,,1,fim,,,,other,lohse,0,0,37,56.1,18,1,36,76.9,,1,0,32,81.9,,0.5,20.8,18,25.8,18,1.155555556,1.433333333,0.979020979,1.131313131,Term G OK,All OK,1.403263403,0.045071738,0.05478979,0.043200453,23.14790542,0.052515032,,
54,21,conroy2011,conroy,2011,ctrl,44,intensive conventional arm therapy,http://www.ncbi.nlm.nih.gov/pubmed/21849168,USA,MD,baltimore,18,18,Time 50 OK,18,1,42,126,56,25th Percentile,,1460,>1year,4,1,,,,,,,,,,,,,,,71.4,,,,,,,,2,fma-ue,ue,fma,,fma,lohse,1,0,21,18.2,12.5,1,19,19.39,,1,0,19,20.02,,0.5,1.19,12.5,1.82,12.5,0.0952,0.1456,0.962025316,0.09158481,Term G OK,All OK,0.140070886,0.047834834,0.048123794,0.04427079,22.5882574,0.044538221,,
208,62,hsieh2011,hsieh,2011,exp,134,high dose robot assisted therapy,http://www.ncbi.nlm.nih.gov/pubmed/21436390,Taiwan,taipei,taipei,30,30,Time 50 OK,30,4,28,,56.04,25th Percentile,,639,>1year,1.750684932,0,,27.3,,,,,,,,,,,,0.64,,,,,,,,,0,fma-ue,ue,fma,,fma,lohse,1,1,6,44,8.17,,6,49.33,8.34,,,,,,0.5,5.33,8.255437602,,8.17,0.645635066,,0.842105263,0.543692687,Term G OK,All OK,,0.20140372,,0.142823691,7.001639525,,,
760,213,yen2008,yen,2008,ctrl,484,conventional general therapy,http://www.ncbi.nlm.nih.gov/pubmed/17507641,Taiwan,taipei,taipei,8.1,8.1,Time 50 OK,8.1,1,28,,56.05,25th Percentile,12.69,715.4,>1year,1.96,1,,,,,4,,,,,,,,,,,,,,,,,,0,bbs,,,balance,balance,lohse,0,0,7,50.57,3.55,,7,51.57,3.1,,,,,,0.5,1,3.332604087,,3.55,0.300065647,,0.869565217,0.260926649,Term G OK,All OK,,0.149288528,,0.112883575,8.858684711,,,
60,23,crosbie2012,crosbie,2012,exp,50,VR mediated UE therapy,http://www.ncbi.nlm.nih.gov/pubmed/22275463,UK,newtonabbey,newtonabbey,6.75,6.75,Time 50 OK,6.75,1,21,201,56.1,25th Percentile,,351,<1year,0.092767123,0,,,,,,,,,,,,,,,,,,,,,,,0,motricity index-ue,ue,,,other,lohse,0,1,9,71.7,9.4,,9,84.9,9.2,,,9,85.2,12,0.5,13.2,9.300537619,13.5,10.77868267,1.419272793,1.252472164,0.903225806,1.281923813,Term G OK,All OK,1.13126518,0.223018626,0.198260362,0.181942354,5.496246355,0.161744146,,
239,71,jin2013,jin,2013,ctrl,157,stretching with overground walking,http://www.ncbi.nlm.nih.gov/pubmed/23535796,China,nanjing,nanjing,4.8,4.8,Time 50 OK,4.8,1,84,,56.3,25th Percentile,,537,>1year,1.471232877,1,,,,,,,,,,,,,,,,,,,,,,,0,6minwt,le,,capacity,capacity,lohse,1,0,63,0.59,0.142,,63,0.593,0.144,,,,,,0.5,0.003,0.143003496,,0.142,0.020978508,,0.987854251,0.020723708,Term G OK,All OK,,0.015876509,,0.015493187,64.54449946,,,
424,121,outermans2010,outermans,2010,ctrl,269,low intensity physiotherapy program,http://www.ncbi.nlm.nih.gov/pubmed/20719820,Netherlands,utrecht,utrecht,9,9,Time 50 OK,9,1,28,,56.3,25th Percentile,8.6,23.5,<90days,0.064383562,0,,,,,,,,,,,53.2,,,,,,,,,,,,6,10mwt,le,,speed,speed,lohse,0,1,21,1.4,0.5,,21,1.4,0.4,,,,,,0.5,0,0.452769257,,0.5,0,,0.962025316,0,Term G OK,All OK,,0.047619048,,0.044071081,22.69061655,,,
732,203,wu2012,wu,2012,exp,462,distributed CIMT,http://www.ncbi.nlm.nih.gov/pubmed/22228607,Taiwan,taipei,taipei,156,93,Time 50 OK,30,1,21,,56.3,25th Percentile,,411,>1year,1.126027397,0,,27.1,,,,,,,,,,,,,,,,,,,,,0,arat,ue,arat,,arat,lohse,0,0,19,35.8,16.5,,19,42.8,12.8,,,,,,0.5,7,14.76634687,,16.5,0.474050898,,0.957746479,0.454020579,Term G OK,All OK,,0.058545375,,0.053702403,18.62114066,,,
19,8,blennerhassett2004,blennerhassett,2004,exp,17,targeted upper extremity intervention + usual therapy,http://www.ncbi.nlm.nih.gov/pubmed/15574110,Australia,victoria,melbourne,31.8,31.8,Time 50 OK,31.8,1,28,180,56.3,25th Percentile,10.5,51.1,<90days,0.14,1,,,,,,,,,,,,,,,,,,,,,,,0,JTHFT-time,ue,,,other,lohse,0,1,11,41.8,18.4,,11,24.3,11.3,0,0,11,23.6,12.2,0.5,-17.5,15.26843148,-18.2,15.61089363,1.146155715,1.16585254,0.923076923,1.05798989,Term G OK,All OK,1.076171576,0.150621496,0.152691461,0.12834021,7.791790274,0.130103967,Yes,sign reversed for time measure
393,114,ng2007,ng,2007,exp,252,functional electrical stimulation,http://www.ncbi.nlm.nih.gov/pubmed/17901383,China,hong kong,hong kong,0,0,Time 50 OK,0,1,28,56,56.4,25th Percentile,,2263,>1year,6.2,0,,,,,,,,,,,,,,,,,,,,,,,2,gait speed 4.6m SSV,le,,speed,speed,lohse,0,0,19,0.55,0.26,,19,0.63,0.28,,,19,0.59,0.27,0.5,0.08,0.270185122,0.04,0.265047166,0.296093284,0.150916536,0.957746479,0.2835823,Term G OK,All OK,0.144539781,0.054938717,0.053230942,0.050394094,19.84359516,0.048827589,,flow of participants through the study is not clear
205,61,housman2009,housman,2009,ctrl,131,conventional physical and occupational therapy,http://www.ncbi.nlm.nih.gov/pubmed/19237734,USA,IL,chicago,24,24,Time 50 OK,24,2,63,243,56.4,25th Percentile,,3372,>1year,9.238356164,0,,,,,,,,,,,,,,,,,,,,,,,1,fma-ue,ue,fma,,fma,lohse,1,0,14,18.1,5,1,14,20.3,,1,0,14,19.6,,0.5,2.2,5,1.5,5,0.44,0.3,0.941176471,0.414117647,Term G OK,All OK,0.282352941,0.078342857,0.074642857,0.069397133,14.40981719,0.066119624,,
516,145,ribeiro2013,ribeiro,2013,exp,331,body weight supported treadmill training,http://www.ncbi.nlm.nih.gov/pubmed/23172402,Brasil,natal,natal,6,6,Time 50 OK,6,1,28,,56.45,25th Percentile,8.31,1000.8,>1year,2.741917808,1,4.72,,,68.3,,,3.72,,,,,,,,,,,1.36,,,,,1,STREAM,,,,other,lohse,0,0,11,63.8,24.9,,11,70,24.6,,,11,,,0.5,6.2,24.75045454,,24.9,0.25050045,,0.923076923,0.231231185,Term G OK,All OK,,0.093761385,,0.079891358,12.5169984,,,
211,63,hsieh2012,hsieh,2012,exp,137,high dose robot assisted therapy,http://www.ncbi.nlm.nih.gov/pubmed/22895994,Taiwan,taipei,taipei,30,30,Time 50 OK,30,4,28,,56.5,25th Percentile,,860,>1year,2.356164384,1,,28.5,,,,,,,,,,,,,,,,<3,,,,,0,fma-ue,ue,fma,,fma,lohse,1,1,18,42.8,8.86,,18,48,8.2,,,,,,0.5,5.2,8.536380966,,8.86,0.609157443,,0.955223881,0.581881736,Term G OK,All OK,,0.065863133,,0.060096991,16.6397682,,Yes,
212,64,hui chan2009,hui chan,2009,ctrl,138,no treatment?,http://www.ncbi.nlm.nih.gov/pubmed/19509438,China,hong kong,hong kong,0,0,Time 50 OK,0,1,28,56,56.6,25th Percentile,7.9,1715.5,>1year,4.7,0,,,,,,,,,,,,,,,,,,,,,,,0,gait speed 4.6m,le,,speed,speed,lohse,0,1,29,0.589,0.249,,29,0.609,0.248,,,29,0.612,0.242,0.5,0.02,0.248500503,0.023,0.245524948,0.080482734,0.093676835,0.972972973,0.078307525,Term G OK,All OK,0.091145029,0.034594439,0.034634058,0.032749739,30.53459449,0.032787245,,
213,64,hui chan2009,hui chan,2009,exp,139,transcutaneous electrical stim only,http://www.ncbi.nlm.nih.gov/pubmed/19509438,China,hong kong,hong kong,0,0,Time 50 OK,0,1,28,56,56.6,25th Percentile,7.9,1715.5,>1year,4.7,0,,,,,,,,,,,,,,,,,,,,,,,0,gait speed 4.6m,le,,speed,speed,lohse,0,1,28,0.577,0.263,,28,0.649,0.289,,,28,0.612,0.273,0.5,0.072,0.27630599,0.035,0.268046638,0.26058067,0.130574292,0.971962617,0.25327467,Term G OK,All OK,0.126913331,0.036926827,0.036018744,0.034885191,28.66545865,0.034027315,,
214,64,hui chan2009,hui chan,2009,exp,140,placebo stim + task specific training,http://www.ncbi.nlm.nih.gov/pubmed/19509438,China,hong kong,hong kong,20,20,Time 50 OK,20,1,28,56,56.6,25th Percentile,7.9,1715.5,>1year,4.7,0,,,,,,,,,,,,,,,,,,,,,,,0,gait speed 4.6m,le,,speed,speed,lohse,0,1,25,0.507,0.245,,25,0.606,0.297,,,25,0.613,0.286,0.5,0.099,0.272244376,0.106,0.266290255,0.363643876,0.398061882,0.968421053,0.352160385,Term G OK,All OK,0.385491506,0.042644737,0.043169065,0.039993912,25.00380558,0.040485647,,
215,64,hui chan2009,hui chan,2009,exp,141,STIM + task specific training,http://www.ncbi.nlm.nih.gov/pubmed/19509438,China,hong kong,hong kong,20,20,Time 50 OK,20,1,28,56,56.6,25th Percentile,7.9,1715.5,>1year,4.7,0,,,,,,,,,,,,,,,,,,,,,,,0,gait speed 4.6m,le,,speed,speed,lohse,0,1,27,0.479,0.268,,27,0.666,0.325,,,27,0.702,0.327,0.5,0.187,0.297866581,0.223,0.298959027,0.627797853,0.745921613,0.970873786,0.609512479,Term G OK,All OK,0.724195741,0.044335743,0.047340723,0.04179069,23.92877457,0.044623172,,
26,11,brock2011,brock,2011,ctrl,22,"""task practice"" intervention",http://www.ncbi.nlm.nih.gov/pubmed/21788266,Australia,victoria,melbourne,6,6,Time 50 OK,6,1,14,,56.6,25th Percentile,15.8,63.6,<90days,0.174246575,1,,,,,,,,,,,,,,,,,,,,,,,1,6minwt,le,,capacity,capacity,lohse,1,0,15,78.5,61.3,,14,119.5,80.2,0,0,,,,0.5,41,71.0305568,,61.3,0.577216368,,0.945454545,0.545731839,Term G OK,All OK,,0.077772625,,0.069519728,14.38440611,,Yes,
724,200,wu2007,wu,2007,ctrl,454,conventional therapy,http://www.ncbi.nlm.nih.gov/pubmed/17678656,Taiwan,taipei,taipei,52.5,52.5,Time 50 OK,52.5,1,21,,56.77,25th Percentile,,359.4,<1year,0.984657534,0,,,84.43,,4.5,,,,,,,,,,,,,,,,,,0,fma-ue,ue,fma,,fma,lohse,0,0,23,41.74,13.47,,23,44.78,13.08,,,,,,0.5,3.04,13.27643213,,13.47,0.228977181,,0.965517241,0.221081416,Term G OK,All OK,,0.044618055,,0.041594002,24.04192797,,Yes,
425,121,outermans2010,outermans,2010,exp,270,time matched high intensity physiotherapy,http://www.ncbi.nlm.nih.gov/pubmed/20719820,Netherlands,utrecht,utrecht,9,9,Time 50 OK,9,1,28,,56.8,25th Percentile,8.6,22.5,<90days,0.061643836,0,,,,,,,,,,,53,,,,,,,,,,,,6,10mwt,le,,speed,speed,lohse,0,1,22,1.5,0.5,,22,1.7,0.5,,,,,,0.5,0.2,0.5,,0.5,0.4,,0.963855422,0.385542169,Term G OK,All OK,,0.049090909,,0.045606303,21.92679376,,,
737,205,yang2006,yang,2006,exp,467,task oriented progessive resistance training,http://www.ncbi.nlm.nih.gov/pubmed/17008338,Taiwan,taipei,taipei,6,6,Time 50 OK,6,1,28,,56.8,25th Percentile,10.2,1881,>1year,5.153424658,0,,,,,,,,,,,,,,,,,,,,,,,0,gait speed 3.7m SSV,le,,speed,speed,lohse,0,0,24,84,12.7,,24,92.5,13.5,,,,,,0.5,8.5,13.10610545,,12.7,0.648552694,,0.967032967,0.627171836,Term G OK,All OK,,0.050429596,,0.047159376,21.20469109,,,
411,118,olawale2011,olawale,2011,exp,263,CPT + treadmill training,http://www.ncbi.nlm.nih.gov/pubmed/21427155,Nigeria,lagos,lagos,51,51,Time 50 OK,51,1,84,,56.8,25th Percentile,6.4,306,<1year,0.838356164,0,,,,,,,,,,,,,,,,,,,,,,,2,10mwt SSV,le,,speed,speed,lohse,1,0,20,30.56,10.73,,20,23.83,11.08,,,,,,0.5,-6.73,10.90640408,,10.73,0.617068646,,0.96,0.5923859,Term G OK,All OK,,0.059519343,,0.054853026,18.23053481,,,sign reversed for time measure
412,118,olawale2011,olawale,2011,exp,264,CPT + overground walking,http://www.ncbi.nlm.nih.gov/pubmed/21427155,Nigeria,lagos,lagos,51,51,Time 50 OK,51,1,84,,56.8,25th Percentile,8.3,321,<1year,0.879452055,0,,,,,,,,,,,,,,,,,,,,,,,2,10mwt SSV,le,,speed,speed,lohse,1,0,20,29.3,10.6,,20,20.03,8.38,,,,,,0.5,-9.27,9.554695181,,10.6,0.970203635,,0.96,0.93139549,Term G OK,All OK,,0.073532377,,0.067767439,14.75634928,,,sign reversed for time measure
744,207,yang2010,yang,2010,ctrl,470,early intervention general exercise,http://www.ncbi.nlm.nih.gov/pubmed/20382280,Taiwan,taipei,taipei,10,10,Time 50 OK,10,1,28,,56.8,25th Percentile,7.6,109.5,<1year,0.3,0,,,,,,,,,,,,,,,,,,,,,,,0,fma-le,le,,,other,lohse,0,0,4,28,3.4,,4,28.5,2.4,,,4,,,0.5,0.5,2.942787794,,3.4,0.169906917,,0.727272727,0.123568667,Term G OK,All OK,,0.253608545,,0.134140057,7.4548947,,,
446,128,park2011,park,2011,ctrl,285,routine physical therapy,http://www.ncbi.nlm.nih.gov/pubmed/21245205,South korea,daejeon,daejeon,20,20,Time 50 OK,20,1,28,,56.9,25th Percentile,7.79,860.1,>1year,2.356438356,1,,>25,,,,,,,,,,,,,,,,,,,,,1,10mwt,le,,speed,speed,lohse,0,0,13,0.45,0.19,,12,0.5,0.23,,,,,,0.5,0.05,0.210082799,,0.19,0.238001398,,0.936170213,0.22280982,Term G OK,All OK,,0.079101718,,0.069325906,14.42462216,,,
646,178,van deldan2013,van deldan,2013,ctrl,404,coventional therapy,http://www.ncbi.nlm.nih.gov/pubmed/23868279,Netherlands,amsterdam,amsterdam,18,18,Time 50 OK,18,1,42,84,56.9,25th Percentile,,77.7,<90days,0.212876712,0,,>23,,,,,,,,61.9,,,,,collected,,,,,,,,3,arat,ue,arat,,arat,lohse,1,0,19,23.3,15.4,1,16,39.2,,0,1,15,40.7,,0.5,15.9,15.4,17.4,15.4,1.032467532,1.12987013,0.957746479,0.988842144,Term G OK,All OK,1.082129138,0.080683926,0.086226487,0.074009616,13.51175772,0.079093687,,Change scores estimated from Figure 2
236,70,jin2012,jin,2012,exp,154,progressive cycling training with lower limb weights,http://www.ncbi.nlm.nih.gov/pubmed/22376194,China,taixing,taixing,46.8,46.8,Time 50 OK,46.8,1,56,,57,25th Percentile,,555,>1year,1.520547945,1,,,,,,,,,,,47.9,,,,,10.3,,,,,,,0,6minwt,le,,capacity,capacity,lohse,1,0,68,0.588,0.18,,68,0.607,0.18,,,,,,0.5,0.019,0.18,,0.18,0.105555556,,0.988764045,0.104369538,Term G OK,All OK,,0.014787809,,0.014457365,69.16889765,,,
198,60,hornby2008,hornby,2008,exp,128,robot assisted gait training,http://www.ncbi.nlm.nih.gov/pubmed/18467648,USA,IL,chicago,6,6,Time 50 OK,6,3,,,57,25th Percentile,10,1500,>1year,4.109589041,1,,,,,,,,,,,,,,,,,,0.8,,,13,,4,gait speed SSV,le,,speed,speed,lohse,1,0,24,0.45,0.19,,24,0.52,0.21,,,24,0.5,0.21,0.5,0.07,0.200249844,0.05,0.200249844,0.349563319,0.249688085,0.967032967,0.338039253,Term G OK,All OK,0.241456609,0.044212386,0.042965503,0.041345334,24.1865261,0.040179309,,"This study conducted an ""on-protocol"" analysis, continuing to randomize participants as old participants withdrew, until there were 24 in each condition"
199,60,hornby2008,hornby,2008,ctrl,129,"usual care, therapist assisted gait training",http://www.ncbi.nlm.nih.gov/pubmed/18467648,USA,IL,chicago,6,6,Time 50 OK,6,3,,,57,25th Percentile,11,2190,>1year,6,1,,,,,,,,,,,,,,,,,,1,,,9.6,,10,gait speed SSV,le,,speed,speed,lohse,1,0,24,0.43,0.22,,24,0.56,0.28,,,24,0.52,0.25,0.5,0.13,0.251793566,0.09,0.235478237,0.516295956,0.382200925,0.967032967,0.49927521,Term G OK,All OK,0.369600895,0.047220032,0.044709949,0.044157943,22.6459824,0.041810632,,"This study conducted an ""on-protocol"" analysis, continuing to randomize participants as old participants withdrew, until there were 24 in each condition"
55,21,conroy2011,conroy,2011,exp,45,robot assisted therapy without gravity compensation,http://www.ncbi.nlm.nih.gov/pubmed/21849168,USA,MD,baltimore,18,18,Time 50 OK,18,1,42,126,57,25th Percentile,,1095,>1year,3,1,,,,,,,,,,,,,,,73.2,,,,,,,,3,fma-ue,ue,fma,,fma,lohse,1,0,20,20.3,14.7,1,17,23.27,,1,0,17,23.6,,0.5,2.97,14.7,3.3,14.7,0.202040816,0.224489796,0.96,0.193959184,Term G OK,All OK,0.215510204,0.051020512,0.051259892,0.047020504,21.26731776,0.047241116,,
228,66,huseman2007,huseman,2007,ctrl,146,conventional physiotherapy,http://www.ncbi.nlm.nih.gov/pubmed/17204680,Germany,bad aibling,bad aibling,20,20,Time 50 OK,20,1,28,,57,25th Percentile,,89,<90days,0.243835616,1,,,,,,,,,,,,,,,,,,,,,,,0,10mwt,le,,speed,speed,lohse,1,1,14,0.12,0.11,,14,0.2,0.19,,,,,,0.5,0.08,0.155241747,,0.11,0.515325301,,0.941176471,0.485012048,Term G OK,All OK,,0.080912863,,0.071673678,13.9521234,,,
33,13,brokaw2014,brokaw,2014,exp,27,robot-assisted UE therapy,http://www.ncbi.nlm.nih.gov/pubmed/24297763,USA,DC,washington DC,12,12,Time 50 OK,12,1,30,,57,25th Percentile,,1095,>1year,3,0,,,,,,,,,,,,6.1,,,,,,,,,,,0,fma,ue,fma,,fma,lohse,0,0,7,25.75,11.03,,7,28.47,12.3,,,,,,0.5,2.72,11.68227076,,11.03,0.232831447,,0.869565217,0.202462128,Term G OK,All OK,,0.14672932,,0.110948446,9.013195192,,,means and SDs estimated from Figure 4
32,13,brokaw2014,brokaw,2014,ctrl,26,conventional therapy,http://www.ncbi.nlm.nih.gov/pubmed/24297763,USA,DC,washington DC,12,12,Time 50 OK,12,1,30,,57,25th Percentile,,1095,>1year,3,0,,,,,,,,,,,,6.1,,,,,,,,,,,0,fma,ue,fma,,fma,lohse,0,0,5,17.6,4.35,,5,18.39,4.38,,,,,,0.5,0.79,4.365025773,,4.35,0.18098404,,0.8,0.144787232,Term G OK,All OK,,0.203275522,,0.130096334,7.686611677,,,means and SDs estimated from Figure 4
395,114,ng2007,ng,2007,exp,254,placebo stim + task relevant therapy,http://www.ncbi.nlm.nih.gov/pubmed/17901383,China,hong kong,hong kong,20,20,Time 50 OK,20,1,28,56,57.1,50th Percentile,,1715.5,>1year,4.7,0,,,,,,,,,,,,,,,,,,,,,,,2,gait speed 4.6m SSV,le,,speed,speed,lohse,0,0,20,0.49,0.25,,20,0.58,0.3,,,20,0.58,0.29,0.5,0.09,0.276134025,0.09,0.270739727,0.325928686,0.332422585,0.96,0.312891538,Term G OK,All OK,0.319125681,0.052655738,0.052762619,0.048527528,20.6068605,0.04862603,,flow of participants through the study is not clear
494,140,pohl2002,pohl,2002,exp,318,limited progressive treadmill training,http://www.ncbi.nlm.nih.gov/pubmed/11823669,Germany,kreischa,kreischa,12,12,Time 50 OK,12,1,28,,57.1,50th Percentile,,117.6,<1year,0.322191781,1,,<26,,,,,>3,,,,,,,,,,0.1,,,,,,0,10mwt SSV,le,,speed,speed,lohse,0,0,20,0.66,0.39,,20,1.22,0.74,,,20,,,0.5,0.56,0.591481192,,0.39,0.946775668,,0.96,0.908904641,Term G OK,All OK,,0.072409604,,0.066732691,14.98515922,,,
325,95,lin2007,lin,2007,exp,210,mCIMT,http://www.ncbi.nlm.nih.gov/pubmed/18042603,Taiwan,taoyuan,taoyuan,105,75,Time 50 OK,30,1,21,,57.11,50th Percentile,,479.1,>1year,1.31260274,0,,84.7,,104,4.5,,,,,,,,,,,,,0.41,,,,,0,fim,,,,other,lohse,0,0,17,104,13.6,,17,113.6,10.55,,,,,,0.5,9.6,12.17091821,,13.6,0.788765468,,0.952380952,0.751205208,Term G OK,All OK,,0.077122087,,0.069952007,14.2955155,,Yes,
291,86,kwon2012,kwon,2012,exp,190,CPT + VR training,http://www.ncbi.nlm.nih.gov/pubmed/23232161,South korea,seoul,seoul,33.3,33.3,Time 50 OK,33.3,1,28,,57.15,50th Percentile,,24.69,<90days,0.067643836,1,,25.31,,,,,,,,,,,,,,,,,,,,,0,fma-ue,ue,fma,,fma,lohse,0,0,13,60.31,5.41,,13,62.92,3.45,,,,,,0.5,2.61,4.5371026,,5.41,0.575256993,,0.936170213,0.538538462,Term G OK,All OK,,0.089650793,,0.07857127,12.72729841,,,
410,118,olawale2011,olawale,2011,ctrl,262,conventional physiotherapy,http://www.ncbi.nlm.nih.gov/pubmed/21427155,Nigeria,lagos,lagos,36,36,Time 50 OK,36,1,84,,57.2,50th Percentile,5.9,309,<1year,0.846575342,0,,,,,,,,,,,,,,,,,,,,,,,3,10mwt SSV,le,,speed,speed,lohse,1,0,20,26.39,11.9,,20,24.65,10.49,,,,,,0.5,-1.74,11.21717656,,11.9,0.155119249,,0.96,0.148914479,Term G OK,All OK,,0.05060155,,0.046634388,21.44340352,,,sign reversed for time measure
392,114,ng2007,ng,2007,ctrl,251,no treatment,http://www.ncbi.nlm.nih.gov/pubmed/17901383,China,hong kong,hong kong,0,0,Time 50 OK,0,1,28,56,57.3,50th Percentile,,1898,>1year,5.2,0,,,,,,,,,,,,,,,,,,,,,,,1,gait speed 4.6m SSV,le,,speed,speed,lohse,0,0,20,0.63,0.25,,20,0.64,0.24,,,20,0.65,0.24,0.5,0.01,0.245051015,0.02,0.245051015,0.040807829,0.081615659,0.96,0.039175516,Term G OK,All OK,0.078351032,0.050041632,0.050166528,0.046118368,21.6833345,0.046233472,,flow of participants through the study is not clear
761,213,yen2008,yen,2008,exp,485,conventional therapy + BWSTT,http://www.ncbi.nlm.nih.gov/pubmed/17507641,Taiwan,taipei,taipei,14.1,14.1,Time 50 OK,14.1,1,28,,57.3,50th Percentile,16.44,719.05,>1year,1.97,1,,,,,4,,,,,,,,,,,,,,,,,,0,bbs,,,balance,balance,lohse,0,0,7,50.29,3.25,,7,52.43,2.88,,,,,,0.5,2.14,3.070578121,,3.25,0.696937161,,0.869565217,0.606032314,Term G OK,All OK,,0.177551529,,0.134254464,7.448541897,,,
660,182,varoqui2011,varoqui,2011,exp,414,balance practice with feedback (group a),http://www.ncbi.nlm.nih.gov/pubmed/21628724,France,montpellier,montpellier,3,3,Time 50 OK,3,1,28,,57.49,50th Percentile,,58.5,<90days,0.160273973,1,,,,54.43,,,2.5,,,,,,,,,,,1.44,,,,,0,pass,,,,other,lohse,0,0,8,26.5,5.58,,8,33,2.78,,,,,,0.5,6.5,4.408219595,,5.58,1.474518195,,0.888888889,1.31068284,Term G OK,All OK,,0.260887744,,0.206133526,4.851224444,,,
745,207,yang2010,yang,2010,ctrl,471,late intervention general exercise,http://www.ncbi.nlm.nih.gov/pubmed/20382280,Taiwan,taipei,taipei,10,10,Time 50 OK,10,1,28,,57.5,50th Percentile,7.4,766.5,>1year,2.1,0,,,,,,,,,,,,,,,,,,,,,,,0,fma-le,le,,,other,lohse,0,0,4,25.8,2.8,,4,25.5,3.4,,,4,,,0.5,-0.3,3.1144823,,2.8,-0.096324195,,0.727272727,-0.07005396,Term G OK,All OK,,0.251159794,,0.13284485,7.527578224,,,
238,71,jin2013,jin,2013,exp,156,progressive cycling intervention,http://www.ncbi.nlm.nih.gov/pubmed/23535796,China,nanjing,nanjing,40.2,40.2,Time 50 OK,40.2,1,84,,57.6,50th Percentile,,561,>1year,1.536986301,1,,,,,,,,,,,,,,,,,,,,,,,0,6minwt,le,,capacity,capacity,lohse,1,0,65,0.59,0.178,,65,0.609,0.179,,,,,,0.5,0.019,0.1785007,,0.178,0.106442159,,0.988235294,0.105189899,Term G OK,All OK,,0.015471769,,0.015109869,66.18191064,,,
713,195,whitall2011,whitall,2011,ctrl,443,dose-matched therapeutic exercise,http://www.ncbi.nlm.nih.gov/pubmed/20930212,USA,MD,baltimore,18,18,Time 50 OK,18,1,42,162,57.7,50th Percentile,9.9,1496.5,>1year,4.1,0,,,,,,,,,,,,,,,55.9,,,,,,,,6,fma-ue,ue,fma,,fma,lohse,1,1,56,31,14.85,1,50,32.9,,0,1,39,31.9,,0.5,1.9,14.85,0.9,14.85,0.127946128,0.060606061,0.98630137,0.126193441,Term G OK,All OK,0.059775841,0.018003305,0.017889938,0.017513443,57.09899533,0.01740316,,"the authors specify ITT, but the numbers in the tables do not reflect this"
152,46,fuzaro2011,fuzaro,2011,exp,100,modified forced use therapy,http://www.ncbi.nlm.nih.gov/pubmed/22378476,Brasil,sao paulo,sao paulo,23,11.5,Time 50 OK,0,1,28,90,57.8,50th Percentile,15.65,924.9,>1year,2.533972603,1,,,,,,,,,,,45,,,,48.61,,,,,,,,12,SIS,,,,other,lohse,0,0,18,48.61,7.31,,18,54.44,8.41,,,18,53.78,9.42,0.5,5.83,7.879219504,5.17,8.431266216,0.739921003,0.61319378,0.955223881,0.706790212,Term G OK,All OK,0.585737342,0.070763419,0.066000184,0.06456827,15.48748325,0.060222043,Yes,
437,124,page2008,page,2008,ctrl,277,standard care,http://www.ncbi.nlm.nih.gov/pubmed/18174447,USA,OH,cincinnati,15,15,Time 50 OK,15,1,70,,57.9,50th Percentile,8.4,1194,>1year,3.271232877,0,,,>69,,,,,,,,,,,,,,,<3,,,,,0,arat,ue,arat,,arat,lohse,1,0,12,26.17,9.02,,12,29.17,10,,,,,,0.5,3,9.522615187,,9.02,0.315039508,,0.930232558,0.293060007,Term G OK,All OK,,0.087468745,,0.075689558,13.21186206,,Yes,
436,124,page2008,page,2008,ctrl,276,no therapy,http://www.ncbi.nlm.nih.gov/pubmed/18174447,USA,OH,cincinnati,0,0,Time 50 OK,0,1,70,,57.9,50th Percentile,8.4,1194,>1year,3.271232877,0,,,>69,,,,,,,,,,,,,,,<3,,,,,0,arat,ue,arat,,arat,lohse,1,0,10,24.3,14.85,,10,25.2,16.75,,,,,,0.5,0.9,15.82853436,,14.85,0.056859339,,0.914285714,0.051985681,Term G OK,All OK,,0.100161649,,0.083726962,11.94358396,,Yes,
438,124,page2008,page,2008,exp,278,mCIMT,http://www.ncbi.nlm.nih.gov/pubmed/18174447,USA,OH,cincinnati,265,135,Time 50 OK,15,1,70,,57.9,50th Percentile,8.4,1194,>1year,3.271232877,0,,,>69,,,,,,,,,,,,,,,<3,,,,,0,arat,ue,arat,,arat,lohse,1,0,13,27.71,7.41,,13,40.54,8.18,,,,,,0.5,12.83,7.804501906,,7.41,1.643922976,,0.936170213,1.538991722,Term G OK,All OK,,0.180864721,,0.158512494,6.308650976,,Yes,
290,86,kwon2012,kwon,2012,ctrl,189,CPT,http://www.ncbi.nlm.nih.gov/pubmed/23232161,South korea,seoul,seoul,23.3,23.3,Time 50 OK,23.3,1,28,,57.92,50th Percentile,,23.92,<90days,0.065534247,1,,24.38,,,,,,,,,,,,,,,,,,,,,0,fma-ue,ue,fma,,fma,lohse,0,0,13,56.38,10.83,,13,61.85,4.54,,,,,,0.5,5.47,8.303628725,,10.83,0.658748143,,0.936170213,0.616700389,Term G OK,All OK,,0.093613428,,0.082044181,12.18855485,,,
604,167,sullivan2007,sullivan,2007,exp,380,BWSTT with cycling,http://www.ncbi.nlm.nih.gov/pubmed/17895349,USA,CA,los angeles,24,24,Time 50 OK,24,1,42,222,58.2,50th Percentile,15.2,693,>1year,1.898630137,1,,,,,,,,,,,45.2,,,,,,,,,,,,2,10mwt SSV,le,,speed,speed,lohse,1,1,20,0.54,0.28,,18,0.63,0.33,,,16,0.64,0.32,0.5,0.09,0.304635483,0.1,0.298308959,0.295435052,0.335222918,0.96,0.28361765,Term G OK,All OK,0.321814002,0.052182047,0.05280936,0.048090974,20.79392278,0.048669106,,
493,140,pohl2002,pohl,2002,exp,317,structured speed dependent treadmill training,http://www.ncbi.nlm.nih.gov/pubmed/11823669,Germany,kreischa,kreischa,12,12,Time 50 OK,12,1,28,,58.2,50th Percentile,,113.4,<1year,0.310684932,1,,<26,,,,,>3,,,,,,,,,,0.3,,,,,,0,10mwt SSV,le,,speed,speed,lohse,0,0,20,0.61,0.32,,20,1.63,0.8,,,20,,,0.5,1.02,0.609261848,,0.32,1.674157019,,0.96,1.607190738,Term G OK,All OK,,0.120070043,,0.110656552,9.036970536,,,
515,145,ribeiro2013,ribeiro,2013,exp,330,"PNF therapy, no other gait therapies given",http://www.ncbi.nlm.nih.gov/pubmed/23172402,Brasil,natal,natal,6,6,Time 50 OK,6,1,28,,58.33,50th Percentile,8.94,593.1,>1year,1.624931507,1,6.44,,,68,,,3.22,,,,,,,,,,,1.33,,,,,2,STREAM,,,,other,lohse,0,0,9,66.2,17.8,,9,74.6,18.2,,,9,,,0.5,8.4,18.00111108,,17.8,0.466637863,,0.903225806,0.42147936,Term G OK,All OK,,0.123208383,,0.100515476,9.948716753,,,
394,114,ng2007,ng,2007,exp,253,functional electrical stim + task relevant training,http://www.ncbi.nlm.nih.gov/pubmed/17901383,China,hong kong,hong kong,20,20,Time 50 OK,20,1,28,56,58.4,50th Percentile,,1825,>1year,5,0,,,,,,,,,,,,,,,,,,,,,,,1,gait speed 4.6m SSV,le,,speed,speed,lohse,0,0,21,0.51,0.28,,21,0.68,0.34,,,21,0.72,0.34,0.5,0.17,0.31144823,0.21,0.31144823,0.545837104,0.674269364,0.962025316,0.525109113,Term G OK,All OK,0.648664198,0.054712813,0.05844379,0.05063631,19.74867442,0.054089301,,flow of participants through the study is not clear
731,203,wu2012,wu,2012,ctrl,461,usual and customary care,http://www.ncbi.nlm.nih.gov/pubmed/22228607,Taiwan,taipei,taipei,30,30,Time 50 OK,30,1,21,,58.6,50th Percentile,,531,>1year,1.454794521,0,,26.1,,,,,,,,,,,,,,,,,,,,,0,arat,ue,arat,,arat,lohse,0,0,18,30.1,19.8,,18,33.9,20.3,,,,,,0.5,3.8,20.05155854,,19.8,0.189511453,,0.955223881,0.181025866,Term G OK,All OK,,0.056553183,,0.051602102,19.37905553,,,
38,15,burgar2011,burgar,2011,exp,32,robot hi,http://www.ncbi.nlm.nih.gov/pubmed/21674393,USA,TX,temple,15.8,15.8,Time 50 OK,15.8,1,21,180,58.6,50th Percentile,,16.6,<90days,0.045479452,1,,>22,,27.9,,,,,,,,,,,,,,0.31,,,,,7,fma,ue,fma,,fma,lohse,1,0,17,19,15.25549081,1,17,33.4,,1,0,11,42.6,,0.5,14.4,15.25549081,23.6,15.25549081,0.943922433,1.546983987,0.952380952,0.898973745,Term G OK,All OK,1.473318083,0.085029105,0.129210572,0.077123904,12.9661486,0.117197798,Yes,
706,194,westlake2009,westlake,2009,exp,442,gait training with lokomat,http://www.ncbi.nlm.nih.gov/pubmed/19523207,USA,CA,san francisco,6,6,Time 50 OK,6,3,28,,58.6,50th Percentile,16.9,1314,>1year,3.6,0,,,,,,,,,,,,,,,,,,,,,,,0,gait speed 4.3m SSV,le,,speed,speed,lohse,1,0,8,0.62,0.31,,8,0.72,0.38,,,,,,0.5,0.1,0.346770818,,0.31,0.2883749,,0.888888889,0.256333245,Term G OK,All OK,,0.130197505,,0.102872103,9.720808371,,,
435,123,page2005,page,2005,exp,275,modified CIMT,http://www.ncbi.nlm.nih.gov/pubmed/15673841,USA,OH,cincinnati,265,140,Time 50 OK,15,1,70,,58.6,50th Percentile,,4,<90days,0.010958904,1,,,>70,,,,,,,,,,,,,,,<3,,,,,0,fma-ue,ue,fma,,fma,lohse,1,0,5,33.9,2.13,,5,52.6,3,,,,,,0.5,18.7,2.601624493,,2.13,7.18781671,,0.8,5.750253368,Term G OK,All OK,,5.366470905,,3.434541379,0.291159689,,,"Outlying effect-size, reject from analysis"
354,106,michielsen2011,michielsen,2011,ctrl,233,homebased upper extermity therapy,http://www.ncbi.nlm.nih.gov/pubmed/21051765,Netherlands,rotterdam,rotterdam,36,36,Time 50 OK,36,1,42,180,58.7,50th Percentile,,1642.5,>1year,4.5,1,,,,,4,,,,,,,,,,,,,,,,,,1,fma-ue,ue,fma,,fma,lohse,1,1,20,36.4,14.7,,20,36.6,14.2,,,20,36.3,16.2,0.5,0.2,14.45216247,-0.1,15.46819317,0.013838759,-0.006464879,0.96,0.013285209,Term G OK,All OK,-0.006206284,0.050004788,0.050001045,0.046084412,21.69931126,0.046080963,,"the authors state an intention to treat principle, but this is not clear from the flowchart and tables. No sample size is reported in the tables for the different timepoints, so it is assumed that all observations were in fact, carried forward."
324,95,lin2007,lin,2007,ctrl,209,standard care,http://www.ncbi.nlm.nih.gov/pubmed/18042603,Taiwan,taoyuan,taoyuan,30,30,Time 50 OK,30,1,21,,58.77,50th Percentile,,498.3,>1year,1.365205479,0,,86.5,,102,4.5,,,,,,,,,,,,,0.32,,,,,2,fim,,,,other,lohse,0,0,15,102,17.8,,15,105.67,15.85,,,,,,0.5,3.67,16.85322669,,17.8,0.217762454,,0.945454545,0.205884502,Term G OK,All OK,,0.06824735,,0.061005234,16.39203613,,Yes,
485,137,piron2010,piron,2010,exp,309,training in a virtual environment with reinforcement ,http://www.ncbi.nlm.nih.gov/pubmed/20581337,Italy,venice,venice,20,20,Time 50 OK,20,1,28,,58.8,50th Percentile,,462,>1year,1.265753425,1,,,,113,,,,,,,,,,,,,,,,,,,0,fma-ue,ue,fma,,fma,lohse,1,1,27,42.4,11.3,,27,49.7,10.1,,,,,,0.5,7.3,10.71680923,,11.3,0.681172898,,0.970873786,0.661332911,Term G OK,All OK,,0.045629565,,0.043010241,23.2502766,,,
323,94,lee2012,lee,2012,exp,208,standard care + mirror box training,http://www.ncbi.nlm.nih.gov/pubmed/22469877,South korea,seoul,seoul,28.4,28.4,Time 50 OK,28.4,1,28,,58.8,50th Percentile,,105,<1year,0.287671233,0,,25.2,,,,,,,,,,,,,,,,,,,,,1,fma-shoulder/elbow,ue,fma,,fma,lohse,0,0,13,14.5,5.3,,13,24,4.8,,,,,,0.5,9.5,5.056184332,,5.3,1.878887196,,0.936170213,1.758958226,Term G OK,All OK,,0.212700657,,0.186413976,5.364404652,,,
22,9,boake2007,boake,2007,ctrl,18,conventional therapy,http://www.ncbi.nlm.nih.gov/pubmed/17172550,USA,TX,houston,36,36,Time 50 OK,36,1,14,90,58.9,50th Percentile,,14,<90days,0.038356164,1,5.3,,,,,,,,,,,,,,,,,,,,,,4,fma-ue,ue,fma,,fma,lohse,1,0,11,36.71,14.22,,9,46.71,14.88,0,0,7,50.14,10.88,0.5,10,14.51703827,13.43,13.06792447,0.688845742,1.027707195,0.923076923,0.635857608,Term G OK,All OK,0.948652795,0.112477657,0.138917367,0.09583895,10.43417108,0.118367461,Yes,
699,192,werner1996,werner,1996,exp,437,intensive outpatient therapy,http://www.ncbi.nlm.nih.gov/pubmed/8630191,USA,MI,ann arbor,96,96,Time 50 OK,96,1,84,270,59,50th Percentile,,1058.5,>1year,2.9,0,,,,75,,,,,,,,,,,,,,,,10,,,5,fim,,,,other,lohse,0,0,33,75,14,1,33,81.6,,0,1,33,82.3,,0.5,6.6,14,7.3,14,0.471428571,0.521428571,0.976377953,0.460292463,Term G OK,All OK,0.509111361,0.033670377,0.034422542,0.032098439,31.15416298,0.032815488,,
650,179,van der lee1999,van der lee,1999,exp,408,forced use therapy,http://www.ncbi.nlm.nih.gov/pubmed/10548673,Netherlands,amsterdam,amsterdam,60,60,Time 50 OK,60,1,14,365,59,50th Percentile,,1241,>1year,3.4,1,,>21,,,,,,,,,,,,,,,,,,,,,0,arat,ue,arat,,arat,lohse,1,1,31,33.4,10.6,,31,39.2,13.1,,,29,38.5,13.6,0.5,5.8,11.91574589,5.1,12.14118099,0.486750897,0.420057983,0.974789916,0.474479866,Term G OK,All OK,0.409468286,0.036079459,0.035104011,0.034283257,29.16875722,0.033356372,,
563,155,schauer2003,schauer,2003,exp,352,musical motor therapy,http://www.ncbi.nlm.nih.gov/pubmed/14606736,Germany,berlin,berlin,16.25,16.25,Time 50 OK,16.25,1,21,,59,50th Percentile,,53,<90days,0.145205479,0,,,,,,,,,,,,,,,,,,,,,,,0,gait speed,le,,speed,speed,lohse,0,0,11,0.64,0.3,,11,0.81,0.29,,,,,,0.5,0.17,0.29504237,,0.3,0.57618843,,0.923076923,0.531866244,Term G OK,All OK,,0.105999687,,0.09031926,11.07183562,,,
696,191,wang2005,wang,2005,exp,434,orthopaedic treatment programme severe group,http://www.ncbi.nlm.nih.gov/pubmed/15759530,Taiwan,taipei,taipei,13.3,13.3,Time 50 OK,13.3,1,28,,59.3,50th Percentile,,20.7,<90days,0.056712329,0,,,,,2 to 3,,,,,,10.67,,,11.33,14.17,,,,,,,,0,stroke impairment assessment set,,,,other,lohse,1,0,11,1,1.86,,11,4,2.63,,,,,,0.5,3,2.277773035,,1.86,1.317075913,,0.923076923,1.215762381,Term G OK,All OK,,0.169758589,,0.144646372,6.913412249,,,
447,128,park2011,park,2011,exp,286,routine PT + community ambulation training,http://www.ncbi.nlm.nih.gov/pubmed/21245205,South korea,daejeon,daejeon,32,32,Time 50 OK,32,1,28,,59.4,50th Percentile,8.46,843,>1year,2.309589041,1,,>25,,,,,,,,,,,,,,,,,,,,,1,10mwt,le,,speed,speed,lohse,0,0,14,0.51,0.18,,13,0.72,0.24,,,,,,0.5,0.21,0.21094075,,0.18,0.995540217,,0.941176471,0.936979028,Term G OK,All OK,,0.106825012,,0.094627,10.56780834,,,
194,59,hidler2009,hidler,2009,exp,126,lokomat gait training,http://www.ncbi.nlm.nih.gov/pubmed/19109447,USA,DC,washington DC,24,24,Time 50 OK,24,3,63,153,59.5,50th Percentile,9.4,110.9,<1year,0.303835616,1,,26.7,,,,,,,,,,,,,,,,,,,8.2,,5,gait speed SSV,le,,speed,speed,lohse,1,0,33,0.34,0.172,1,33,0.46,,1,0,33,0.49,,0.5,0.12,0.172,0.15,0.172,0.697674419,0.872093023,0.976377953,0.681193921,Term G OK,All OK,0.851492401,0.037678024,0.041826458,0.035918984,27.84043112,0.039873744,,
241,72,johannsen2010,johannsen,2010,exp,159,bilateral leg training with auditory cuing,http://www.ncbi.nlm.nih.gov/pubmed/19822721,UK,birmingham,birmingham,7.5,7.5,Time 50 OK,7.5,1,42,90,59.5,50th Percentile,13.4,1532,>1year,4.197260274,1,,,,,,,,,,,,,,,,,,,,,,,1,fma-le,le,,,other,lohse,1,0,11,25.39,3.33,1,11,28.19,,1,0,11,25.59,,0.5,2.8,3.33,0.2,3.33,0.840840841,0.06006006,0.923076923,0.776160776,Term G OK,All OK,0.055440055,0.12304606,0.091073055,0.10484398,9.537982057,0.07760071,,change means and standard deviations calculated from figures
654,180,van nes2006,van nes,2006,exp,410,balance vibration trianing + CPT,http://www.ncbi.nlm.nih.gov/pubmed/16902175,Netherlands,nijmegen,nijmegen,220.7,220.7,Time 50 OK,220.7,1,42,84,59.7,50th Percentile,,38.9,<90days,0.106575342,1,,,,,,,1,10.3,,47.4,23.9,,,,,5.3,,,,,,,0,bbs,le,,balance,balance,lohse,1,1,27,23.9,14.8,,27,40.6,12.8,,,27,44.3,10.9,0.5,16.7,13.83618445,20.4,12.99711506,1.206980152,1.569579087,0.970873786,1.17182539,Term G OK,All OK,1.523863192,0.064014835,0.082658861,0.060340122,16.57272088,0.077913905,,
702,193,werner2002,werner,2002,exp,440,treadmill therapy,http://www.ncbi.nlm.nih.gov/pubmed/12468788,Germany,berlin,berlin,3.33,3.33,Time 50 OK,3.33,3,14,,59.7,50th Percentile,10.2,51.52,<90days,0.141150685,1,,,,,,,1.2,,,,,,,,,2,1,,,,,,,fac,le,,,other,lohse,1,0,15,1.2,0.59,,14,1.6,0.74,,,,,,0.5,0.4,0.666449965,,0.59,0.600195095,,0.945454545,0.567457181,Term G OK,All OK,,0.078674472,,0.070325875,14.21951735,,,
714,195,whitall2011,whitall,2011,exp,444,bilateral arm training with auditory cuing,http://www.ncbi.nlm.nih.gov/pubmed/20930212,USA,MD,baltimore,18,18,Time 50 OK,18,1,42,162,59.8,50th Percentile,12.5,1642.5,>1year,4.5,0,,,,,,,,,,,,,,,54.6,,,,,,,,13,fma-ue,ue,fma,,fma,lohse,1,1,55,32.3,14.26,1,42,33.4,,0,1,39,32.3,,0.5,1.1,14.26,0,14.26,0.07713885,0,0.986046512,0.076062494,Term G OK,All OK,0,0.018235913,0.018181818,0.017730554,56.39981695,0.017677959,,"the authors specify ITT, but the numbers in the tables do not reflect this"
647,178,van deldan2013,van deldan,2013,exp,405,mCIMT,http://www.ncbi.nlm.nih.gov/pubmed/23868279,Netherlands,amsterdam,amsterdam,198,108,Time 50 OK,18,1,42,84,59.8,50th Percentile,,64.4,<90days,0.176438356,0,,>23,,,,,,,,65.4,,,,,collected,,,,,,,,1,arat,ue,arat,,arat,lohse,1,0,22,23.8,16.8,1,21,38.4,,0,1,20,42.9,,0.5,14.6,16.8,19.1,16.8,0.869047619,1.136904762,0.963855422,0.837636259,Term G OK,All OK,1.095811819,0.062619176,0.074830737,0.058174297,17.18972212,0.069519047,,Change scores estimated from Figure 2
736,205,yang2006,yang,2006,ctrl,466,usual care/no rehabilitation (chronic stage),http://www.ncbi.nlm.nih.gov/pubmed/17008338,Taiwan,taipei,taipei,0,0,Time 50 OK,0,1,28,,60,50th Percentile,10.4,1920,>1year,5.260273973,0,,,,,,,,,,,,,,,,,,,,,,,0,gait speed 3.7m SSV,le,,speed,speed,lohse,0,0,24,77.9,14.3,,24,77.7,15.4,,,,,,0.5,-0.2,14.86018169,,14.3,-0.013458786,,0.967032967,-0.013015089,Term G OK,All OK,,0.04167044,,0.038968227,25.66193222,,,
56,21,conroy2011,conroy,2011,exp,46,robot assisted therapy with gravity compensation,http://www.ncbi.nlm.nih.gov/pubmed/21849168,USA,MD,baltimore,18,18,Time 50 OK,18,1,42,126,60,50th Percentile,,1825,>1year,5,1,,,,,,,,,,,,,,,70.6,,,,,,,,5,fma-ue,ue,fma,,fma,lohse,1,0,21,16.5,10.6,1,16,18.2,,1,0,16,19.11,,0.5,1.7,10.6,2.61,10.6,0.160377358,0.246226415,0.962025316,0.154287079,Term G OK,All OK,0.236876045,0.04823145,0.049062558,0.044637855,22.40251016,0.04540704,,
229,66,huseman2007,huseman,2007,exp,147,lokomat gait training,http://www.ncbi.nlm.nih.gov/pubmed/17204680,Germany,bad aibling,bad aibling,20,20,Time 50 OK,20,1,28,,60,50th Percentile,,79,<90days,0.216438356,1,,,,,,,,,,,,,,,,,,,,,,,2,10mwt,le,,speed,speed,lohse,1,1,16,0.14,0.08,,16,0.2,0.12,,,,,,0.5,0.06,0.10198039,,0.08,0.588348405,,0.949152542,0.558432385,Term G OK,All OK,,0.073317308,,0.06605087,15.139846,,,
142,44,fisher2011,fisher,2011,ctrl,96,CPT,http://www.ncbi.nlm.nih.gov/pubmed/21642064,USA,TX,houston,24,24,Time 50 OK,24,2,56,,60,50th Percentile,14,81,<90days,0.221917808,0,,,,,,,,,,,,,,,,,,,,,,,0,walk time (8 meters),le,,,other,lohse,0,0,10,105,95,,10,57,65,,,,,,0.5,-48,81.39410298,,95,0.589723312,,0.914285714,0.5391756,Term G OK,All OK,,0.117388679,,0.098127353,10.19083843,,Yes,sign reversed for time measure
141,44,fisher2011,fisher,2011,exp,95,robot assited gait therapy,http://www.ncbi.nlm.nih.gov/pubmed/21642064,USA,TX,houston,24,24,Time 50 OK,24,2,56,,60,50th Percentile,14,57,<90days,0.156164384,0,,,,,,,,,,,,,,,,,,,,,,,0,walk time (8 meters),le,,,other,lohse,0,0,10,143,105,,10,56,73,,,,,,0.5,-87,90.42676595,,105,0.962104517,,0.914285714,0.879638416,Term G OK,All OK,,0.146282255,,0.122280024,8.177950636,,Yes,sign reversed for time measure
624,171,tanaka2012,tanaka,2012,ctrl,390,no therapy,http://www.ncbi.nlm.nih.gov/pubmed/22275464,Japan,tsukuba,tsukuba,0,0,Time 50 OK,0,1,28,56,60,50th Percentile,8.5,1962,>1year,5.375342466,1,,>23,,78.2,,,,,,,,,,,,,,,,,,,0,gait speed,le,,speed,speed,lohse,0,0,5,0.86,0.16,,5,0.88,0.16,,,,,,0.5,0.02,0.16,,0.16,0.125,,0.8,0.1,Term G OK,All OK,,0.2015625,,0.129,7.751937984,,Yes,
122,40,duncan2011,duncan,2011,exp,86,early locomotor,http://www.nejm.org/doi/full/10.1056/NEJMoa1010790,USA,NC,durham,54,54,Time 50 OK,54,3,98,365,60.1,50th Percentile,12.3,64.1,<90days,0.175616438,1,,26,,,,,,,,,,,,,54.1,,,,3.370503597,,,,,gait speed comfortable,le,,speed,speed,lohse,1,1,139,0.37,0.22,1,139,0.62,,1,0,139,0.6,,0.5,0.25,0.22,0.23,0.22,1.136363636,1.045454545,0.994555354,1.130176539,Term G OK,All OK,1.039762415,0.011839289,0.01112581,0.011710718,85.39186069,0.011004988,Yes,
659,182,varoqui2011,varoqui,2011,ctrl,413,standing practice (group c),http://www.ncbi.nlm.nih.gov/pubmed/21628724,France,montpellier,montpellier,3,3,Time 50 OK,3,1,28,,60.12,50th Percentile,,72.14,<90days,0.197643836,1,,,,51.29,,,3,,,,,,,,,,,2.71,,,,,0,pass,,,,other,lohse,0,0,7,27.57,4.65,,7,31.14,4.45,,,,,,0.5,3.57,4.551098768,,4.65,0.784425955,,0.869565217,0.682109527,Term G OK,All OK,,0.186808863,,0.141254339,7.079428548,,,
372,110,morone2011,morone,2011,ctrl,241,CPT for the low motricity group,http://www.ncbi.nlm.nih.gov/pubmed/21444654,Italy,rome,rome,60,60,Time 50 OK,60,1,28,100,60.17,50th Percentile,17.43,20,<90days,0.054794521,1,,>24,,,,,0,,,16.25,,,,,,,,1.67,,,,,7,fac,le,,,other,lohse,1,1,12,0,0.39,,12,1.2,0.8,,,12,2.05,1.15,0.5,1.2,0.629325035,2.05,0.858661749,1.906804803,2.387436032,0.930232558,1.77377191,Term G OK,All OK,2.220870727,0.234829357,0.320827117,0.203205501,4.921126619,0.277622167,,
564,156,schmid2012,schmid,2012,ctrl,353,waitlisted control group,http://www.ncbi.nlm.nih.gov/pubmed/22836351,USA,IN,indianapolis,0,0,Time 50 OK,0,1,56,,60.2,50th Percentile,,1092,>1year,2.991780822,1,,,,,,,,,,,,,,,,,,,,,,,1,bbs,le,,balance,balance,lohse,0,1,10,41.9,6.4,,10,43.8,6.3,,,,,,0.5,1.9,6.350196847,,6.4,0.299203323,,0.914285714,0.273557324,Term G OK,All OK,,0.104476131,,0.087333517,11.4503576,,,
701,193,werner2002,werner,2002,exp,439,robotic gait trainer therapy,http://www.ncbi.nlm.nih.gov/pubmed/12468788,Germany,berlin,berlin,3.33,3.33,Time 50 OK,3.33,3,14,,60.3,50th Percentile,8.6,48.51,<90days,0.13290411,1,,,,,,,1.1,,,,,,,,,2,1,,,,,,,fac,le,,,other,lohse,1,0,15,1.1,0.6,,15,2.1,0.9,,,,,,0.5,1,0.764852927,,0.6,1.307440901,,0.945454545,1.236125943,Term G OK,All OK,,0.123646724,,0.110525865,9.047655949,,,Data are taken up to the cross-over point
313,93,lee2008,lee,2008,exp,206,cycling + progressive resistence training,http://www.ncbi.nlm.nih.gov/pubmed/18422947,Australia,sydney,sydney,30,30,Time 50 OK,30,1,77,,60.5,50th Percentile,10.6,1896,>1year,5.194520548,1,,,,,,,,,,,,,,,,,,,,,,,1,6minwt,le,,capacity,capacity,lohse,0,1,12,266,123.5,,12,290.2,136.2,,,,,,0.5,24.2,130.005173,,123.5,0.186146439,,0.930232558,0.173159478,Term G OK,All OK,,0.084777104,,0.073360393,13.63133374,,,
251,75,jung2012,jung,2012,ctrl,165,VR treadmill training,https://www.jstage.jst.go.jp/article/jpts/24/11/24_1133/_pdf,South korea,seoul,seoul,7.5,7.5,Time 50 OK,7.5,1,21,,60.5,50th Percentile,,378,>1year,1.035616438,1,,26.4,,,>4,,,,,,,,,,,,,,,,,,0,tug,le,,balance,balance,lohse,0,0,11,21.9,3.5,,11,19.2,4.5,,,,,,0.5,-2.7,4.031128874,,3.5,0.669787567,,0.923076923,0.618265446,Term G OK,All OK,,0.111300699,,0.094836099,10.54450795,,,sign reversed for time measure
602,167,sullivan2007,sullivan,2007,exp,378,BWSTT with upper extremity ergometry,http://www.ncbi.nlm.nih.gov/pubmed/17895349,USA,CA,los angeles,24,24,Time 50 OK,24,1,42,222,60.6,50th Percentile,13.7,825,>1year,2.260273973,1,,,,,,,,,,,42.1,,,,,,,,,,,,1,10mwt SSV,le,,speed,speed,lohse,1,1,20,0.5,0.23,,19,0.63,0.32,,,19,0.65,0.33,0.5,0.13,0.277454647,0.15,0.28309582,0.468545045,0.529855934,0.96,0.449803243,Term G OK,All OK,0.508661696,0.055488361,0.057018683,0.051138074,19.5549015,0.052548418,,
73,28,de deigo2013,de deigo,2013,ctrl,61,traditional therapy,http://www.ncbi.nlm.nih.gov/pubmed/23524843,Spain,barcelona,barcelona,16,16,Time 50 OK,16,1,56,,60.6,50th Percentile,,1821,>1year,4.989041096,0,,,,,,,,,,,,,,,,,,,,,,,0,fma,ue,fma,,fma,lohse,0,0,9,33.73,7.3,,9,36.7,7.6,0,,,,,0.5,2.97,7.451509914,,7.3,0.398576937,,0.903225806,0.360004976,Term G OK,All OK,,0.119936865,,0.097846517,10.22008785,,Yes,
580,159,shin2010,shin,2010,ctrl,360,no specified physical therapy,http://www.koreascience.or.kr/article/ArticleFullRecord.jsp?cn=SHGSCZ_2010_v11n1_368,South korea,asan,asan,0,0,Time 50 OK,0,1,42,,60.69,50th Percentile,9.23,2145,>1year,5.876712329,1,,24.19,,,,,,,,,,,,,,,,,,,,,0,10mwt,le,,speed,speed,lohse,0,0,16,0.87,0.19,,16,0.88,0.19,,,,,,0.5,0.01,0.19,,0.19,0.052631579,,0.949152542,0.049955397,Term G OK,All OK,,0.062586565,,0.056383645,17.73563947,,,
522,147,richards2004,richards,2004,ctrl,335,CPT,http://www.ncbi.nlm.nih.gov/pubmed/15537991,Canada,quebec,quebec city,44.9,44.9,Time 50 OK,44.9,2,56,,60.7,50th Percentile,12,52.6,<90days,0.144109589,1,,,,,,,,,,,,,,,,,,,,,,,1,gait speed SSV,le,,speed,speed,lohse,1,1,31,24.34,12.29,,31,56.14,36.63,,,31,67.71,33.73,0.5,31.8,27.32033126,43.37,25.38461148,1.163968317,1.708515414,0.974789916,1.134624578,Term G OK,All OK,1.665443597,0.054110036,0.079339112,0.051416189,19.4491272,0.075389244,,
581,159,shin2010,shin,2010,exp,361,game-based therapy using PS2 eyetoy,http://www.koreascience.or.kr/article/ArticleFullRecord.jsp?cn=SHGSCZ_2010_v11n1_368,South korea,asan,asan,18,18,Time 50 OK,18,1,42,,60.75,50th Percentile,7.53,2075.7,>1year,5.686849315,1,,25.06,,,,,,,,,,,,,,,,,,,,,0,10mwt,le,,speed,speed,lohse,0,0,16,0.86,0.32,,16,1.1,0.34,,,,,,0.5,0.24,0.33015148,,0.32,0.726939039,,0.949152542,0.689976037,Term G OK,All OK,,0.079013761,,0.071182751,14.04834719,,,
429,122,page2004,page,2004,ctrl,272,CPT,http://www.ncbi.nlm.nih.gov/pubmed/14970962,USA,OH,cincinnati,30,30,Time 50 OK,30,1,70,,60.75,50th Percentile,,1140,>1year,3.123287671,0,,,>70,,,,,,,,,,,,,,,<3,,,,,0,fma-ue,ue,fma,,fma,lohse,1,0,4,29.55,7.2,,4,35.5,7.2,,,,,,0.5,5.95,7.2,,7.2,0.826388889,,0.727272727,0.601010101,Term G OK,All OK,,0.335364824,,0.177383048,5.63751729,,,standard deviations are estimated from the standard errors  in Table 3
15,6,bale2008,bale,2008,exp,13,functional strength training,http://www.ncbi.nlm.nih.gov/pubmed/18955423,Norway,Frde,Frde,16.67,16.67,Time 50 OK,16.67,1,28,,60.8,50th Percentile,,49.4,<90days,0.135342466,1,,,,,,,,,,,,,,,,,,,,,,,0,gait speed SSV,le,,speed,speed,lohse,0,1,8,0.13,0.2,,8,0.36,0.2,,,,,,0.5,0.23,0.2,,0.2,1.15,,0.888888889,1.022222222,Term G OK,All OK,,0.20765625,,0.164074074,6.094808129,,,
549,151,sackley1997,sackley,1997,exp,344,balance training with augmented visual feedback,http://www.ncbi.nlm.nih.gov/pubmed/9442992,UK,nottingham,nottingham,12,12,Time 50 OK,12,1,28,84,60.8,50th Percentile,,140.7,<1year,0.385479452,0,,,,,,,,,,,,,,,,10.4,,,,,,,0,rivermead motor assessment,,,,other,lohse,0,0,13,10.4,3.5,,13,17,2.9,,,12,13.8,4.4,0.5,6.6,3.214031736,3.4,3.956063041,2.053495591,0.859440298,0.936170213,1.922421405,Term G OK,All OK,0.804582407,0.23910939,0.105332216,0.209558977,4.77192633,0.092314699,,
742,206,yang2008,yang,2008,ctrl,468,treadmill training,http://www.ncbi.nlm.nih.gov/pubmed/18358724,Taiwan,taipei,taipei,3,3,Time 50 OK,3,1,21,51,60.89,50th Percentile,9.25,2226.5,>1year,6.1,0,,,,,,,,,,,,,,,,,,,,,,,0,gait speed 12m MAX,le,,speed,speed,lohse,0,0,12,0.71,0.57,,9,0.73,0.63,,,9,0.77,0.71,0.5,0.02,0.595999823,0.06,0.63273425,0.033557057,0.09482654,0.930232558,0.031215867,Term G OK,All OK,0.088210735,0.083380253,0.083708003,0.072151652,13.85969652,0.072435265,,
722,199,wolf2006; 2010,wolf,2006,exp,452,cimt,http://www.ncbi.nlm.nih.gov/pubmed/17077374,USA,GA,atlanta,261.6,160.8,Time 50 OK,60,1,14,365,61,50th Percentile,,179.8,<1year,0.49260274,1,,28,,,,,,,,,,,,,52.5,,,0.88,,,,,7,wmft-time,ue,wmft,,wmft,lohse,1,1,105,2.96,1.37,,98,2.38,1.37,,,80,2.23,1.37,0.5,-0.58,1.37,-0.73,1.37,0.423357664,0.532846715,0.992771084,0.420297247,Term G OK,All OK,0.528994811,0.010377294,0.010875836,0.010227803,97.77270837,0.010719164,Yes,"Outcome measure is WMFT-time, so lower numbers mean better performance; Authors report ITT analysis, but different numbers are reported for the different timepoints in the tables"
562,155,schauer2003,schauer,2003,ctrl,351,conventional gait therapy,http://www.ncbi.nlm.nih.gov/pubmed/14606736,Germany,berlin,berlin,16.25,16.25,Time 50 OK,16.25,1,21,,61,50th Percentile,,67,<90days,0.183561644,0,,,,,,,,,,,,,,,,,,,,,,,0,gait speed,le,,speed,speed,lohse,0,0,12,0.77,0.3,,12,0.8,0.35,,,,,,0.5,0.03,0.32596012,,0.3,0.092035799,,0.930232558,0.085614696,Term G OK,All OK,,0.083686275,,0.072416463,13.80901467,,,
356,107,mirelman2009,mirelman,2009,exp,235,robot assisted therapy,http://www.ncbi.nlm.nih.gov/pubmed/18988916,Israel,tel aviv,tel aviv,7.5,7.5,Time 50 OK,7.5,4,28,90,61,50th Percentile,8.32,1746,>1year,4.783561644,0,,,,,,,,,,,46,,,,,,,,,,,,0,gait speed SSV,le,,speed,speed,lohse,1,0,9,0.67,0.28,,9,0.68,,,,9,0.67,0.29,0.5,0.01,0.28,0,0.285043856,0.035714286,0,0.903225806,0.032258065,Term G OK,All OK,0,0.111181973,0.111111111,0.090704128,11.02485655,0.090646317,,active time in therapy was much lower than scheduled time
35,14,brunner2012,brunner,2012,exp,29,modified CIMT,http://www.ncbi.nlm.nih.gov/pubmed/22561098,Norway,bergen,bergen,106,66,Time 50 OK,26,1,28,118,61,50th Percentile,,48.43,<90days,0.132684932,1,,>24,,,,,,,,,,,,,,,,,,,,,1,arat,ue,arat,,arat,lohse,1,0,14,26.46,13.18,,13,39.69,13.4,,,13,44.23,15.08,0.5,13.23,13.28605464,17.77,14.1239343,0.995780941,1.258148022,0.941176471,0.937205592,Term G OK,All OK,1.184139315,0.106842132,0.127962016,0.094642165,10.56611501,0.113350436,,
478,135,piron2007,piron,2007,ctrl,304,CPT,http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=4362151&tag=1,Italy,venice,venice,30,30,Time 50 OK,30,1,42,,61.2,50th Percentile,6.6,78,<90days,0.21369863,1,,,,,,,,,,,,,,,,,,,,,,,,fim,,,,other,lohse,1,0,13,88.2,30,,13,95.9,28.3,,,,,,0.5,7.7,29.16239016,,30,0.264038714,,0.936170213,0.247185179,Term G OK,All OK,,0.079604479,,0.069766533,14.33352006,,,
27,11,brock2011,brock,2011,exp,23,bobath + task specific practice,http://www.ncbi.nlm.nih.gov/pubmed/21788266,Australia,victoria,melbourne,6,6,Time 50 OK,6,1,14,,61.3,50th Percentile,13,60.3,<90days,0.165205479,1,,,,,,,,,,,,,,,,,,,,,,,2,6minwt,le,,capacity,capacity,lohse,1,0,14,102.6,64.5,,12,192.5,113.5,0,0,,,,0.5,89.9,90.32072483,,64.5,0.995341879,,0.941176471,0.936792357,Term G OK,All OK,,0.106810909,,0.094614508,10.56920362,,Yes,
605,167,sullivan2007,sullivan,2007,exp,381,BWSTT with progessive lower extremity resistance training,http://www.ncbi.nlm.nih.gov/pubmed/17895349,USA,CA,los angeles,24,24,Time 50 OK,24,1,42,222,61.4,50th Percentile,11.2,621,>1year,1.701369863,1,,,,,,,,,,,40.4,,,,,,,,,,,,4,10mwt SSV,le,,speed,speed,lohse,1,1,20,0.57,0.35,,16,0.67,0.37,,,14,0.77,0.3,0.5,0.1,0.358960919,0.2,0.330600779,0.278581859,0.604959252,0.96,0.267438585,Term G OK,All OK,0.580760882,0.051940196,0.059149392,0.047868085,20.89074589,0.05451208,,
479,135,piron2007,piron,2007,exp,305,reinforcing practice in a virtual environment + CPT,http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=4362151&tag=1,Italy,venice,venice,30,30,Time 50 OK,30,1,42,,61.5,50th Percentile,9.4,75,<90days,0.205479452,1,,,,,,,,,,,,,,,,,,,,,,,,fim,,,,other,lohse,1,0,25,93.4,28.6,,15,110.2,13.9,,,,,,0.5,16.8,24.24435908,,28.6,0.692944695,,0.968421053,0.671062231,Term G OK,All OK,,0.049603447,,0.046520064,21.49610112,,,
636,176,treger2012,treger,2012,ctrl,400,standard care,http://www.ncbi.nlm.nih.gov/pubmed/22750958,Israel,tel aviv,tel aviv,17.5,17.5,Time 50 OK,17.5,1,14,,61.5,50th Percentile,,23.3,<90days,0.063835616,1,3.4,,,27.5,,,,,,,,,,,,,,,,,,,0,mft,,,,other,lohse,0,0,19,6.3,22,1,19,9.8,,,,,,,0.5,3.5,22,,22,0.159090909,,0.957746479,0.152368758,Term G OK,All OK,,0.053297629,,0.04888876,20.45459938,,Yes,
102,36,dromerick2000,dromerick,2000,exp,78,CIMT,http://www.ncbi.nlm.nih.gov/pubmed/11108760,USA,MO,st. louis,104,62,Time 50 OK,20,1,14,,61.5,50th Percentile,,6,<90days,0.016,1,10.2,26.3,,,,,,,,,,,,>3,,,,,,,,,0,arat,ue,arat,,arat,lohse,1,0,11,27.3,19.9,,11,52.8,5.9,,,,,,0.5,25.5,14.67685252,,19.9,1.737429736,,0.923076923,1.603781294,Term G OK,All OK,,0.228121004,,0.194375293,5.144686779,,Yes,
492,140,pohl2002,pohl,2002,ctrl,316,conventional gait training,http://www.ncbi.nlm.nih.gov/pubmed/11823669,Germany,kreischa,kreischa,15,15,Time 50 OK,15,1,28,,61.6,50th Percentile,,112.7,<1year,0.308767123,1,,<26,,,,,>3,,,,,,,,,,0.1,,,,,,0,10mwt SSV,le,,speed,speed,lohse,0,0,20,0.66,0.42,,20,0.97,0.64,,,20,,,0.5,0.31,0.541294744,,0.42,0.572700924,,0.96,0.549792887,Term G OK,All OK,,0.058199659,,0.053636805,18.64391438,,,
248,74,jonsdottir2010,jonsdottir,2010,exp,162,task oriented biofeedback with a progressive schedule,http://www.ncbi.nlm.nih.gov/pubmed/20053951,Italy,milan,milan,15.75,15.75,Time 50 OK,15.75,1,49,91,61.6,50th Percentile,,2153,>1year,5.898630137,0,,>24,,,,,,,95.2,,,,,,,,,,,,,,0,height normalized speed,le,,,other,lohse,0,1,10,28.7,10.8,,10,39.6,7.6,,,9,38.8,8.9,0.5,10.9,9.338094024,10.1,9.951174923,1.167261753,1.014955528,0.914285714,1.067210746,Term G OK,All OK,0.92795934,0.168125,0.151506736,0.140538776,7.115473953,0.126647264,,
136,42,fang2003,fang,2003,ctrl,92,"not clear described as CPT and ""no professional rehabilitation""",http://www.ncbi.nlm.nih.gov/pubmed/12971705,China,guangzhou,guangzhou,11.25,11.25,Time 50 OK,11.25,1,30,180,61.8,50th Percentile,10.94,7,<90days,0.019178082,1,,18.85,,,,,,33.53,,,,,13.1,,,,,,,,,,0,fma-ue,ue,fma,,fma,lohse,0,0,78,22.99,21.91,,78,28.66,21.4,1,0,12,48.52,26.65,0.5,5.67,21.65650133,25.53,22.5570366,0.261815143,1.131797605,0.990228013,0.259256689,Term G OK,All OK,1.120737694,0.013259918,0.021031832,0.013002032,76.91105513,0.020622795,Yes,
357,107,mirelman2009,mirelman,2009,exp,236,robot assisted therapy + VR interface,http://www.ncbi.nlm.nih.gov/pubmed/18988916,Israel,tel aviv,tel aviv,8.2,8.2,Time 50 OK,8.2,4,28,90,61.8,50th Percentile,9.94,1131,>1year,3.098630137,0,,,,,,,,,,,48,,,,,,,,,,,,0,gait speed SSV,le,,speed,speed,lohse,1,0,9,0.65,0.25,,9,0.81,,,,9,0.76,0.18,0.5,0.16,0.25,0.11,0.217830209,0.64,0.504980464,0.903225806,0.578064516,Term G OK,All OK,0.456111387,0.133866667,0.12527807,0.109210683,9.156613369,0.102203962,,active time in therapy was much lower than scheduled time
746,207,yang2010,yang,2010,exp,472,early intervention BWSTT,http://www.ncbi.nlm.nih.gov/pubmed/20382280,Taiwan,taipei,taipei,10,10,Time 50 OK,10,1,28,,61.8,50th Percentile,2.91,109.5,<1year,0.3,0,,,,,,,,,,,,,,,,,,,,,,,0,fma-le,le,,,other,lohse,0,0,5,23.6,6.9,,5,26.8,6.7,,,5,,,0.5,3.2,6.800735254,,6.9,0.470537358,,0.8,0.376429887,Term G OK,All OK,,0.222140541,,0.142169946,7.033835407,,,
190,58,hesse2011,hesse,2011,ctrl,124,continuous low intensity,http://www.ncbi.nlm.nih.gov/pubmed/7762049,Germany,berlin,berlin,65,65,Time 50 OK,65,1,365,455,61.9,50th Percentile,9.4,103.6,<1year,0.283835616,1,,,,,,,,,,,,8.6,,,,8.5,,5.3,,,,,0,rivermead mobility,,,,other,lohse,1,1,25,8.5,3.5,,25,11.2,2.7,,,25,11.3,2.7,0.5,2.7,3.125699922,2.8,3.125699922,0.863806529,0.895799363,0.968421053,0.836528428,Term G OK,All OK,0.867510962,0.054923234,0.05604913,0.05150917,19.4140189,0.052565079,Yes,
72,28,de deigo2013,de deigo,2013,exp,60,sensory stimulation + functional activity training,http://www.ncbi.nlm.nih.gov/pubmed/23524843,Spain,barcelona,barcelona,44,44,Time 50 OK,44,1,56,,61.9,50th Percentile,,1341,>1year,3.673972603,0,,,,,,,,,,,,,,,,,,,,,,,0,fma,ue,fma,,fma,lohse,0,0,12,24.3,4.6,,12,29.4,4.9,0,,,,,0.5,5.1,4.752367831,,4.6,1.073149256,,0.930232558,0.998278377,Term G OK,All OK,,0.131318722,,0.113634373,8.800154158,,Yes,
409,117,noh2008,noh,2008,exp,261,aquatic exercise therapy,http://cre.sagepub.com/content/22/10-11/966.full.pdf,South korea,seoul,seoul,24,24,Time 50 OK,24,1,56,,61.9,50th Percentile,,1022,>1year,2.8,0,,,,,,,,,,,,,,,,,,,,,,,3,bbs,le,,balance,balance,lohse,1,0,13,43.3,5.2,,10,50.9,2.8,,,,,,0.5,7.6,4.337214379,,5.2,1.752276769,,0.936170213,1.640429316,Term G OK,All OK,,0.195018226,,0.170916834,5.850798757,,,
649,179,van der lee1999,van der lee,1999,ctrl,407,bimanual training using neurodevelopmental methods,http://www.ncbi.nlm.nih.gov/pubmed/10548673,Netherlands,amsterdam,amsterdam,60,60,Time 50 OK,60,1,14,365,62,50th Percentile,,985.5,>1year,2.7,1,,>21,,,,,,,,,,,,,,,,,,,,,0,arat,ue,arat,,arat,lohse,1,1,31,28.3,13.3,,30,30,13.9,,,29,30.7,14.2,0.5,1.7,13.59822396,2.4,13.74184398,0.125016326,0.17464905,0.974789916,0.121864654,Term G OK,All OK,0.170246133,0.032510146,0.032750037,0.030891641,32.37121654,0.031119589,,
566,157,schwartz2009,schwartz,2009,ctrl,355,regular physiotherapy,http://www.ncbi.nlm.nih.gov/pubmed/19627940,Israel,jerusalem,jerusalem,20,20,Time 50 OK,20,2,42,,62,50th Percentile,7.5,21.6,<90days,0.059178082,1,10.5,,,,,,,,,,,,,,,,,,,,,,3,FIM motor,,,,other,lohse,0,1,30,42.8,11,,30,60.3,14.8,,,,,,0.5,17.5,13.03917175,,11,1.342109785,,0.973913043,1.307098226,Term G OK,All OK,,0.063354311,,0.060091983,16.64115494,,,
66,25,dahl2008,dahl,2008,exp,54,CIMT,http://cre.sagepub.com/content/22/5/436.short,Norway,trondheim,trondheim,204,132,Time 50 OK,60,1,14,180,62,50th Percentile,,630,>1year,1.726027397,1,,,,,,,,,,,,,,,,,,,,,,,0,wmft,ue,wmft,,wmft,lohse,1,1,18,2.17,0.78,,18,1.56,0.57,0,0,18,1.82,0.8,0.5,-0.61,0.683117852,-0.35,0.790063289,0.892964513,0.443002485,0.955223881,0.852981027,Term G OK,All OK,0.423166553,0.077705156,0.061006978,0.070902277,14.1039194,0.055665979,Yes,sign reversed for time measure
398,115,ng2008,ng,2008,exp,257,electromechanical gait training + FES,http://stroke.ahajournals.org/content/39/1/154.short,China,hong kong,hong kong,50,50,Time 50 OK,50,1,28,180,62,50th Percentile,10,16.1,<90days,0.044109589,1,,>21,,,,,<3,,,,,,,,,,,,,,,,0,fim,,,,other,lohse,0,1,16,65,16.8,,16,86.4,20.5,,,16,94,20.2,0.5,21.4,18.74153142,29,18.57794391,1.141849058,1.560990825,0.949152542,1.083788936,Term G OK,All OK,1.48161841,0.103244352,0.138646636,0.093011861,10.75131697,0.124905444,,
637,176,treger2012,treger,2012,exp,401,mcimt,http://www.ncbi.nlm.nih.gov/pubmed/22750958,Israel,tel aviv,tel aviv,57.5,37.5,Time 50 OK,17.5,1,14,,62,50th Percentile,,39.8,<90days,0.109041096,1,3.5,,,17.4,,,,,,,,,,,,,,,,,,,0,mft,,,,other,lohse,0,0,9,10.2,21.6,1,9,15.6,,,,,,,0.5,5.4,21.6,,21.6,0.25,,0.903225806,0.225806452,Term G OK,All OK,,0.114583333,,0.093479015,10.69758812,,Yes,
484,137,piron2010,piron,2010,ctrl,308,CPT,http://www.ncbi.nlm.nih.gov/pubmed/20581337,Italy,venice,venice,20,20,Time 50 OK,20,1,28,,62.2,75th Percentile,,453,>1year,1.24109589,1,,,,104,,,,,,,,,,,,,,,,,,,3,fma-ue,ue,fma,,fma,lohse,1,1,23,43.9,9.7,,23,46.5,9.7,,,,,,0.5,2.6,9.7,,9.7,0.268041237,,0.965517241,0.258798436,Term G OK,All OK,,0.045040133,,0.041987472,23.81662797,,,
434,123,page2005,page,2005,ctrl,274,traditional rehabilitation,http://www.ncbi.nlm.nih.gov/pubmed/15673841,USA,OH,cincinnati,15,15,Time 50 OK,15,1,70,,62.2,75th Percentile,,4.8,<90days,0.013150685,1,,,>70,,,,,,,,,,,,,,,<3,,,,,0,fma-ue,ue,fma,,fma,lohse,1,0,5,35,6.6,,5,39.4,6.98,,,,,,0.5,4.4,6.792657801,,6.6,0.647758231,,0.8,0.518206585,Term G OK,All OK,,0.241959073,,0.154853806,6.457703726,,,
496,141,pohl2007,pohl,2007,exp,320,mixed pure locomotor training with physiotherapy,http://www.ncbi.nlm.nih.gov/pubmed/17213237,Germany,berlin,berlin,13.5,13.5,Time 50 OK,13.5,4,28,208,62.3,75th Percentile,12,29.4,<90days,0.080547945,1,,,,,,,0.99,37.9,,,,,,,,,,,,,,,5,fac,le,,,other,lohse,1,1,77,0.99,0.88,,72,3.2,1.4,,,64,3.8,1.7,0.5,2.21,1.160619117,2.81,1.316536769,1.904156125,2.134387786,0.99009901,1.885303094,Term G OK,All OK,2.113255234,0.036531237,0.042568904,0.035811428,27.92404704,0.041730128,,
74,29,dean2000,dean,2000,ctrl,62,upper limb training,http://www.ncbi.nlm.nih.gov/pubmed/10768528,Australia,sydney,sydney,0,0,Time 50 OK,0,1,28,60,62.3,75th Percentile,3.3,474.5,>1year,1.3,0,,,,,,,,,,,,,,,,,,,,,,,1,6minwt,le,,capacity,capacity,lohse,1,0,6,259,154.6,,5,264.3,159.1,0,0,4,261.5,157.3,0.5,5.3,156.6159634,2.5,155.6179898,0.033840739,0.016064981,0.842105263,0.028497465,Term G OK,All OK,0.013528405,0.1667621,0.166688174,0.118257888,8.456095546,0.118205464,Yes,
191,58,hesse2011,hesse,2011,exp,125,intermittent high intensity,http://www.ncbi.nlm.nih.gov/pubmed/7762049,Germany,berlin,berlin,120,120,Time 50 OK,120,1,365,455,62.4,75th Percentile,11.3,114.8,<1year,0.314520548,1,,,,,,,,,,,,8.1,,,,9.4,,6.7,,,,,0,rivermead mobility,,,,other,lohse,1,1,25,9.4,2.8,,25,12.2,2.1,,,25,12.2,1.7,0.5,2.8,2.474873734,2.8,2.316246964,1.13137085,1.208852097,0.968421053,1.095643349,Term G OK,All OK,1.17067782,0.0656,0.069226468,0.06152226,16.25427935,0.064923305,Yes,
131,41,eich2004,eich,2004,exp,89,treadmill walking + conventional therapy,http://www.ncbi.nlm.nih.gov/pubmed/15473116,Germany,berlin,berlin,30,30,Time 50 OK,30,3,42,84,62.4,75th Percentile,6,42.7,<90days,0.116986301,1,,,,,,,,,67.8,,,,,,,,,,,,,,0,10mwt,le,,speed,speed,lohse,0,1,25,0.4,0.17,,25,0.71,0.3,0,0,24,0.77,0.35,0.5,0.31,0.243823707,0.37,0.273320792,1.271410414,1.353720649,0.968421053,1.231260611,Term G OK,All OK,1.310971576,0.072329689,0.076651192,0.067833627,14.74195092,0.071886503,Yes,
697,191,wang2005,wang,2005,exp,435,bobath therapy less severe group,http://www.ncbi.nlm.nih.gov/pubmed/15759530,Taiwan,taipei,taipei,13.3,13.3,Time 50 OK,13.3,1,28,,62.4,75th Percentile,,21.6,<90days,0.059178082,0,,,,,4 to 5,,,,,,16,,,17.86,15.1,,,,,,,,1,stroke impairment assessment set,,,,other,lohse,1,0,11,10.27,3.13,,11,11,2.83,,,,,,0.5,0.73,2.98377278,,3.13,0.244656699,,0.923076923,0.225836953,Term G OK,All OK,,0.093629859,,0.079779288,12.53458166,,,
687,190,walker2000,walker,2000,ctrl,431,conventional PT and OT with additional balance training,http://www.ncbi.nlm.nih.gov/pubmed/10960936,Canada,ontario,kingston,65,65,Time 50 OK,65,1,36.7,66.7,62.4,75th Percentile,13.3,35.1,<90days,0.096164384,0,,,,,,,,,,,,,,,,,,,,,,,,bbs,le,,balance,balance,lohse,0,0,16,36.9,11,,16,48.8,6.2,,,16,50.9,4.1,0.5,11.9,8.928605714,14,8.300903565,1.332794882,1.686563383,0.949152542,1.265025651,Term G OK,All OK,1.600805923,0.118010694,0.151390501,0.106314719,9.406035302,0.136386272,,
36,15,burgar2011,burgar,2011,exp,30,robot lo,http://www.ncbi.nlm.nih.gov/pubmed/21674393,USA,TX,temple,8.6,8.6,Time 50 OK,8.6,1,21,180,62.5,75th Percentile,,17.3,<90days,0.04739726,1,,>22,,28.4,,,,,,,,,,,,,,0.44,,,,,5,fma,ue,fma,,fma,lohse,1,0,19,26.7,21.79449472,1,19,33.5,,1,0,14,42.6,,0.5,6.8,21.79449472,15.9,21.79449472,0.312005398,0.729542034,0.957746479,0.298822071,Term G OK,All OK,0.698716314,0.055193352,0.066637673,0.050627665,19.75204663,0.061125293,Yes,
124,40,duncan2011,duncan,2011,exp,88,home exercise program,http://www.nejm.org/doi/full/10.1056/NEJMoa1010790,USA,NC,durham,54,54,Time 50 OK,54,3,98,365,62.6,75th Percentile,13.3,62.9,<90days,0.172328767,1,,26,,,,,,,,,,,,,54.4,,,,3.25,,,,,gait speed comfortable,le,,speed,speed,lohse,1,1,126,0.39,0.22,1,126,0.62,,1,0,126,0.64,,0.5,0.23,0.22,0.25,0.22,1.045454545,1.136363636,0.993987976,1.039169248,Term G OK,All OK,1.129531791,0.012273711,0.013060803,0.012126575,82.46351505,0.012904231,Yes,
653,180,van nes2006,van nes,2006,exp,409,exercise therapy with music + CPT,http://www.ncbi.nlm.nih.gov/pubmed/16902175,Netherlands,nijmegen,nijmegen,186.6,186.6,Time 50 OK,186.6,1,42,84,62.6,75th Percentile,,34,<90days,0.093150685,1,,,,,,,1,9.9,,50.6,23.7,,,,,5.2,,,,,,,0,bbs,le,,balance,balance,lohse,1,1,26,23.7,18.6,,26,41.1,14.3,,,26,44.9,11.9,0.5,17.4,16.58990657,21.2,15.61361585,1.0488305,1.357789265,0.96969697,1.017047757,Term G OK,All OK,1.316644136,0.059616258,0.073915225,0.056057896,17.83870019,0.069503389,,
648,178,van deldan2013,van deldan,2013,exp,406,bilateral arm training with auditory cuing,http://www.ncbi.nlm.nih.gov/pubmed/23868279,Netherlands,amsterdam,amsterdam,18,18,Time 50 OK,18,1,42,84,62.6,75th Percentile,,54.6,<90days,0.149589041,0,,>23,,,,,,,,63.9,,,,,collected,,,,,,,,1,arat,ue,arat,,arat,lohse,1,0,19,25.8,16.1,1,18,39.9,,0,1,17,44.4,,0.5,14.1,16.1,18.6,16.1,0.875776398,1.155279503,0.957746479,0.838771761,Term G OK,All OK,1.106464876,0.072815376,0.087754493,0.066791966,14.97186054,0.080495294,,Change scores estimated from Figure 2
249,74,jonsdottir2010,jonsdottir,2010,ctrl,163,conventional physiotherapy,http://www.ncbi.nlm.nih.gov/pubmed/20053951,Italy,milan,milan,15.75,15.75,Time 50 OK,15.75,1,49,91,62.6,75th Percentile,,657,>1year,1.8,0,,>24,,,,,,,93.6,,,,,,,,,,,,,,0,height normalized speed,le,,,other,lohse,0,1,10,26.3,11.9,,10,27.9,14.3,,,9,28.4,14.3,0.5,1.6,13.15484702,2.1,13.08436427,0.121628172,0.160496907,0.914285714,0.1112029,Term G OK,All OK,0.14674003,0.100739671,0.101287963,0.084210141,11.87505434,0.084668469,,
139,43,feys1998,feys,1998,ctrl,93,standard care,http://www.ncbi.nlm.nih.gov/pubmed/9550512,Belgium,leuven,leuven,15,15,Time 50 OK,15,2,42,365,62.78,75th Percentile,,24.02,<90days,0.065808219,1,,,,,,,,,,,,,,,,,,,,,,,4,fma-ue,ue,fma,,fma,lohse,0,0,50,2.357142857,0.782868222,,46,2.792857143,0.883883476,,,39,3.160714286,0.833375849,0.5,0.435714286,0.832756893,0.803571429,0.805318753,0.523219068,0.997830269,0.984615385,0.515169544,Term G OK,All OK,0.982479034,0.022737582,0.029956652,0.022043346,45.36516371,0.029042,Yes,primary outcome was the log of the Brunnstrom Fugl Meyer; estimated from Figure 1
104,37,dromerick2009,dromerick,2009,exp,80,lo cimt,http://www.ncbi.nlm.nih.gov/pubmed/19458319,USA,DC,washington DC,70,50,Time 50 OK,30,3,14,90,62.8,75th Percentile,,8.8,<90days,0.024109589,1,5.1,,,57.1,,,,,,,,,,,,,,,,,,,0,arat,ue,arat,,arat,lohse,1,1,19,22.7,14.3,,19,42.1,3.82,0,0,19,46.86,3.51,0.5,19.4,10.4661932,24.16,10.41177458,1.853587034,2.320449776,0.957746479,1.775266455,Term G OK,All OK,2.222402602,0.143046971,0.19432861,0.131213885,7.621144668,0.17825342,Yes,
521,147,richards2004,richards,2004,exp,334,treadmill training and isokinetic exercise,http://www.ncbi.nlm.nih.gov/pubmed/15537991,Canada,quebec,quebec city,39.1,39.1,Time 50 OK,39.1,2,56,,62.9,75th Percentile,12,52,<90days,0.142465753,1,,,,,,,,,,,,,,,,,,,,,,,2,gait speed SSV,le,,speed,speed,lohse,1,1,32,26.51,14.22,,32,52.77,33.25,,,32,62.17,34.94,0.5,26.26,25.57118398,35.66,26.67406981,1.026937197,1.336878859,0.975609756,1.001889948,Term G OK,All OK,1.304272057,0.047728125,0.059175704,0.045428317,22.0127019,0.056324287,,
312,93,lee2008,lee,2008,exp,205,sham cycling + progressive resistance training,http://www.ncbi.nlm.nih.gov/pubmed/18422947,Australia,sydney,sydney,15,15,Time 50 OK,15,1,77,,62.9,75th Percentile,9.3,1362,>1year,3.731506849,1,,,,,,,,,,,,,,,,,,,,,,,1,6minwt,le,,capacity,capacity,lohse,0,1,12,239.8,141,,12,247.2,148,,,,,,0.5,7.4,144.5423813,,141,0.051196057,,0.930232558,0.047624239,Term G OK,All OK,,0.083442543,,0.072205554,13.84935015,,,
374,110,morone2011,morone,2011,ctrl,243,CPT for the high motricity group,http://www.ncbi.nlm.nih.gov/pubmed/21444654,Italy,rome,rome,60,60,Time 50 OK,60,1,28,86.78,62.92,75th Percentile,9.59,20,<90days,0.054794521,1,,>24,,,,,0.43,,,52.25,,,,,,,,1.17,,,,,5,fac,le,,,other,lohse,1,1,12,0.43,0.91,,12,2.5,1,,,12,3.52,0.92,0.5,2.07,0.956059622,3.09,0.915013661,2.165136936,3.376998761,0.930232558,2.014080871,Term G OK,All OK,3.141394196,0.278659081,0.558505026,0.241132791,4.147092545,0.483292613,,
7,3,ada2013,ada,2013,ctrl,5,no specified physical therapy,http://www.ncbi.nlm.nih.gov/pubmed/23464674,Australia,new south wales,sydney,0,0,Time 50 OK,0,1,120,365,63,75th Percentile,,570,>1year,1.561643836,0,,,,,,,,,,,,,,,,,,,,,,,3,6minwt,le,,capacity,capacity,lohse,1,1,34,244,263,,31,263,115,,,31,2552,125,0.5,19,206.2256046,2308,208.978126,0.09213211,11.04421809,0.977099237,0.090022214,Term G OK,All OK,10.79129707,0.029536593,1.823158136,0.028199262,35.46192095,1.740610856,,
343,102,macko2005,macko,2005,exp,226,treadmill based aerobic training,http://www.ncbi.nlm.nih.gov/pubmed/16151035,USA,MD,baltimore,48.24,48.24,Time 50 OK,48.24,1,180,,63,75th Percentile,10,1050,>1year,2.876712329,1,,,,,,,,,,,,,,,,11.3,,,,,,,,6minwt,le,,capacity,capacity,lohse,0,0,32,761,73,,32,922,79,,,,,,0.5,161,76.05918748,,73,2.116772547,,0.975609756,2.065143948,Term G OK,All OK,,0.101261344,,0.096382005,10.37538076,,,first valid functional measure used
279,84,kuys2011,kuys,2011,exp,185,CPT + HI treadmill,http://www.ncbi.nlm.nih.gov/pubmed/20921032,Australia,brisbane,brisbane,36.3,36.3,Time 50 OK,36.3,2,42,126,63,75th Percentile,14,52,<90days,0.142465753,0,,28,,,,,,,76,,,,,"<4,5,6",,,,,,,,,2,10mwt,le,,speed,speed,lohse,0,1,15,0.34,0.2,,13,0.63,0.3,0,0,12,0.72,0.35,0.5,0.29,0.251151196,0.38,0.276224546,1.154682936,1.375692367,0.945454545,1.09170023,Term G OK,All OK,1.300654602,0.111109756,0.129750983,0.099319266,10.06853997,0.115982366,Yes,"The authors report and intention to treat analysis, but according to their tables, it does not look like missing data were carried forward."
721,198,wittenberg2003,wittenberg,2003,ctrl,451,placebo like intervention with no expected effects (focused on the unaffected arm),http://www.ncbi.nlm.nih.gov/pubmed/12645445,USA,MD,bethesda,0,0,Time 50 OK,0,1,10,,63,75th Percentile,,840,>1year,2.301369863,1,,,,,,,,,,,,,,,,,,,,,,,0,wmft,ue,wmft,,wmft,lohse,0,0,7,5.5,2.6,1,7,5.85,,,,,,,0.5,0.35,2.6,,2.6,0.134615385,,0.869565217,0.117056856,Term G OK,All OK,,0.144151522,,0.10899926,9.174374211,,,
625,171,tanaka2012,tanaka,2012,exp,391,GaitMaster 4,http://www.ncbi.nlm.nih.gov/pubmed/22275464,Japan,tsukuba,tsukuba,4,4,Time 50 OK,4,1,28,56,63,75th Percentile,10,1662,>1year,4.553424658,1,,>23,,79.9,,,,,,,,,,,,,,,,,,,0,gait speed,le,,speed,speed,lohse,0,0,7,0.75,0.42,,7,0.85,0.45,,,,,,0.5,0.1,0.435258544,,0.42,0.229748506,,0.869565217,0.199781309,Term G OK,All OK,,0.146627455,,0.110871422,9.01945679,,Yes,
23,9,boake2007,boake,2007,exp,19,CIMT,http://www.ncbi.nlm.nih.gov/pubmed/17172550,USA,TX,houston,162,106,Time 50 OK,36,1,14,90,63.1,75th Percentile,,14,<90days,0.038356164,1,4.9,,,,,,,,,,,,,,,,,,,,,,1,fma-ue,ue,fma,,fma,lohse,1,0,10,29.44,12.11,,9,47.89,6.71,0,0,9,53.44,8.63,0.5,18.45,9.941184981,24,10.61542745,1.855915571,2.260860442,0.914285714,1.696837093,Term G OK,All OK,2.067072404,0.27222113,0.355574497,0.227554643,4.394548873,0.297231253,Yes,
337,100,luft2008,luft,2008,exp,222,progressive BWS treadmill training,http://www.ncbi.nlm.nih.gov/pubmed/18757284,Germany,tubingen,tubingen,48.24,48.24,Time 50 OK,48.24,1,168,,63.2,75th Percentile,8.7,1875,>1year,5.136986301,1,3.5,>18,,,,,,,,,,,,,,,,,,,>16,,22,10mwt SSV,le,,speed,speed,lohse,1,0,37,0.55,0.3,,37,0.63,,,,,,,0.5,0.08,0.3,,0.3,0.266666667,,0.979020979,0.261072261,Term G OK,All OK,,0.027987988,,0.026825985,37.27728917,,Yes,"too many inferences had to be made (CI from figure, df for CI, etc) to get an accurate effect size"
123,40,duncan2011,duncan,2011,ctrl,87,late locomotor (pre-crossover),http://www.nejm.org/doi/full/10.1056/NEJMoa1010790,USA,NC,durham,22.5,22.5,Time 50 OK,22.5,3,98,98,63.3,75th Percentile,12.5,64.18,<90days,0.175835616,1,,26.2,,,,,,,,,,,,,55.7,,,,3.08,,,,,gait speed comfortable,le,,speed,speed,lohse,1,1,143,0.38,0.23,1,143,0.51,,1,0,143,,,0.5,0.13,0.23,,0.23,0.565217391,,0.994708995,0.562226823,Term G OK,All OK,,0.008110037,,0.008024444,124.619226,,Yes,
723,199,wolf2006; 2010,wolf,2006,ctrl,453,standard care,http://www.ncbi.nlm.nih.gov/pubmed/17077374,USA,GA,atlanta,0,0,Time 50 OK,0,1,14,365,63.3,75th Percentile,,187.7,<1year,0.514246575,1,,27.5,,,,,,,,,,,,,52.2,,,0.92,,,,,11,wmft-time,ue,wmft,,wmft,lohse,1,1,115,3.18,1.37,,104,3.1,1.37,,,86,2.87,1.37,0.5,-0.08,1.37,-0.31,1.37,0.058394161,0.226277372,0.993406593,0.058009144,Term G OK,All OK,0.224785434,0.008710478,0.008918267,0.008595993,116.333273,0.008801051,Yes,"Outcome measure is WMFT-time, so lower numbers mean better performance; Authors report ITT analysis, but different numbers are reported for the different timepoints in the tables"
735,204,yang2005,yang,2005,exp,465,CPT + additional backward walking,http://www.ncbi.nlm.nih.gov/pubmed/15859527,Taiwan,taipei,taipei,10.5,10.5,Time 50 OK,10.5,1,21,,63.38,75th Percentile,,163.5,<1year,0.447945205,0,,,,,3.615384615,,,,,,,,,,,,,,,,,,0,gait speed 9m SSV,le,,speed,speed,lohse,0,0,13,24.83,6.69,,13,33.42,5.2,,,,,,0.5,8.59,5.991498143,,6.69,1.433698183,,0.936170213,1.342185533,Term G OK,All OK,,0.155980403,,0.136703513,7.315100966,,Yes,
603,167,sullivan2007,sullivan,2007,exp,379,cycling with upper extremity ergomety,http://www.ncbi.nlm.nih.gov/pubmed/17895349,USA,CA,los angeles,24,24,Time 50 OK,24,1,42,222,63.4,75th Percentile,8.6,852,>1year,2.334246575,1,,,,,,,,,,,42.6,,,,,,,,,,,,2,10mwt SSV,le,,speed,speed,lohse,1,1,20,0.43,0.25,,18,0.44,0.28,,,14,0.43,0.26,0.5,0.01,0.264590879,0,0.254109966,0.037794198,0,0.96,0.03628243,Term G OK,All OK,0,0.05003571,0.05,0.04611291,21.68590098,0.04608,,
734,204,yang2005,yang,2005,ctrl,464,conventional therapy,http://www.ncbi.nlm.nih.gov/pubmed/15859527,Taiwan,taipei,taipei,6,6,Time 50 OK,6,1,21,,63.42,75th Percentile,,219.9,<1year,0.602465753,0,,,,,3.583333333,,,,,,,,,,,,,,,,,,0,gait speed 9m SSV,le,,speed,speed,lohse,0,0,12,25.97,14.86,,12,29.62,16.35,,,,,,0.5,3.65,15.62277344,,14.86,0.233633293,,0.930232558,0.217333296,Term G OK,All OK,,0.085607688,,0.074079124,13.49907971,,Yes,
416,119,olney2006,olney,2006,exp,265,strength and conditioning training,http://www.ncbi.nlm.nih.gov/pubmed/16410482,Canada,ontario,kingston,45,45,Time 50 OK,45,1,70,365,63.5,75th Percentile,,1496.5,>1year,4.1,0,,,,,,,,,,,,,,,,,,,,,,,3,6minwt,le,,capacity,capacity,lohse,1,1,37,0.73,0.36,,34,0.82,0.38,,,29,0.78,0.37,0.5,0.09,0.369700231,0.05,0.364408768,0.243440475,0.137208554,0.979020979,0.238333333,Term G OK,All OK,0.134330053,0.027827882,0.027281435,0.026672526,37.49176212,0.026148766,,"the authors state intention to treat, but also state that no missing values were imputed and observations were not carried forward."
336,100,luft2008,luft,2008,ctrl,221,stretching,http://www.ncbi.nlm.nih.gov/pubmed/18757284,Germany,tubingen,tubingen,0,0,Time 50 OK,0,1,168,,63.6,75th Percentile,10,1338,>1year,3.665753425,1,3.6,>18,,,,,,,,,,,,,,,,,,,>16,,20,10mwt SSV,le,,speed,speed,lohse,1,0,34,0.53,0.28,,34,0.57,,,,,,,0.5,0.04,0.28,,0.28,0.142857143,,0.977099237,0.139585605,Term G OK,All OK,,0.029711885,,0.028366617,35.25270567,,Yes,"too many inferences had to be made (CI from figure, df for CI, etc) to get an accurate effect size"
250,75,jung2012,jung,2012,ctrl,164,treadmill training,https://www.jstage.jst.go.jp/article/jpts/24/11/24_1133/_pdf,South korea,seoul,seoul,7.5,7.5,Time 50 OK,7.5,1,21,,63.6,75th Percentile,,462,>1year,1.265753425,1,,26.3,,,>4,,,,,,,,,,,,,,,,,,0,tug,le,,balance,balance,lohse,0,0,10,23.8,4.9,,10,23,5.2,,,,,,0.5,-0.8,5.052227232,,4.9,0.158346005,,0.914285714,0.144773491,Term G OK,All OK,,0.101253673,,0.084639805,11.81477202,,,sign reversed for time measure
428,122,page2004,page,2004,ctrl,271,no specified physical therapy,http://www.ncbi.nlm.nih.gov/pubmed/14970962,USA,OH,cincinnati,0,0,Time 50 OK,0,1,70,,63.67,75th Percentile,,1035,>1year,2.835616438,0,,,>70,,,,,,,,,,,,,,,<3,,,,,0,fma-ue,ue,fma,,fma,lohse,1,0,6,32.55,7.1,,6,29.7,7.1,,,,,,0.5,-2.85,7.1,,7.1,-0.401408451,,0.842105263,-0.338028169,Term G OK,All OK,,0.180094062,,0.127712133,7.830109611,,,standard deviations are estimated from the standard errors  in Table 3
268,80,kihoon2012,kihoon,2012,ctrl,176,CPT,https://www.jstage.jst.go.jp/article/jpts/24/11/24_1205/_article,South korea,seoul,seoul,6,6,Time 50 OK,6,1,28,,63.7,75th Percentile,,0,NA,,0,,15.7,,,,,,,,,,,,,,,,,,,,,1,wmft,ue,wmft,,wmft,lohse,0,0,14,26,5.1,,14,28,5.3,,,,,,0.5,2,5.20096145,,5.1,0.384544285,,0.941176471,0.361924033,Term G OK,All OK,,0.076709797,,0.067950547,14.71658499,,,
698,191,wang2005,wang,2005,exp,436,orthopaedic treatment programme less severe group,http://www.ncbi.nlm.nih.gov/pubmed/15759530,Taiwan,taipei,taipei,13.3,13.3,Time 50 OK,13.3,1,28,,63.8,75th Percentile,,19.6,<90days,0.05369863,0,,,,,4 to 5,,,,,,33.46,,,23.31,13.31,,,,,,,,1,stroke impairment assessment set,,,,other,lohse,1,0,12,10.36,2.84,,12,11.27,2.97,,,,,,0.5,0.91,2.905727103,,2.84,0.313174626,,0.930232558,0.291325234,Term G OK,All OK,,0.087419931,,0.075647317,13.21923949,,,
587,161,smania2012,smania,2012,exp,365,mCIMT,http://www.ncbi.nlm.nih.gov/pubmed/22661278,Italy,verona,verona,140,80,Time 50 OK,20,1,14,90,63.93,75th Percentile,,333,<1year,0.912328767,1,,>23,,,,,,,,"<11,>26",,,,,,,0.73,,,,,,4,wmft,ue,wmft,,wmft,lohse,0,1,30,2.81,0.87,,30,3.62,0.78,,,30,4.05,0.53,0.5,0.81,0.826226361,1.24,0.720347139,0.980360877,1.721392276,0.973913043,0.954786245,Term G OK,All OK,1.67648639,0.049351791,0.082719856,0.0468105,21.36272845,0.078460331,Yes,
495,141,pohl2007,pohl,2007,ctrl,319,physiotherapy every week day,http://www.ncbi.nlm.nih.gov/pubmed/17213237,Germany,berlin,berlin,11.3,11.3,Time 50 OK,11.3,4,28,208,64,75th Percentile,11.6,31.5,<90days,0.08630137,1,,,,,,,1.19,36.8,,,,,,,,,,,,,,,6,fac,le,,,other,lohse,1,1,78,1.2,1.1,,72,2.1,1.5,,,64,2.6,1.8,0.5,0.9,1.307256256,1.4,1.457223387,0.688464864,0.960731218,0.990228013,0.681737194,Term G OK,All OK,0.951342965,0.015858871,0.018737208,0.01555044,64.30686206,0.018372798,,
333,98,lo2010,lo,2010,exp,218,intensive usual care,http://www.nejm.org/doi/full/10.1056/NEJMoa0911341,USA,RI,providence,32,32,Time 50 OK,32,4,84,252,64,75th Percentile,,1752,>1year,4.8,1,,,,,,,,,,,,,,,50.5,,,1,,,,,8,fma-ue,ue,fma,,fma,lohse,1,0,50,17.3,8.4,1,46,21.31,,1,0,46,20.2,,0.5,4.01,8.4,2.9,8.4,0.477380952,0.345238095,0.984615385,0.47003663,Term G OK,All OK,0.33992674,0.022278926,0.021191893,0.021598693,46.29909782,0.020544851,,
276,83,kiper2011,kiper,2011,ctrl,182,CPT + CPT,http://www.ncbi.nlm.nih.gov/pubmed/22127938,Italy,venice,venice,40,40,Time 50 OK,40,1,28,,64,75th Percentile,,171,<1year,0.468493151,0,,>24,,,,,,,,,,,,,,,,,,,,,0,fma-ue,ue,fma,,fma,lohse,0,0,40,44.8,17.4,,40,46.4,17.1,,,,,,0.5,1.6,17.25065216,,17.4,0.092750117,,0.980645161,0.090954953,Term G OK,All OK,,0.025107532,,0.024145033,41.41638572,,,
277,83,kiper2011,kiper,2011,exp,183,CPT + reinforcing feedback in a VE,http://www.ncbi.nlm.nih.gov/pubmed/22127938,Italy,venice,venice,40,40,Time 50 OK,40,1,28,,64,75th Percentile,,171,<1year,0.468493151,0,,>24,,,,,,,,,,,,,,,,,,,,,0,fma-ue,ue,fma,,fma,lohse,0,0,40,39.1,17,,40,48.9,15.2,,,,,,0.5,9.8,16.12513566,,17,0.607746825,,0.980645161,0.595983983,Term G OK,All OK,,0.029616953,,0.028481585,35.11040555,,,
9,3,ada2013,ada,2013,exp,7,two months of walking therapy,http://www.ncbi.nlm.nih.gov/pubmed/23464674,Australia,new south wales,sydney,12,12,Time 50 OK,12,1,60,365,64,75th Percentile,,600,>1year,1.643835616,0,,,,,,,,,,,,,,,,,,,,,,,1,6minwt,le,,capacity,capacity,lohse,1,1,34,225,118,,33,259,145,,,33,230,122,0.5,34,131.9843814,5,119.9858966,0.257606238,0.041671564,0.977099237,0.251706859,Term G OK,All OK,0.040717254,0.030387661,0.029437302,0.029011797,34.46873698,0.028104467,,
342,102,macko2005,macko,2005,ctrl,225,stretching and low intensity aerobic exercise,http://www.ncbi.nlm.nih.gov/pubmed/16151035,USA,MD,baltimore,5.76,5.76,Time 50 OK,5.76,1,180,,64,75th Percentile,8,1170,>1year,3.205479452,1,,,,,,,,,,,,,,,,11.7,,,,,,,,6minwt,le,,capacity,capacity,lohse,0,0,29,848,109,,29,868,100,,,,,,0.5,20,104.5968451,,109,0.191210356,,0.972972973,0.186042509,Term G OK,All OK,,0.035113128,,0.033240769,30.08353988,,,first valid functional measure used
132,41,eich2004,eich,2004,ctrl,90,conventional therapy dosage matched to exp group,http://www.ncbi.nlm.nih.gov/pubmed/15473116,Germany,berlin,berlin,30,30,Time 50 OK,30,3,42,84,64,75th Percentile,4.8,65.6,<90days,0.179726027,1,,,,,,,,,65.6,,,,,,,,,,,,,,0,10mwt,le,,speed,speed,lohse,0,1,25,0.44,0.22,,25,0.6,0.22,0,0,25,0.58,0.22,0.5,0.16,0.22,0.14,0.22,0.727272727,0.636363636,0.968421053,0.70430622,Term G OK,All OK,0.616267943,0.050578512,0.048099174,0.047434518,21.08169414,0.045109297,Yes,
269,80,kihoon2012,kihoon,2012,exp,177,VR training using the IREX system,https://www.jstage.jst.go.jp/article/jpts/24/11/24_1205/_article,South korea,seoul,seoul,26,26,Time 50 OK,26,1,28,,64,75th Percentile,,0,NA,,0,,16,,,,,,,,,,,,,,,,,,,,,1,wmft,ue,wmft,,wmft,lohse,0,0,15,26.8,12.4,,15,35.3,11.9,,,,,,0.5,8.5,12.15257174,,12.4,0.699440429,,0.945454545,0.661289133,Term G OK,All OK,,0.082973897,,0.074169064,13.48271026,,,
284,85,kwakkel/kwakkel1999/2002,kwakkel,1999,ctrl,186,conventional therapy,http://www.ncbi.nlm.nih.gov/pubmed/10421300,Netherlands,amsterdam,amsterdam,73.5,73.5,Time 50 OK,73.5,2,140,364,64.1,75th Percentile,15,7.5,<90days,0.02,1,,26,,,,,,,,,,,15,,,,,,,,,4.8,3,10mwt SSV,le,,speed,speed,lohse,0,1,37,0,0,,37,0.37,0.41,,,37,0.53,0.44,0.5,0.37,0.41,0.53,0.44,0.902439024,1.204545455,0.979020979,0.883506737,Term G OK,All OK,1.17927527,0.038032381,0.046634186,0.036453356,27.43231652,0.044698031,Yes,0 SD at baseline; FU is added from Kwakkel et al 2002
482,136,piron2009,piron,2009,ctrl,306,CPT for the upper limb,http://www.ncbi.nlm.nih.gov/pubmed/19841835,Italy,venice,venice,20,20,Time 50 OK,20,1,30,60,64.4,75th Percentile,,357,<1year,0.978082192,1,,,,,,,,,,,,,,,,,1.3,,,,,,,fma-ue,ue,fma,,fma,lohse,1,0,18,47.3,4.6,,18,49.5,4.8,,,18,48.8,5.1,0.5,2.2,4.701063709,1.5,4.856439025,0.467979193,0.308868286,0.955223881,0.447024901,Term G OK,All OK,0.295038363,0.061639015,0.058205545,0.056242683,17.78009061,0.053109804,,
600,166,sullivan2002,sullivan,2002,exp,376,BWSTT at high speed,http://www.ncbi.nlm.nih.gov/pubmed/11994808,USA,CA,los angeles,4,4,Time 50 OK,4,3,28,118,64.4,75th Percentile,,816,>1year,2.235616438,0,,27,,,,,,,,,,,,,,,,,,,,,0,10mwt SSV,le,,speed,speed,lohse,1,0,8,0.57,0.26,,8,0.72,0.34,,,8,0.78,0.42,0.5,0.15,0.302654919,0.21,0.349284984,0.49561395,0.601228251,0.888888889,0.440545734,Term G OK,All OK,0.534425112,0.140352074,0.147592213,0.110895466,9.01750122,0.11661607,,
286,85,kwakkel/kwakkel1999/2002,kwakkel,1999,exp,188,leg intensive therapy + CPT,http://www.ncbi.nlm.nih.gov/pubmed/10421300,Netherlands,amsterdam,amsterdam,117.17,117.17,Time 50 OK,117.17,2,140,364,64.5,75th Percentile,9.7,7,<90days,0.02,1,,27,,,,,,,,,,,15,,,,,,,,,4,5,10mwt SSV,le,,speed,speed,lohse,0,1,31,0,0,,31,0.65,0.46,,,31,0.64,0.46,0.5,0.65,0.46,0.64,0.46,1.413043478,1.391304348,0.974789916,1.377420533,Term G OK,All OK,1.356229448,0.064462772,0.06347948,0.061253518,16.32559292,0.060319179,Yes,0 SD at baseline; FU is added from Kwakkel et al 2002
105,37,dromerick2009,dromerick,2009,exp,81,hi cimt,http://www.ncbi.nlm.nih.gov/pubmed/19458319,USA,DC,washington DC,130.8,80.4,Time 50 OK,30,3,14,90,64.5,75th Percentile,,9.94,<90days,0.026,1,5.31,,,59.8,,,,,,,,,,,,,,,,,,,0,arat,ue,arat,,arat,lohse,1,1,16,25.4,18,,16,33.9,4.16,0,0,16,38,3.76,0.5,8.5,13.06341456,12.6,13.00264588,0.650672147,0.969033542,0.949152542,0.617587123,Term G OK,All OK,0.91976065,0.075730445,0.091844563,0.068224842,14.6574176,0.082741898,Yes,
49,20,cho2013,cho,2013,exp,43,virtual reality walking + conventional therapy,http://www.ncbi.nlm.nih.gov/pubmed/23598900,South korea,seoul,seoul,33,33,Time 50 OK,33,1,42,,64.57,75th Percentile,4.35,288.28,<1year,0.789808219,1,,26.71,,,2.85,,,,,,,,,,,,,,,,,,1,BBS,le,,,other,lohse,0,0,8,36.71,2.28,,7,40.85,1.67,0,0,,,,0.5,4.14,2.021465576,,2.28,2.048019045,,0.888888889,1.820461374,Term G OK,All OK,,0.387148876,,0.305895408,3.269091244,,Yes,
61,23,crosbie2012,crosbie,2012,ctrl,51,standard therapy matched to the control group,http://www.ncbi.nlm.nih.gov/pubmed/22275463,UK,newtonabbey,newtonabbey,6.75,6.75,Time 50 OK,6.75,1,21,201,64.6,75th Percentile,,300,<1year,0.092767123,0,,,,,,,,,,,,,,,,,,,,,,,0,motricity index-ue,ue,,,other,lohse,0,1,9,77.4,19.5,,8,85,22.1,,,8,81.6,20.9,0.5,7.6,20.75390726,4.2,20.16543247,0.366196105,0.208277209,0.903225806,0.330757772,Term G OK,All OK,0.18812135,0.118561088,0.113521078,0.096724134,10.33868135,0.092612409,,
103,37,dromerick2009,dromerick,2009,ctrl,79,ctrl,http://www.ncbi.nlm.nih.gov/pubmed/19458319,USA,DC,washington DC,20,20,Time 50 OK,20,3,14,90,64.7,75th Percentile,,10.4,<90days,0.028493151,1,5.5,,,56.7,,,,,,,,,,,,,,,,,,,0,arat,ue,arat,,arat,lohse,1,1,17,19.7,13.9,,17,36.2,4.05,0,0,17,45.34,3.68,0.5,16.5,10.23749237,25.64,10.16740872,1.611722813,2.521783152,0.952380952,1.534974108,Term G OK,All OK,2.40169824,0.135225013,0.24586442,0.122653073,8.15307742,0.223006276,Yes,
34,14,brunner2012,brunner,2012,exp,28,bimanual therapy,http://www.ncbi.nlm.nih.gov/pubmed/22561098,Norway,bergen,bergen,26,26,Time 50 OK,26,1,28,118,64.8,75th Percentile,,36.9,<90days,0.10109589,1,,>24,,,,,,,,,,,,,,,,,,,,,1,arat,ue,arat,,arat,lohse,1,0,16,30.07,13.99,,15,45.27,13.8,,,15,45.53,14.49,0.5,15.2,13.89860015,15.46,14.23357238,1.093635318,1.086164428,0.949152542,1.038026743,Term G OK,All OK,1.030935728,0.099876194,0.099367286,0.089977519,11.11388724,0.089519049,,
443,127,pang2006,pang,2006,exp,283,circuit based upper extremity training,http://www.ncbi.nlm.nih.gov/pubmed/16401430,Canada,vancouver,vancouver,57,57,Time 50 OK,57,1,133,,64.9,75th Percentile,8.7,1861.5,>1year,5.1,1,,28.1,,,,,,,,,,,,,,,,,,,,,3,wmft,ue,wmft,,wmft,lohse,0,0,30,2.9,1.6,,30,3.1,1.8,,,,,,0.5,0.2,1.702938637,,1.6,0.117444044,,0.973913043,0.114380286,Term G OK,All OK,,0.033563218,,0.031834935,31.4120321,,,
14,6,bale2008,bale,2008,ctrl,12,training as usual,http://www.ncbi.nlm.nih.gov/pubmed/18955423,Norway,Frde,Frde,16.67,16.67,Time 50 OK,16.67,1,28,,64.9,75th Percentile,,32,<90days,0.087671233,1,,,,,,,,,,,,,,,,,,,,,,,0,gait speed SSV,le,,speed,speed,lohse,0,1,10,0.38,0.3,,10,0.46,0.3,,,,,,0.5,0.08,0.3,,0.3,0.266666667,,0.914285714,0.243809524,Term G OK,All OK,,0.103555556,,0.086563991,11.55214759,,,
567,157,schwartz2009,schwartz,2009,exp,356,robot assisted gait training,http://www.ncbi.nlm.nih.gov/pubmed/19627940,Israel,jerusalem,jerusalem,20,20,Time 50 OK,20,2,42,,65,75th Percentile,8.5,23.6,<90days,0.064657534,1,10.4,,,,,,,,,,,,,,,,,,,,,,8,FIM motor,,,,other,lohse,0,1,37,44.1,13.1,,37,66.9,15.6,,,,,,0.5,22.8,14.40433962,,13.1,1.582856319,,0.979020979,1.549649543,Term G OK,All OK,,0.060884245,,0.058356458,17.13606402,,,
720,198,wittenberg2003,wittenberg,2003,exp,450,modified CIMT,http://www.ncbi.nlm.nih.gov/pubmed/12645445,USA,MD,bethesda,216,136,Time 50 OK,56,1,10,,65,75th Percentile,,1020,>1year,2.794520548,1,,,,,,,,,,,,,,,,,,,,,,,0,wmft,ue,wmft,,wmft,lohse,0,0,9,6.7,2,1,9,7.55,,,,,,,0.5,0.85,2,,2,0.425,,0.903225806,0.383870968,Term G OK,All OK,,0.121145833,,0.098832813,10.11809711,,,
48,20,cho2013,cho,2013,ctrl,42,treadmill training + conventional therapy,http://www.ncbi.nlm.nih.gov/pubmed/23598900,South korea,seoul,seoul,33,33,Time 50 OK,33,1,42,,65.14,75th Percentile,4.74,312,<1year,0.854794521,1,,26.14,,,2.57,,,,,,,,,,,,,,,,,,1,BBS,le,,,other,lohse,0,0,8,35.14,3.53,,7,37,3.21,0,0,,,,0.5,1.86,3.386067608,,3.53,0.549309764,,0.888888889,0.488275346,Term G OK,All OK,,0.143858826,,0.113666233,8.797687524,,Yes,
310,93,lee2008,lee,2008,ctrl,203,sham cycling + sham PRT,http://www.ncbi.nlm.nih.gov/pubmed/18422947,Australia,sydney,sydney,0,0,Time 50 OK,0,1,77,,65.3,75th Percentile,6,1974,>1year,5.408219178,1,,,,,,,,,,,,,,,,,,,,,,,0,6minwt,le,,capacity,capacity,lohse,0,1,12,273.2,162,,12,278.1,162.1,,,,,,0.5,4.9,162.0500077,,162,0.03023758,,0.930232558,0.028127981,Term G OK,All OK,,0.08337143,,0.072144017,13.86116329,,,
686,190,walker2000,walker,2000,exp,430,balance training with visual feedback + CPT,http://www.ncbi.nlm.nih.gov/pubmed/10960936,Canada,ontario,kingston,70,70,Time 50 OK,70,1,39.3,69.3,65.4,75th Percentile,13.8,40.9,<90days,0.112054795,0,,,,,,,,,,,,,,,,,,,,,,,,bbs,le,,balance,balance,lohse,0,0,16,35.9,7.5,,16,46.6,6,,,16,47.9,5.1,0.5,10.7,6.791538854,12,6.413267498,1.575489772,1.871121079,0.949152542,1.495380123,Term G OK,All OK,1.775979329,0.140067751,0.17190919,0.126185713,7.924827433,0.154871365,,
135,42,fang2003,fang,2003,exp,91,additional early physiotherapy,http://www.ncbi.nlm.nih.gov/pubmed/12971705,China,guangzhou,guangzhou,15,15,Time 50 OK,15,1,30,180,65.49,75th Percentile,10.94,7,<90days,0.019178082,1,,19.37,,,,,,25.7,,,,,14.04,,,,,,,,,,28,fma-ue,ue,fma,,fma,lohse,0,0,50,16.5,16.34,,50,25.89,20.83,1,0,14,41.86,23.82,0.5,9.39,18.72010283,25.36,18.16540739,0.501599809,1.396060074,0.984615385,0.493882889,Term G OK,All OK,1.374582227,0.022516024,0.039489837,0.021828552,45.8115591,0.038284112,Yes,
140,43,feys1998,feys,1998,exp,94,SC + sensory therapy,http://www.ncbi.nlm.nih.gov/pubmed/9550512,Belgium,leuven,leuven,30,30,Time 50 OK,30,2,42,365,65.62,75th Percentile,,21.4,<90days,0.058630137,1,,,,,,,,,,,,,,,,,,,,,,,10,fma-ue,ue,fma,,fma,lohse,0,0,50,2.367857143,0.782868222,,40,2.932142857,0.707106781,,,37,3.45,0.63134534,0.5,0.564285714,0.750236705,1.082142857,0.72258311,0.752143571,1.49760331,0.984615385,0.740572131,Term G OK,All OK,1.474563259,0.0256572,0.042428157,0.02487382,40.20291214,0.041132717,Yes,primary outcome was the log of the Brunnstrom Fugl Meyer; estimated from Figure 1
417,119,olney2006,olney,2006,exp,266,one week supervised followed by 9 weeks home training,http://www.ncbi.nlm.nih.gov/pubmed/16410482,Canada,ontario,kingston,45,45,Time 50 OK,45,1,70,365,65.8,75th Percentile,,1241,>1year,3.4,0,,,,,,,,,,,,,,,,,,,,,,,3,6minwt,le,,capacity,capacity,lohse,1,1,35,0.76,0.34,,32,0.87,0.37,,,25,0.91,0.36,0.5,0.11,0.354624395,0.15,0.348415131,0.310187346,0.430520912,0.977777778,0.303294294,Term G OK,All OK,0.420953781,0.029945946,0.031219261,0.028629803,34.92863713,0.029847155,,"the authors state intention to treat, but also state that no missing values were imputed and observations were not carried forward."
441,126,pang2005,pang,2005,exp,281,intensive progressive lower extremity training,http://www.ncbi.nlm.nih.gov/pubmed/16181164,Canada,vancouver,vancouver,57,57,Time 50 OK,57,1,133,,65.8,75th Percentile,9.1,1898,>1year,5.2,1,,27.6,,,,,,,,,,,,,,,,,,,,,2,6minwt,le,,capacity,capacity,lohse,0,1,32,328.1,143.5,,32,392.7,151.1,,,,,,0.5,64.6,147.3490075,,143.5,0.438414897,,0.975609756,0.427721851,Term G OK,All OK,,0.034253244,,0.032602731,30.67227712,,,
688,190,walker2000,walker,2000,ctrl,432,conventional PT and OT,http://www.ncbi.nlm.nih.gov/pubmed/10960936,Canada,ontario,kingston,52,52,Time 50 OK,52,1,36.6,66.6,65.8,75th Percentile,9.9,42,<90days,0.115068493,0,,,,,,,,,,,,,,,,,,,,,,,,bbs,le,,balance,balance,lohse,0,0,14,36.1,13.4,,14,46.5,8.9,,,14,47.1,9.3,0.5,10.4,11.37475274,11,11.53364643,0.914305588,0.953731334,0.941176471,0.860522907,Term G OK,All OK,0.897629491,0.101284097,0.103914409,0.089718785,11.14593783,0.09204875,,
332,98,lo2010,lo,2010,exp,217,intensive Robot assisted therapy,http://www.nejm.org/doi/full/10.1056/NEJMoa0911341,USA,RI,providence,33,33,Time 50 OK,33,4,84,252,66,75th Percentile,,1314,>1year,3.6,1,,,,,,,,,,,,,,,49.2,,,0.8,,,,,5,fma-ue,ue,fma,,fma,lohse,1,0,49,19.7,10.7,1,47,23.57,,1,0,47,24.5,,0.5,3.87,10.7,4.8,10.7,0.361682243,0.448598131,0.984293194,0.35600137,Term G OK,All OK,0.441552087,0.021743,0.022461636,0.021065338,47.47134843,0.021761576,,
700,192,werner1996,werner,1996,ctrl,438,no outpatient therapy,http://www.ncbi.nlm.nih.gov/pubmed/8630191,USA,MI,ann arbor,0,0,Time 50 OK,0,1,84,270,66,75th Percentile,,1204.5,>1year,3.3,0,,,,70,,,,,,,,,,,,,,,,13,,,0,fim,,,,other,lohse,0,0,16,70,19,1,16,71.5,,0,1,16,70.5,,0.5,1.5,19,0.5,19,0.078947368,0.026315789,0.949152542,0.074933095,Term G OK,All OK,0.024977698,0.062694771,0.062521641,0.056481127,17.70502915,0.056325156,,
483,136,piron2009,piron,2009,exp,307,VR based telerehabilitation,http://www.ncbi.nlm.nih.gov/pubmed/19841835,Italy,venice,venice,20,20,Time 50 OK,20,1,30,60,66,75th Percentile,,441,>1year,1.208219178,1,,,,,,,,,,,,,,,,,2.4,,,,,,,fma-ue,ue,fma,,fma,lohse,1,0,18,48.5,7.8,,18,53.6,7.7,,,18,53.1,7.3,0.5,5.1,7.750161289,4.6,7.554137939,0.658050821,0.608937782,0.955223881,0.628585859,Term G OK,All OK,0.581671911,0.067584191,0.065855701,0.061667375,16.21602995,0.060090209,,
408,117,noh2008,noh,2008,ctrl,260,conventional gait and exercise training,http://cre.sagepub.com/content/22/10-11/966.full.pdf,South korea,seoul,seoul,24,24,Time 50 OK,24,1,56,,66,75th Percentile,,584,>1year,1.6,0,,,,,,,,,,,,,,,,,,,,,,,2,bbs,le,,balance,balance,lohse,1,0,12,42.3,7.3,,10,44.5,6.7,,,,,,0.5,2.2,7.036334273,,7.3,0.312662803,,0.930232558,0.29084912,Term G OK,All OK,,0.087406585,,0.075635768,13.22125796,,,
4,2,ada2003,ada,2003,exp,4,overground and treadmill walking,http://www.ncbi.nlm.nih.gov/pubmed/14586916,Australia,new south wales,sydney,6,6,Time 50 OK,6,1,28,49,66,75th Percentile,11,840,>1year,2.301369863,0,,,,,,,,,,,,,,,,,,,,,,,1,10mwt SSV,le,,speed,speed,lohse,0,0,13,0.62,0.24,,11,0.75,0.26,0,0,13,0.83,0.26,0.5,0.13,0.249289901,0.21,0.25019992,0.521481214,0.839328805,0.936170213,0.488195179,Term G OK,All OK,0.785754626,0.08738241,0.104018186,0.076583226,13.05768968,0.091163064,Yes,
75,29,dean2000,dean,2000,exp,63,circuit training,http://www.ncbi.nlm.nih.gov/pubmed/10768528,Australia,sydney,sydney,12,12,Time 50 OK,12,1,28,60,66.2,75th Percentile,4.7,839.5,>1year,2.3,0,,,,,,,,,,,,,,,,,,,,,,,2,6minwt,le,,capacity,capacity,lohse,1,0,6,207.9,119,,4,250,135,0,0,4,277.7,130.5,0.5,42.1,125.23977,69.8,123.4381171,0.3361552,0.565465528,0.842105263,0.283078064,Term G OK,All OK,0.476181497,0.17608336,0.193312605,0.124867978,8.008458341,0.137085947,Yes,
57,22,cooke2010,cooke,2010,ctrl,47,conventional therapy,http://www.ncbi.nlm.nih.gov/pubmed/19704158,UK,norfolk,norwich,9.2,9.2,Time 50 OK,9.2,1,42,84,66.4,75th Percentile,,36.76,<90days,0.100712329,1,,,,,,,,,,>28,,,,,,29.4,,,,,,,7,10mwt,le,,speed,speed,lohse,1,1,38,0.17,0.224,,31,0.3,0.35,0,0,24,0.44,0.39,0.5,0.13,0.287332352,0.27,0.298742141,0.45243774,0.903789466,0.979591837,0.443204317,Term G OK,All OK,0.885344783,0.029009209,0.037063624,0.027837242,35.92309899,0.035566259,Yes,
43,17,cauraugh2003,cauraugh,2003,exp,37,bilateral arm training + 10s stimulation,http://www.ncbi.nlm.nih.gov/pubmed/14568122,USA,FL,gainesville,6,6,Time 50 OK,6,1,14,,66.4,75th Percentile,,1022,>1year,2.8,0,,,,,,,,,,,,,,,,,,,,,,,0,box and block test,ue,,,other,lohse,0,0,10,22.9,15.8,,10,27.8,15.5,,,,,,0.5,4.9,15.65071883,,15.8,0.313084661,,0.914285714,0.286248833,Term G OK,All OK,,0.1049011,,0.087688756,11.40397065,,,
42,17,cauraugh2003,cauraugh,2003,exp,36,bilateral arm training + 5s stimulation,http://www.ncbi.nlm.nih.gov/pubmed/14568122,USA,FL,gainesville,6,6,Time 50 OK,6,1,14,,66.4,75th Percentile,,1022,>1year,2.8,0,,,,,,,,,,,,,,,,,,,,,,,0,box and block test,ue,,,other,lohse,0,0,10,15.7,10.12,,10,19.5,7.59,,,,,,0.5,3.8,8.944900782,,10.12,0.424823046,,0.914285714,0.388409642,Term G OK,All OK,,0.109023731,,0.091134939,10.9727401,,,
41,17,cauraugh2003,cauraugh,2003,ctrl,35,bilateral arm training,http://www.ncbi.nlm.nih.gov/pubmed/14568122,USA,FL,gainesville,6,6,Time 50 OK,6,1,14,,66.4,75th Percentile,,1022,>1year,2.8,0,,,,,,,,,,,,,,,,,,,,,,,0,box and block test,ue,,,other,lohse,0,0,6,15.1,7.8,,6,14.5,11.3,,,,,,0.5,-0.6,9.709016428,,7.8,-0.061798227,,0.842105263,-0.052040612,Term G OK,All OK,,0.166984918,,0.118415898,8.44481203,,,
673,185,vistin1998,vistin,1998,exp,421,BWSTT,http://www.ncbi.nlm.nih.gov/pubmed/9626282,Canada,quebec,montreal,7.92,7.92,Time 50 OK,7.92,1,42,90,66.5,75th Percentile,,68.1,<90days,0.186575342,0,,,,,,,,,,,23.3,,,,,,,,,,,,7,bbs,le,,balance,balance,lohse,0,0,50,23.3,15.3,,43,35.1,15.27,,,43,40.4,20.65,0.5,11.8,15.28616116,17.1,17.96827332,0.771940049,0.95167742,0.984615385,0.760064048,Term G OK,All OK,0.937036229,0.025958914,0.029056899,0.025166323,39.73564195,0.028169718,,
601,166,sullivan2002,sullivan,2002,exp,377,BWSTT at variable speed,http://www.ncbi.nlm.nih.gov/pubmed/11994808,USA,CA,los angeles,4,4,Time 50 OK,4,3,28,118,66.5,75th Percentile,,828,>1year,2.268493151,0,,28.7,,,,,,,,,,,,,,,,,,,,,0,10mwt SSV,le,,speed,speed,lohse,1,0,8,0.52,0.31,,8,0.59,0.34,,,8,0.63,0.4,0.5,0.07,0.32534597,0.11,0.357840747,0.215155578,0.307399314,0.888888889,0.191249402,Term G OK,All OK,0.273243835,0.127893245,0.130905896,0.101051453,9.89594875,0.103431819,,
397,115,ng2008,ng,2008,exp,256,electromechanical gait training,http://stroke.ahajournals.org/content/39/1/154.short,China,hong kong,hong kong,50,50,Time 50 OK,50,1,28,180,66.6,75th Percentile,11.3,18.9,<90days,0.051780822,1,,>21,,,,,<3,,,,,,,,,,,,,,,,0,fim,,,,other,lohse,0,1,17,78.6,12,,17,103.2,17.6,,,17,107.2,15.1,0.5,24.6,15.06253631,28.6,13.638365,1.633191084,2.097025559,0.952380952,1.55542008,Term G OK,All OK,1.997167199,0.137273915,0.188162241,0.124511488,8.031387433,0.170668699,,
672,185,vistin1998,vistin,1998,ctrl,420,treadmill walking with full weight bearing,http://www.ncbi.nlm.nih.gov/pubmed/9626282,Canada,quebec,montreal,7.92,7.92,Time 50 OK,7.92,1,42,90,66.7,75th Percentile,,78.4,<90days,0.214794521,0,,,,,,,,,,,21.9,,,,,,,,,,,,14,bbs,le,,balance,balance,lohse,0,0,50,21.9,16.6,,36,27.76,21.3,,,36,34.35,21.3,0.5,5.86,18.70242854,12.45,18.70242854,0.313328292,0.665688949,0.984615385,0.308507857,Term G OK,All OK,0.655447581,0.020981746,0.024431418,0.02034112,49.16150143,0.023685464,,
161,48,GAPS Group2004,GAPS Group,2004,ctrl,103,conventional therapy,http://www.ncbi.nlm.nih.gov/pubmed/15293487,UK,glasgow,glasgow,11.66666667,11.66666667,Time 50 OK,11.66666667,1,28,180,67,75th Percentile,,40,<90days,0.109589041,1,,,,,,,,10.3,,100,,,,,,4.6,,,0.628571429,,,,0,motricity,,,,other,lohse,0,1,35,100,43,,35,111,45,,,34,121,51,0.5,11,44.01136217,21,47.11038166,0.249935459,0.445761619,0.977777778,0.244381338,Term G OK,All OK,0.435855805,0.029463825,0.031410049,0.028168871,35.50018032,0.030029558,Yes,
311,93,lee2008,lee,2008,exp,204,cycling + sham progressive resistence training,http://www.ncbi.nlm.nih.gov/pubmed/18422947,Australia,sydney,sydney,15,15,Time 50 OK,15,1,77,,67.2,Remaining,10.6,1572,>1year,4.306849315,1,,,,,,,,,,,,,,,,,,,,,,,2,6minwt,le,,capacity,capacity,lohse,0,1,12,249.3,158.3,,12,261.5,162.7,,,,,,0.5,12.2,160.5150772,,158.3,0.076005321,,0.930232558,0.070702624,Term G OK,All OK,,0.083574034,,0.072319337,13.82756039,,,
58,22,cooke2010,cooke,2010,exp,48,CPT+CPT,http://www.ncbi.nlm.nih.gov/pubmed/19704158,UK,norfolk,norwich,23,23,Time 50 OK,23,1,42,84,67.5,Remaining,,32.43,<90days,0.088849315,1,,,,,,,,,,>28,,,,,,28.9,,,,,,,3,10mwt,le,,speed,speed,lohse,1,1,35,0.27,0.36,,32,0.55,0.49,0,0,28,0.59,0.48,0.5,0.28,0.426966041,0.32,0.417392373,0.65578986,0.766664703,0.977777778,0.641216752,Term G OK,All OK,0.749627709,0.034715148,0.036968211,0.033189396,30.13010541,0.035343435,Yes,
86,32,di lauro2003,di lauro,2003,ctrl,68,conventional therapy,http://www.ncbi.nlm.nih.gov/pubmed/14586603,Italy,naples,naples,10.5,10.5,Time 50 OK,10.5,1,14,180,67.6,Remaining,,1,<90days,0.002739726,1,10.6,,,,,,,1.4,,,,,,,,,,,,,,,3,bartel,,,,other,lohse,0,0,29,1.5,1.5,,26,3.2,2.6,0,0,22,7.7,3,0.5,1.7,2.092213777,6.2,2.267786838,0.812536471,2.733943021,0.972972973,0.790576026,Term G OK,All OK,2.66005267,0.045865785,0.16335249,0.043420056,23.03083165,0.154641949,Yes,
386,112,morris2008,morris,2008,ctrl,247,unilateral arm training,http://www.ncbi.nlm.nih.gov/pubmed/18586126,UK,dundee,dundee,10,10,Time 50 OK,10,4,42,126,67.8,Remaining,,23.2,<90days,0.063561644,1,,,,,,,,,65.7,,,,,5.5,,4.3,,,,,,,4,arat,ue,arat,,arat,lohse,1,0,50,18.5,17.2,,46,34.3,19.8,,,39,37.6,21.2,0.5,15.8,18.49035401,19.1,19.05071272,0.854499594,1.002587162,0.984615385,0.841353447,Term G OK,All OK,0.987162744,0.027301696,0.03005181,0.026468105,37.78132209,0.029134252,,
509,144,rabadi2008,rabadi,2008,ctrl,327,conventional occupational and physical therapy,http://www.ncbi.nlm.nih.gov/pubmed/19052246,USA,OK,oklahoma city,74,74,Time 50 OK,74,1,30.95,,67.8,Remaining,12.66,22.5,<90days,0.061643836,1,,16,,40.3,,,,,,6.1,,,,,,,,1,,,,,0,fma - shoulder elbow scale,ue,fma,,fma,lohse,1,0,10,5.2,6.56,,10,9.05,6.039950331,,,,,,0.5,3.85,6.305339008,,6.56,0.610593656,,0.914285714,0.558257057,Term G OK,All OK,,0.118641231,,0.099174384,10.08324892,,,
387,112,morris2008,morris,2008,exp,248,bilateral task specific training,http://www.ncbi.nlm.nih.gov/pubmed/18586126,UK,dundee,dundee,10,10,Time 50 OK,10,4,42,126,67.9,Remaining,,22.6,<90days,0.061917808,1,,,,,,,,,58.5,,,,,2,,3.4,,,,,,,5,arat,ue,arat,,arat,lohse,1,0,56,13.4,15.3,,51,27.9,19.5,,,46,29,21.9,0.5,14.5,17.42670365,15.6,18.56270454,0.832056383,0.84039478,0.98630137,0.82065835,Term G OK,All OK,0.828882523,0.024038552,0.024163066,0.023384472,42.7634201,0.023505598,,
548,151,sackley1997,sackley,1997,ctrl,343,balance training without visual feedback,http://www.ncbi.nlm.nih.gov/pubmed/9442992,UK,nottingham,nottingham,12,12,Time 50 OK,12,1,28,84,67.9,Remaining,,131.8,<1year,0.36109589,0,,,,,,,,,,,,,,,,10.2,,,,,,,1,rivermead motor assessment,,,,other,lohse,0,0,13,10.2,4.1,,12,12.7,4.5,,,12,15.5,4.7,0.5,2.5,4.295953607,5.3,4.397182893,0.58194297,1.205317161,0.936170213,0.544797674,Term G OK,All OK,1.128382023,0.08994837,0.132799595,0.078832071,12.68519255,0.116387512,,
162,48,GAPS Group2004,GAPS Group,2004,exp,104,CPT + CPT,http://www.ncbi.nlm.nih.gov/pubmed/15293487,UK,glasgow,glasgow,23.33333333,23.33333333,Time 50 OK,23.33333333,1,28,180,68,Remaining,,35,<90days,0.095890411,1,,,,,,,,11.8,,110,,,,,,5.2,,,0.685714286,,,,1,motricity,,,,other,lohse,0,1,35,110,43,,34,119,46,,,32,124,42,0.5,9,44.50289275,14,42.52601014,0.202234045,0.329210287,0.977777778,0.197739955,Term G OK,All OK,0.321894503,0.029155694,0.030119706,0.027874284,35.87536096,0.028795926,Yes,
89,33,dias2007,dias,2007,ctrl,71,conventional therapy using the bobath method,http://www.ncbi.nlm.nih.gov/pubmed/18084173,Portugal,lisbon,lisbon,16.67,16.67,Time 50 OK,16.67,1,35,90,68,Remaining,10.69,1453.5,>1year,3.982191781,0,,>19,,,,,,,,56.2,34.6,,,,,10,,,,,,,0,motricity index -le,le,,,other,lohse,1,0,20,56.2,10.46,1,20,59.91,,1,0,20,61.24,,0.5,3.71,10.46,5.04,10.46,0.354684512,0.481835564,0.96,0.340497132,Term G OK,All OK,0.462562141,0.053145028,0.055804138,0.048978457,20.41713972,0.051429093,Yes,Difference scores are divided by the standard deviation at baseline
37,15,burgar2011,burgar,2011,ctrl,31,standard care,http://www.ncbi.nlm.nih.gov/pubmed/21674393,USA,TX,temple,9.4,9.4,Time 50 OK,9.4,1,21,180,68.1,Remaining,,10.6,<90days,0.029041096,1,,>22,,26.9,,,,,,,,,,,,,,0.33,,,,,6,fma,ue,fma,,fma,lohse,1,0,18,24.2,20.3646753,1,18,38.2,,1,0,12,39.5,,0.5,14,20.3646753,15.3,20.3646753,0.687464926,0.751300955,0.955223881,0.656682915,Term G OK,All OK,0.717660614,0.068683556,0.071234809,0.062670494,15.95647228,0.064998391,Yes,
240,72,johannsen2010,johannsen,2010,exp,158,bilateral arm training with auditory cuing,http://www.ncbi.nlm.nih.gov/pubmed/19822721,UK,birmingham,birmingham,7.5,7.5,Time 50 OK,7.5,1,42,90,68.1,Remaining,10.19,2253,>1year,6.17260274,1,,,,,,,,,,,,,,,,,,,,,,,2,fma ue,ue,fma,,fma,lohse,1,0,10,37.41,21.72,1,10,42.41,,1,0,10,38.51,,0.5,5,21.72,1.1,21.72,0.230202578,0.050644567,0.914285714,0.210470929,Term G OK,All OK,0.046303604,0.102649661,0.100128244,0.085806737,11.65409658,0.083699038,,change means and standard deviations calculated from figures
586,161,smania2012,smania,2012,ctrl,364,conventional therapy,http://www.ncbi.nlm.nih.gov/pubmed/22661278,Italy,verona,verona,20,20,Time 50 OK,20,1,14,90,68.25,Remaining,,281.4,<1year,0.770958904,1,,>23,,,,,,,,"<11,>26",,,,,,,0.74,,,,,,3,wmft,ue,wmft,,wmft,lohse,0,1,29,2.4,0.81,,29,2.92,0.86,,,29,3.01,0.75,0.5,0.52,0.835374168,0.61,0.78057671,0.622475557,0.781473483,0.972972973,0.605651893,Term G OK,All OK,0.760352578,0.041163376,0.045012083,0.038968397,25.66182027,0.042611877,Yes,
375,110,morone2011,morone,2011,exp,244,robot assisted therapy for the high motricity group,http://www.ncbi.nlm.nih.gov/pubmed/21444654,Italy,rome,rome,60,60,Time 50 OK,60,1,28,96.33,68.33,Remaining,13.35,21.92,<90days,0.060054795,1,,>24,,,,,0,,,52,,,,,,,,1.75,,,,,4,fac,le,,,other,lohse,1,1,12,0,0.43,,12,2.2,0.8,,,12,3.59,1.1,0.5,2.2,0.642222703,3.59,0.83513472,3.425602973,4.29870764,0.930232558,3.186607417,Term G OK,All OK,3.998797805,0.572281489,0.853286974,0.495213836,2.019329686,0.738377046,,
115,39,duncan2003,duncan,2003,exp,85,home exercise program,http://www.ncbi.nlm.nih.gov/pubmed/12920254,USA,FL,gainesville,50.66,50.66,Time 50 OK,50.66,3,84,,68.5,Remaining,9,77.5,<90days,0.212328767,1,,,,,,,,,,,,,,,,,,,,,,,6,fma-ue,ue,fma,,fma,lohse,0,1,44,24.1,3.7,1,44,26.84,,,,,,,0.5,2.74,3.7,,3.7,0.740540541,,0.98245614,0.727548601,Term G OK,All OK,,0.028959094,,0.027951899,35.77574461,,Yes,
171,52,globas2012,globas,2012,exp,111,high intensity treadmill training,http://www.ncbi.nlm.nih.gov/pubmed/21885867,Switzerland,zurich,zurich,19.5,19.5,Time 50 OK,19.5,2,90,365,68.6,Remaining,6.7,1800,>1year,4.931506849,1,4.2,,,,,,,,91.7,,,,,,,13.2,,,,,,,2,6minwt,le,,capacity,capacity,lohse,0,1,18,274.4,113,,18,332.1,138,,,18,305.9,158,0.5,57.7,126.1209737,31.5,137.3553785,0.457497261,0.229332119,0.955223881,0.437012309,Term G OK,All OK,0.219063517,0.061369548,0.057016478,0.055996808,17.85816077,0.052024837,Yes,
285,85,kwakkel/kwakkel1999/2002,kwakkel,1999,exp,187,arm intensive therapy + CPT,http://www.ncbi.nlm.nih.gov/pubmed/10421300,Netherlands,amsterdam,amsterdam,114.5,114.5,Time 50 OK,114.5,2,140,364,69,Remaining,9.8,7.2,<90days,0.02,1,,27,,,,,,,,,,,15,,,,,,,,,4.4,4,10mwt SSV,le,,speed,speed,lohse,0,1,33,0,0,,33,0.55,0.46,,,33,0.59,0.44,0.5,0.55,0.46,0.59,0.44,1.195652174,1.340909091,0.976377953,1.167408422,Term G OK,All OK,1.309234073,0.051963396,0.057546018,0.049537428,20.18675657,0.054859419,Yes,0 SD at baseline; FU is added from Kwakkel et al 2002
511,144,rabadi2008,rabadi,2008,exp,329,arm ergometer training,http://www.ncbi.nlm.nih.gov/pubmed/19052246,USA,OK,oklahoma city,82.7,82.7,Time 50 OK,82.7,1,34.92,,69.2,Remaining,10.22,22.2,<90days,0.060821918,1,,17,,42.3,,,,,,9.4,,,,,,,,1.2,,,,,0,fma - shoulder elbow scale,ue,fma,,fma,lohse,1,0,10,7.8,4.18,,10,6.92,4.490434277,,,,,,0.5,-0.88,4.337994929,,4.18,-0.202858697,,0.914285714,-0.185470809,Term G OK,All OK,,0.102057583,,0.085311808,11.7217068,,,arm ergometer training could arguably coded as less time in therapy as it is more exercise than task specific practice
183,55,harris2009,harris,2009,ctrl,119,usual care,http://www.ncbi.nlm.nih.gov/pubmed/19359633,Canada,vancouver,vancouver,31.2,31.2,Time 50 OK,31.2,2,28,118,69.3,Remaining,11.7,20.8,<90days,0.056986301,1,,26.9,,,,,,,,,,,,,,,,,,,,,0,Chedoke Arm Hand,,,,other,lohse,1,1,50,32.7,17.2,,50,40.1,14.7,,,50,45.4,7.9,0.5,7.4,15.99890621,12.7,13.38375881,0.462531619,0.948911302,0.984615385,0.455415748,Term G OK,All OK,0.934312666,0.022139355,0.029004327,0.021463384,46.59097559,0.028118751,,SD was estimated from CI at follow up
87,32,di lauro2003,di lauro,2003,exp,69,CPT + CPT,http://www.ncbi.nlm.nih.gov/pubmed/14586603,Italy,naples,naples,28,28,Time 50 OK,28,1,14,180,69.3,Remaining,,1,<90days,0.002739726,1,10.8,,,,,,,1.5,,,,,,,,,,,,,,,4,bartel,,,,other,lohse,0,0,31,1.4,1.4,,27,3.2,2,0,0,24,8,2.8,0.5,1.8,1.705034562,6.6,2.124075826,1.055697075,3.107233706,0.974789916,1.029082863,Term G OK,All OK,3.028900083,0.050233812,0.187982279,0.04773294,20.9498933,0.178623653,Yes,
182,55,harris2009,harris,2009,exp,118,supplementary arm and hand therapy plus usual care,http://www.ncbi.nlm.nih.gov/pubmed/19359633,Canada,vancouver,vancouver,43.2,43.2,Time 50 OK,43.2,2,28,118,69.4,Remaining,15.3,20.5,<90days,0.056164384,1,,26.7,,,,,,,,,,,,,,,,,,,,,0,Chedoke Arm Hand,,,,other,lohse,1,1,53,32.6,15.3,,53,46.7,14.7,,,53,45.4,14.7,0.5,14.1,15.0029997,12.8,15.0029997,0.939812056,0.853162718,0.985507246,0.926191592,Term G OK,All OK,0.840798041,0.027200441,0.025734779,0.026417735,37.85335874,0.024994249,,SD was estimated from CI at follow up
305,90,lau2011,lau,2011,exp,198,progressive increases in treadmill speed within a session,http://www.ncbi.nlm.nih.gov/pubmed/21698340,China,hong kong,hong kong,20,20,Time 50 OK,20,1,14,,69.5,Remaining,,12.9,<90days,0.035342466,0,,>23,,,,,,,,,,,,,,,,0 or 1,,,,,2,10mwt SSV,le,,speed,speed,lohse,0,0,15,0.28,0.19,,13,0.64,0.32,,,,,,0.5,0.36,0.258263431,,0.19,1.393925567,,0.945454545,1.317893263,Term G OK,All OK,,0.131434283,,0.117487042,8.511576962,,,
8,3,ada2013,ada,2013,exp,6,four months of walking training,http://www.ncbi.nlm.nih.gov/pubmed/23464674,Australia,new south wales,sydney,24,24,Time 50 OK,24,1,120,365,70,Remaining,,660,>1year,1.808219178,0,,,,,,,,,,,,,,,,,,,,,,,0,6minwt,le,,capacity,capacity,lohse,1,1,34,232,124,,34,289,131,,,34,250,130,0.5,57,127.5480302,18,127.0354281,0.446890477,0.141692757,0.977099237,0.436656344,Term G OK,All OK,0.138447884,0.032348693,0.029707012,0.030884038,32.37918565,0.028361965,,
114,39,duncan2003,duncan,2003,ctrl,84,standard care,http://www.ncbi.nlm.nih.gov/pubmed/12920254,USA,FL,gainesville,28.65,28.65,Time 50 OK,28.65,3,84,,70.2,Remaining,11.4,73.5,<90days,0.201369863,1,,,,,,,,,,,,,,,,,,,,,,,2,fma-ue,ue,fma,,fma,lohse,0,1,48,23.7,3.5,1,48,25.46,,,,,,,0.5,1.76,3.5,,3.5,0.502857143,,0.983957219,0.494789916,Term G OK,All OK,,0.023467347,,0.022720424,44.01326313,,Yes,
88,33,dias2007,dias,2007,exp,70,bodyweight supported treadmill training,http://www.ncbi.nlm.nih.gov/pubmed/18084173,Portugal,lisbon,lisbon,16.67,16.67,Time 50 OK,16.67,1,35,90,70.35,Remaining,7.36,1413,>1year,3.871232877,0,,>19,,,,,,,,51.5,36.85,,,,,10.55,,,,,,,0,motricity index - le,le,,,other,lohse,1,0,20,51.5,14.02,1,20,54.63,,1,0,20,59.95,,0.5,3.13,14.02,8.45,14.02,0.223252496,0.602710414,0.96,0.214322397,Term G OK,All OK,0.578601997,0.051246042,0.059081496,0.047228352,21.17372209,0.054449507,Yes,Difference scores are divided by the standard deviation at baseline
599,166,sullivan2002,sullivan,2002,exp,375,BWSTT at slow speed,http://www.ncbi.nlm.nih.gov/pubmed/11994808,USA,CA,los angeles,4,4,Time 50 OK,4,3,28,118,70.9,Remaining,,675,>1year,1.849315068,0,,27,,,,,,,,,,,,,,,,,,,,,0,10mwt SSV,le,,speed,speed,lohse,1,0,8,0.53,0.29,,8,0.59,0.36,,,8,0.69,0.45,0.5,0.06,0.326879183,0.16,0.378549865,0.183554057,0.422665585,0.888888889,0.163159161,Term G OK,All OK,0.375702742,0.127105756,0.136165387,0.100429239,9.957259559,0.107587467,,
553,153,salbach/higgins2004/2006,salbach,2004,exp,348,functional lower extremity training,http://www.ncbi.nlm.nih.gov/pubmed/15293485,Canada,quebec,montreal,18,18,Time 50 OK,18,1,42,,71,Remaining,12,239,<1year,0.654794521,1,,,,,,,,,,,42,,,,,,,,,,,,3,6minwt,le,,capacity,capacity,lohse,0,1,44,209,126,,44,249,136,,,,,,0.5,40,131.0953851,,126,0.305121343,,0.98245614,0.299768337,Term G OK,All OK,,0.023785216,,0.022957968,43.55786192,,,
388,113,mudge2009,mudge,2009,ctrl,249,group social and educational classes,http://www.ncbi.nlm.nih.gov/pubmed/19969159,New zealand,auckland,auckland,0,0,Time 50 OK,0,1,28,90,71,Remaining,,2117,>1year,5.8,0,,,,,,,,,,,,,,,,,,,,,,,2,10mwt SSV,le,,speed,speed,lohse,0,1,27,0.62,0.27,,27,0.63,0.25,,,27,0.63,0.25,0.5,0.01,0.260192237,0.01,0.260192237,0.038433122,0.038433122,0.970873786,0.037313711,Term G OK,All OK,0.037313711,0.037064391,0.037064391,0.034936743,28.62316044,0.034936743,,
59,22,cooke2010,cooke,2010,exp,49,CPT+FST,http://www.ncbi.nlm.nih.gov/pubmed/19704158,UK,norfolk,norwich,23.5,23.5,Time 50 OK,23.5,1,42,84,71.2,Remaining,,33.86,<90days,0.092767123,1,,,,,,,,,,>28,,,,,,30.3,,,,,,,0,10mwt,le,,speed,speed,lohse,1,1,36,0.23,0.29,,36,0.42,0.39,0,0,29,0.46,0.37,0.5,0.19,0.343656806,0.23,0.327973576,0.552877164,0.701276007,0.978417266,0.540944563,Term G OK,All OK,0.686140554,0.032023238,0.034608167,0.030655857,32.62019392,0.03313041,Yes,
101,36,dromerick2000,dromerick,2000,ctrl,77,standard care,http://www.ncbi.nlm.nih.gov/pubmed/11108760,USA,MO,st. louis,20,20,Time 50 OK,20,1,14,,71.4,Remaining,,0,NA,0,1,7.5,23.5,,,,,,,,,,,,>3,,,,,,,,,0,arat,ue,arat,,arat,lohse,1,0,9,27.9,20.7,,9,44.3,11.1,,,,,,0.5,16.4,16.60873264,,20.7,0.987432356,,0.903225806,0.891874386,Term G OK,All OK,,0.165279037,,0.134837424,7.416338657,,Yes,
727,201,wuB2007,wuB,2007,ctrl,457,modified CIMT,http://www.ncbi.nlm.nih.gov/pubmed/17321816,Taiwan,taipei,taipei,120,75,Time 50 OK,30,1,21,,71.44,Remaining,,201,<1year,0.550684932,0,,,82.92,,4.5,,,,,,,,,,,,,0.26,,,,,0,fma-ue,ue,fma,,fma,lohse,1,0,13,41.85,11.33,,13,49.54,12.84,,,,,,0.5,7.69,12.10856102,,11.33,0.635087851,,0.936170213,0.594550329,Term G OK,All OK,,0.092436022,,0.081012286,12.34380672,,,
726,201,wuB2007,wuB,2007,ctrl,456,traditional rehabilitation,http://www.ncbi.nlm.nih.gov/pubmed/17321816,Taiwan,taipei,taipei,30,30,Time 50 OK,30,1,21,,71.94,Remaining,,249.6,<1year,0.683835616,0,,,83.06,,4.5,,,,,,,,,,,,,0.32,,,,,0,fma-ue,ue,fma,,fma,lohse,1,0,13,47.08,10.94,,13,49.38,10.18,,,,,,0.5,2.3,10.56683491,,10.94,0.21766215,,0.936170213,0.203768821,Term G OK,All OK,,0.078745262,,0.069013503,14.48991801,,,
678,187,wade1992,wade,1992,ctrl,424,delayed physiotherapy,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1881332/,UK,oxford,oxford,0,0,Time 50 OK,0,1,,,72,Remaining,,1788,>1year,4.898630137,0,,,,,,,4,,,,,,,,,,,,,,,,4,10mwt,le,,speed,speed,lohse,0,0,43,44.3,37.2,,39,47.9,38.6,,,,,,0.5,3.6,37.87145363,,37.2,-0.095058406,,0.982035928,-0.09335077,Term G OK,All OK,,0.023360885,,0.02252911,44.38701751,,,sign reversed for time measure; data only taken up to the 28 week assessment
278,84,kuys2011,kuys,2011,ctrl,184,conventional therapy,http://www.ncbi.nlm.nih.gov/pubmed/20921032,Australia,brisbane,brisbane,30,30,Time 50 OK,30,2,42,126,72,Remaining,17,49,<90days,0.134246575,0,,28,,,,,,,80,,,,,"<4,5,6",,,,,,,,,0,10mwt,le,,speed,speed,lohse,0,1,15,0.58,0.36,,15,0.68,0.37,0,0,12,0.66,0.41,0.5,0.1,0.365034245,0.08,0.382805434,0.273946901,0.208983449,0.945454545,0.259004342,Term G OK,All OK,0.197584352,0.06916823,0.068122469,0.061828395,16.17379846,0.060893606,Yes,"The authors report and intention to treat analysis, but according to their tables, it does not look like missing data were carried forward."
352,105,mcclellan2004,mcclellan,2004,ctrl,231,"upper body exercises serving as ""sham"" mobility training",http://www.ncbi.nlm.nih.gov/pubmed/15482247,Australia,sydney,sydney,0,0,Time 50 OK,0,1,42,98,72,Remaining,,135,<1year,0.369863014,0,,,,,,,,,,,,,,,,,,,,,,,2,standing functiol reach,ue,,,other,lohse,0,0,10,20.5,5.3,,9,17.8,7.4,,,10,17.7,8.4,0.5,-2.7,6.374997116,-2.8,7.02317592,-0.423529603,-0.398680032,0.914285714,-0.387227066,Term G OK,All OK,-0.364507458,0.108968866,0.107947288,0.091089077,10.97826472,0.090235121,,"arm training was counted as 0 hours because mobility was the outcome (""sham"" training)"
304,90,lau2011,lau,2011,ctrl,197,gait training on the treadmill at steady speed,http://www.ncbi.nlm.nih.gov/pubmed/21698340,China,hong kong,hong kong,20,20,Time 50 OK,20,1,14,,72.1,Remaining,,12.7,<90days,0.034794521,0,,>23,,,,,,,,,,,,,,,,0 or 1,,,,,2,10mwt SSV,le,,speed,speed,lohse,0,0,15,0.3,0.19,,13,0.52,0.21,,,,,,0.5,0.22,0.199480093,,0.19,1.102866939,,0.945454545,1.04271056,Term G OK,All OK,,0.107210516,,0.095833797,10.43473212,,,
84,31,desrosiers2005,desrosiers,2005,exp,66,cpt + repetition of unilateral and symmetrical tasks,http://www.ncbi.nlm.nih.gov/pubmed/16180593,Canada,quebec,sherbrooke,15,15,Time 50 OK,15,1,35,,72.2,Remaining,,34.2,<90days,0.09369863,1,,,83.5,124.1,,,,,,,,,,,,,,,,10.1,,,3,fma-ue,ue,fma,,fma,lohse,0,0,20,42.9,20,,17,46.1,18.4,0,,,,,0.5,3.2,19.28504972,,20,0.165931644,,0.96,0.159294378,Term G OK,All OK,,0.050688333,,0.046714367,21.40669058,,Yes,
98,35,donaldson2009,donaldson,2009,ctrl,74,conventional therapy,http://www.ncbi.nlm.nih.gov/pubmed/19109444,UK,east anglia,norwich,2.81,2.81,Time 50 OK,2.81,3,42,72,72.6,Remaining,,13.4,<90days,0.036712329,1,,,,,,,,,,,,,,,,,,,,,,,2,arat,ue,arat,,arat,lohse,1,1,10,34,13.35664629,,8,45,13.93,,,5,,,0.5,11,13.61046082,,13.35664629,0.808201878,,0.914285714,0.738927432,Term G OK,All OK,,0.132659514,,0.110892524,9.017740457,,Yes,
100,35,donaldson2009,donaldson,2009,exp,76,CPT + FST,http://www.ncbi.nlm.nih.gov/pubmed/19109444,UK,east anglia,norwich,17.7,17.7,Time 50 OK,17.7,3,42,72,72.6,Remaining,,21.7,<90days,0.059452055,1,,,,,,,,,,,,,,,,,,,,,,,0,arat,ue,arat,,arat,lohse,1,1,10,26,9.295160031,,10,43.6,18.9,,,8,,,0.5,17.6,14.89311922,,9.295160031,1.181753785,,0.914285714,1.080460603,Term G OK,All OK,,0.1698271,,0.141961592,7.044158817,,Yes,
552,153,salbach/higgins2004/2006,salbach,2004,ctrl,347,upper extremity therapy,http://www.ncbi.nlm.nih.gov/pubmed/15293485,Canada,quebec,montreal,0,0,Time 50 OK,0,1,42,,73,Remaining,8,217,<1year,0.594520548,1,,,,,,,,,,,40,,,,,,,,,,,,4,6minwt,le,,capacity,capacity,lohse,0,1,47,204,131,,47,209,132,,,,,,0.5,5,131.5009506,,131,0.038022539,,0.983606557,0.037399219,Term G OK,All OK,,0.021291976,,0.0205996,48.54463193,,,"upper extremity therapy was given when lower extremity funciton was the outcome, coded as 0 hours of therapy."
99,35,donaldson2009,donaldson,2009,exp,75,CPT + CPT,http://www.ncbi.nlm.nih.gov/pubmed/19109444,UK,east anglia,norwich,13.8,13.8,Time 50 OK,13.8,3,42,72,73.3,Remaining,,25.6,<90days,0.070136986,1,,,,,,,,,,,,,,,,,,,,,,,0,arat,ue,arat,,arat,lohse,1,1,10,33.7,14.72446943,,10,41.8,17.83,,,6,,,0.5,8.1,16.35112993,,14.72446943,0.495378609,,0.914285714,0.452917585,Term G OK,All OK,,0.112269998,,0.093848554,10.65546519,,Yes,
396,115,ng2008,ng,2008,ctrl,255,conventional overground gait training,http://stroke.ahajournals.org/content/39/1/154.short,China,hong kong,hong kong,50,50,Time 50 OK,50,1,28,180,73.4,Remaining,11.5,17.5,<90days,0.047945205,1,,>21,,,,,<3,,,,,,,,,,,,,,,,0,fim,,,,other,lohse,0,1,21,78.6,8.9,,21,98.2,14.3,,,21,102.5,16.5,0.5,19.6,11.91007976,23.9,13.25631925,1.645664881,1.802913731,0.962025316,1.583171278,Term G OK,All OK,1.734448653,0.112100307,0.125011855,0.103748017,9.638738445,0.115697561,,
298,88,langhammer2010,langhammer,2010,ctrl,193,treadmill therapy + CPT,http://www.ncbi.nlm.nih.gov/pubmed/20026572,Norway,oslo,oslo,35.85,35.85,Time 50 OK,35.85,3,15.9,,74,Remaining,13.3,419,>1year,1.147945205,0,,,,,,,,,,,,,,5.4,,,,,,,,,3,6minwt,le,,capacity,capacity,lohse,0,1,21,277.7,139.9,,21,320.6,153.8,,,,,,0.5,42.9,147.01437,,139.9,0.291808209,,0.962025316,0.280726884,Term G OK,All OK,,0.049646477,,0.045947452,21.76399248,,Yes,
85,31,desrosiers2005,desrosiers,2005,ctrl,67,CPT dosage matched to experimental group,http://www.ncbi.nlm.nih.gov/pubmed/16180593,Canada,quebec,sherbrooke,15,15,Time 50 OK,15,1,35,,74.3,Remaining,,35.4,<90days,0.096986301,1,,,86.1,117.3,,,,,,,,,,,,,,,,11.6,,,5,fma-ue,ue,fma,,fma,lohse,0,0,21,47,16.1,,16,51.3,14.1,0,,,,,0.5,4.3,15.27495616,,16.1,0.281506536,,0.962025316,0.270816415,Term G OK,All OK,,0.049505855,,0.045817308,21.82581307,,Yes,
541,150,rydwik2006,rydwik,2006,exp,342,"""stimulo"" device",http://www.ncbi.nlm.nih.gov/pubmed/16944822,Sweden,jrflla,jrflla,9,9,Time 50 OK,9,1,42,84,74.9,Remaining,8.7,1278,>1year,3.501369863,1,,,,,,,,,,,,,,,,,,,,,,,1,TUG,le,,,other,lohse,0,0,9,25,12,,8,23,9,,,4,,,0.5,-2,10.70513895,,12,0.18682616,,0.903225806,0.168746209,Term G OK,All OK,,0.113050223,,0.092228278,10.84266151,,Yes,sign reversed for time measure
299,88,langhammer2010,langhammer,2010,exp,194,outdoor walking,http://www.ncbi.nlm.nih.gov/pubmed/20026572,Norway,oslo,oslo,41.5,41.5,Time 50 OK,41.5,3,16.9,,75,Remaining,10.4,349,<1year,0.956164384,0,,,,,,,,,,,,,,5.3,,,,,,,,,2,6minwt,le,,capacity,capacity,lohse,0,1,18,299.4,159.3,,18,310.1,164.4,,,,,,0.5,10.7,161.8700868,,159.3,0.066102392,,0.955223881,0.063142584,Term G OK,All OK,,0.055676931,,0.050802564,19.68404587,,Yes,
540,150,rydwik2006,rydwik,2006,ctrl,341,no therapy,http://www.ncbi.nlm.nih.gov/pubmed/16944822,Sweden,jrflla,jrflla,0,0,Time 50 OK,0,1,42,84,75.3,Remaining,4.9,1647,>1year,4.512328767,1,,,,,,,,,,,,,,,,,,,,,,,0,TUG,le,,,other,lohse,0,0,9,47,45,,9,44,40,,,9,,,0.5,-3,42.57346591,,45,0.070466426,,0.903225806,0.063647095,Term G OK,All OK,,0.111386973,,0.09087137,11.00456612,,Yes,sign reversed for time measure
389,113,mudge2009,mudge,2009,exp,250,circuit training,http://www.ncbi.nlm.nih.gov/pubmed/19969159,New zealand,auckland,auckland,12,12,Time 50 OK,12,1,28,90,76,Remaining,,1215.45,>1year,3.33,0,,,,,,,,,,,,,,,,,,,,,,,1,10mwt SSV,le,,speed,speed,lohse,0,1,31,0.76,0.3,,31,0.79,0.28,,,31,0.77,0.26,0.5,0.03,0.290172363,0.01,0.280713377,0.103386828,0.035623525,0.974789916,0.100780437,Term G OK,All OK,0.034725453,0.032430465,0.032278533,0.030815927,32.45075185,0.030671558,,
510,144,rabadi2008,rabadi,2008,exp,328,robot assisted therapy,http://www.ncbi.nlm.nih.gov/pubmed/19052246,USA,OK,oklahoma city,85.85,85.85,Time 50 OK,85.85,1,36.32,,79.5,Remaining,6.17,19,<90days,0.052054795,1,,16.56,,34.6,,,,,,5.9,,,,,,,,1,,,,,0,fma - shoulder elbow scale,ue,fma,,fma,lohse,1,0,10,5.8,3.79,,10,8.03,5.565608682,,,,,,0.5,2.23,4.761307594,,3.79,0.468358735,,0.914285714,0.4282137,Term G OK,All OK,,0.110967995,,0.092760185,10.78048734,,,
308,92,laver2012,laver,2012,ctrl,201,CPT,http://www.ncbi.nlm.nih.gov/pubmed/22409245,Australia,adelaide,adelaide,4.2,4.2,Time 50 OK,4.2,1,14.95,,84.6,Remaining,,2,<90days,0.005479452,0,,26.1,,,,,,,,,,,,,,,,,,,,,0,tug,le,,balance,balance,lohse,1,1,22,35.41,19.05,,22,28.86,11.71,,,,,,0.5,-6.55,15.81180888,,19.05,0.414247355,,0.963855422,0.399274559,Term G OK,All OK,,0.049354565,,0.045851244,21.80965908,,,sign reversed for time measure
309,92,laver2012,laver,2012,exp,202,balance training using Wii fit,http://www.ncbi.nlm.nih.gov/pubmed/22409245,Australia,adelaide,adelaide,4.2,4.2,Time 50 OK,4.2,1,12.3,,85.2,Remaining,,2,<90days,0.005479452,0,,26.23,,,,,,,,,,,,,,,,,,,,,2,tug,le,,balance,balance,lohse,1,1,22,37.95,18.77,,22,27.9,10.44,,,,,,0.5,-10.05,15.18727263,,18.77,0.661738302,,0.963855422,0.63782005,Term G OK,All OK,,0.055406763,,0.05147384,19.42734406,,,sign reversed for time measure
